Membrane Stress Resistance Mechanisms In Bacillus Subtilis by Kingston, Anthony
  
 
MEMBRANE STRESS RESISTANCE MECHANISMS IN BACILLUS SUBTILIS 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
by 
Anthony Walter Kingston 
January 2014
  
 
 
 
 
 
 
 
 
 
 
© 2014 Anthony Walter Kingston
 MEMBRANE STRESS RESISTANCE MECHANISMS IN BACILLUS SUBTILIS 
 
Anthony Kingston, Ph. D. 
Cornell University 2014 
 
Bacteria exist in environments that can inflict a variety of stresses upon the 
cell, many of which target the cell membrane. As a result, bacterial survival often 
depends upon the ability of cells to adjust the cell membrane in response to 
environmental stress.  This process is controlled by the cell envelope stress response 
(CESR), the signal transducing regulatory systems that allow cells to sense and 
respond to conditions that perturb the cell wall or membrane.
 
 In Bacillus subtilis, a 
major component of CESR is controlled by extracytoplasmic function sigma (ECF ) 
factors.  Numerous studies have associated ECF  factors with membrane stress 
adaptations, but the specific details concerning the effects of particular  factors on 
membrane composition and the underlying mechanisms involved are largely 
unknown.  Here, we investigate these details using B. subtilis as a model system. The 
majority of this work consists of two main projects.  In one project, I characterized a 
novel homeoviscous adaptation in which an ECF  promoter modifies fatty acid 
composition by regulating the membrane biosynthesis genes fabHa and fabF. The 
altered expression of these genes leads to a greater proportion of straight chain fatty 
acids in the membrane and an increase in average fatty acid chain length.  Such 
changes in the lipid profile of B. subtilis reduce membrane fluidity thereby conferring 
resistance against detergents and antimicrobial compounds produced by competing 
 Bacillus strains. The second project focuses on ECF  factor-mediated lantibiotic 
resistance mechanisms in B. subtilis.  I’ve identified six distinct lantibiotic resistance 
loci activated by ECF  factors.  These loci include genes encoding phage shock 
proteins, tellurite resistance related proteins, signal peptide peptidase, and proteins that 
synthesize and modify teichoic acids.  My work has made substantial progress on 
defining the resistance mechanisms associated with these genes.
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CHAPTER 1 
INTRODUCTION 
 
1.1: The cell envelope of Bacillus subtilis  
Most prokaryotes are enclosed in a cell envelope that serves as the primary line 
of defense against environmental stress (96). However, environments can abruptly 
change the stresses that they inflict upon the cell and bacteria must have mechanisms 
in place to adapt to these changes. The signal transducing regulatory systems that 
allow cells to sense and respond to conditions that perturb the cell wall or membrane 
are collectively known as the cell envelope stress response (CESR) (51). This chapter 
will summarize CESR mechanisms and relevant background information in Bacillus 
subtilis, a model Gram positive soil bacterium. As with most Gram positive bacteria, 
the cell envelope of B. subtilis consists of a phospholipid bilayer surrounded by a thick 
peptidoglycan cell wall interspersed with teichoic acids (Figure 1.1). 
 
1.1.1: The cell membrane 
The inner layer of the cell envelope is a protein-embedded lipid bilayer known 
as the plasma membrane (16). It completely surrounds the cytoplasm and primarily 
functions as a selectively permeable barrier responsible for regulating what enters and 
exits the cell. The plasma membrane is also involved in signal transduction, protein 
transport, division, and other essential processes. 
Most bacteria use the type II fatty acid synthase system (FAS II) to begin 
synthesizing membrane lipids. This pathway consists of an initiation phase followed  
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Figure 1.1: The Gram positive bacterial cell envelope. A. Overall organization of the 
cell envelope. B, C, & D. Detailed structures of B. peptidoglycan, C. membrane lipids, 
and D teichoic acids. GlcNAc and MurNAc refer to the repeating subunits of 
peptidoglycan, N-acetylglucosamine and N-acetylmuramic acid respectively. The R 
group of phospholipids represents H for phosphatidic acid (PA), CH2-CHOH-CH2OH 
for phosphatidylglycerol (PPG), CH2-CHOH-CH2-Lys for lysyl-phosphatidylglycerol 
(lys-PPG), and CH2-CH2-NH3
+
 for phosphatidylethanolamine (PE). The glycolipid 
shown has a single glucosyl residue, but di-, and tri-glucosyl residues are possible. 
The X group of newly synthesized teichoic acids is H, but can be modified to D-alanyl 
or -glycosyl for wall teichoic acid (WTA) and to D-alanyl, -GlcNAc, or -
Galactosyl for lipoteichoic acid (LTA). Adapted from (68) and (81). 
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by progressive elongation cycles (76, 104). The initiation phase is characterized by a 
key step in which a FabH enzyme catalyzes the condensation of an acyl-CoA with 
malonyl-ACP to form a ketoacyl-ACP. This ketoacyl-ACP serves as the first substrate 
for the elongation phase, a cyclic series of reactions that add two carbons to the 
growing FA chain for every round of elongation (104). In B. subtilis, each elongation 
cycle is initiated by FabF which condenses the growing ketoacyl-ACP product with 
malonyl-ACP until the fatty acid reaches the desired length, usually between 14 and 
18 carbons long (74). The long chain acyl-ACP products are then transferred to the 
membrane where acyltransferases convert them to phosphatidic acid (PA). PA is a 
phosphoglycerol containing two fatty acid chains that serves as a central intermediate 
in lipid synthesis. 
In B. subtilis, PA matures into either the phospholipids, 
phosphatidylethanolamine (PE), phosphatidylglycerol (PG), lysylphosphatidylglycerol 
(LPG), and cardiolipin (CL), or into various glycolipids (GL) (74). These lipid 
components are primarily differentiated by the structure and charge of their head 
groups. LPG maintains a net positive charge, PE and GL are neutral, and PG and CL 
have anionic character (25). In addition, CL is formed by the condensation of two PG 
molecules and is therefore much bulkier than the other lipids. The relative proportions 
of these different lipids are tightly regulated to maintain the optimum net charge and 
fluidity of the membrane relative to the extracellular environment (109). Lipid content 
is ~50% PE, 30% GL, 16% PG, 2.4% LPG, and 0.8% CL in actively growing cells 
(76), but PG and CL levels increase (to ~45% & 25%) and the amount of PE reduces 
(to 20%) as they approach stationary phase (60). Presumably, these adjustments are a 
 5 
 
response to changing environmental conditions associated with stationary phase (e.g. 
nutrient limitation). 
The plasma membrane displays substantial heterogeneity, with specific 
proteins and lipids aggregating in lipid domains (22, 61). These domains are known as 
lipid rafts and have been shown to play roles in sporulation, biofilm formation, signal 
transduction, and other cell processes. A key factor in the formation of these lipid rafts 
are the NfeD proteins (30). Bioinformatic analysis has shown that NfeD homologs are 
present in most bacterial genomes and typically associate with a member of the SPFH 
(stomatin-prohibitin-flotillin-HflC/K) protein family. This family includes flotillins 
which are central to the formation of lipid rafts in eukaryotes (88). B. subtilis contains 
two NfeD proteins, YuaF and YqeZ, which are co-transcribed with corresponding 
flotillin homologs, FloT (YuaG) and YqfA, respectively. Previous studies have shown 
that both FloT and YqfA localize to discrete foci in the membrane and contribute to 
lipid raft formation and function (22, 61). 
 
1.1.2: The cell wall 
The Gram positive cell wall is characterized by a thick outer layer of 
peptidoglycan consisting of N-acetylglucosamine (GlcNAc) N-acetylmuramic acid 
(MurNAc) disaccharide repeats (96). MurNAc is attached to a short peptide chain that 
can cross-link to the peptide chain of another peptidoglycan subunit to form a 
connected network of glycan strands across the entire cell. This network is essential 
for maintaining cell shape and preventing lysis due to the osmotic pressure of the 
cytoplasm.  
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Synthesis of the cell wall begins inside the cell. The MurA-F ligases initially 
produce uridine diphosphate N-acetylmuramic acid (UDP-MurNAc) pentapeptide 
(73). MraY then attaches this molecule to undecaprenyl phosphate carrier lipid (UP) to 
form lipid I (UPP-MurNAc). A GlcNAc molecule is subsequently transferred to lipid I 
by MurG to form lipid II which contains a complete PG subunit attached to 
undecaprenyl pyrophosphate (UPP). Lipid II translocates to the outer membrane where 
the PG subunit is exposed to high molecular weight penicillin binding proteins that 
have both transglycolase and transpeptidase activities. Transglycosylases incorporate 
the GlcNAc-MurNAc-pentapeptide from lipid II onto a peptidoglycan strand and 
transpeptidases cross-link the stem peptides. Meanwhile, UPP is recycled back to UP 
and transported to the cytoplasm. As peptidoglycan is synthesized, it is simultaneously 
broken down by peptidoglycan hydrolases called autolysins (28). This dynamic feature 
allows for cell growth, sporulation, motility, and other essential cell processes. 
In vegetative B.subtilis cells, the cell wall is approximately 10-20 layers thick 
and an individual PG polymer contains an average of 97 disaccharides (28). Each 
peptide side chain consists of L-Ala-D-Glu-mDAP-D-Ala-D-Ala with cross linking 
occuring between the 3
rd
 (mDAP) and 4th (D-Ala) amino acids of adjacent side 
chains. About 30% of PG side chains are cross-linked in non-stressed B. subtilis cells, 
but this percentage can vary depending on the growth conditions. 
 
1.1.3: Teichoic acids 
In B. subtilis and most other Gram positive bacteria, a major proportion of the 
cell envelope consists of teichoic acids (TAs). TAs are glycopolymers that extend into 
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and beyond the cell wall (81). They can either be covalently attached to glycolipids 
that insert into the membrane (lipoteichoic acid or LTA) or to peptidoglycan (wall 
teichoic acid or WTA). B. subtilis also produces teichuronic acid under low-phosphate 
conditions, but since this polymer is a response to nutrient limitation rather than 
envelope stress, it will not be discussed further (102). LTA and WTA are involved in 
many critical cell functions including cation homeostasis, division, host infection, 
autolysis, biofilm formation, and antibiotic resistance (102). They are also a major 
determinant of the elasticity, porosity, shape, and strength of the cell wall (81). Neither 
WTA nor LTA alone are essential to B. subtilis, but a strain lacking both is not viable 
and LTA- or WTA-depleted cells are growth deficient. Although LTA and WTA have 
similar functions, they independently contribute to the cell envelope and are 
synthesized by completely different pathways. 
In B. subtilis, WTA synthesis is initiated in the cytoplasm by TagO which 
transfers a GlcNAc phosphate to membrane-anchored undecaprenyl phosphate (99). 
This molecule is converted into a mature TA by the TagABEF enzymes with TagF 
solely responsible for attaching glycerol phosphates to the linkage unit to form the 
polymer. The TagGH ABC transporter then exports the mature TA from the cell. 
When the exported TA reaches the cell wall, one of three LCP transferases (TagT, 
TagU, or TagV) covalently attach the phosphate group of the GlcNac residue to 
peptidoglycan to complete WTA synthesis (53). 
The synthesis of LTA begins when PgcA (phosphoglucomutase) and GtaB (α-
glucose-1-phosphate uridyltransferase) convert glucose-6-phosphate to UDP-glucose 
(86). The glucose moieties from two UDP-glucose molecules are then transferred to 
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diacylglycerol (DAG) by the glycosyltransferase UgtP to form the glycolipid Glc2-
DAG. This glycolipid is transferred to the outer leaflet of the cytoplasmic membrane 
where it serves as a foundation for the polyglycerolphosphate chain. LTA synthases 
are then responsible for creating this chain. B. subtilis has 3 functional LTA synthases, 
LtaS, LtaSa, and YqgS (107). All of these Mn
2+
-dependent enzymes cleave the 
glycerolphosphate head group from phosphatidylglycerol and attach it to the growing 
LTA chain. LtaS is regarded as the primary LTA synthase responsible for 
housekeeping functions and the bulk of LTA synthesis, LtaSa is considered the stress 
induced LTA synthase because its located downstream of a M dependent promoter, 
and YqgS is thought to play a role in sporulation (94).  B. subtilis may utilize multiple 
LTA synthases to optimize LTA for various growth or stress conditions.  For example, 
LtaSa synthesizes longer LTAs than those produced by LtaS or YqgS which may help 
make the cell envelope less permeable to antimicrobial agents (107).  B. subtilis also 
has an LTA primase, YvgJ, which can only transfer the initial glycerol-phosphate 
subunit onto the membrane-embedded glycolipid (107). However, this priming 
activity is not necessary for the LTA synthases to function correctly.  
Once synthesized, TAs can be further modified by substituting the hydroxyl 
groups of polyglycerol phosphate monomers with various functional groups. The most 
well-studied example of this is the D-alanylation of LTA and WTA through the 
activity of the Dlt proteins (82). Most Gram positive bacteria D-alanylate a significant 
proportion of TAs and can vary the degree of D-alanylation to modify the charge of 
the cell envelope (81). Other modifications include substitutions of -GlcNAc or -
galactosyl in LTAs and -glycosyl in WTAs. 
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1.2: Stresses that target the cell envelope 
This dissertation references a variety of stresses that target the cell envelope. 
Some inhibit the cell wall, others disrupt the phospholipid membrane, and many have 
multiple functions. The cell envelope active agents that are relevant to later chapters 
will be described in more detail here. 
 
1.2.1: Cell wall active agents 
The cell wall is a prime target for antibiotics because it is highly conserved 
among bacteria but not present in animals. Most cell wall antibiotics inhibit 
peptidoglycan synthesis (55). Such inhibition does not harm the cell directly, but 
growth, division, and autolysins will weaken a cell wall in this state which can lead to 
lysis from osmotic pressure (89). From the discovery of penicillin, our history of 
antibiotic use has involved cell wall active agents and a majority of the antibiotics in 
use today target the cell wall (95). Structures of all the compounds discussed below 
are shown in Figure 1.2. 
 
β -lactam antibiotics 
β-lactam antibiotics, such as the cephalosporins and penicillins are 
characterized by the presence of a β-lactam ring (67). This ring structurally mimics the 
D-ala-D-ala residues of PG side chains. The PBPs that normally interact with the D-
ala-D-ala residues will form a complex with these antibiotics. Complex formation is 
irreversible and inactivates the PBPs, thereby reducing the amount of PG cross-linking 
by transpeptidases. 
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Figure 1.2: Structures of cell wall antibiotics A. penicillin, B. cephalosporin, C. D-
cycloserine, and D. vancomycin. For penicillin and cephalosporin, only the core 
structure is shown with R, R
1
, and R
2
 representing variable function groups.  
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Vancomycin 
Vancomycin is a glycopeptide antibiotic active against a broad range of Gram 
positive bacteria. It disrupts cells by binding to the terminal D-ala-D-ala resides of 
uncrosslinked side chains on lipid II (87). This sterically hinders both the 
transglycosylation and transpeptidation activities of PBPs necessary for peptidoglycan 
synthesis. 
 
D-cycloserine 
D-cycloserine is a D-alanine analog and therefore competitively inhibits D-
alanine racemace and D-alanine-D-alanine ligase. Both of these enzymes are 
necessary for synthesizing the terminal D-ala-D-ala resides on peptidoglycan side 
chains (26). Since the side chains are synthesized in the cytoplasm, D-cycloserine 
must permeate the cell envelope before it can disrupt the cell. 
 
Despite the effectiveness of these antibiotics, their widespread use has caused 
many pathogenic bacteria to evolve into strains that are resistant to cell wall active 
agents (80). As a result, many researchers are searching for new antibiotics that inhibit 
other aspects of bacterial physiology. 
 
1.2.2: Membrane active agents 
The cell membrane is an attractive antibiotic target for several reasons. Since 
bacterial cell membranes are substantially different than eukaryotic membranes (35), 
the potential for host toxicity with a membrane antibiotic is relatively low. The 
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essential nature of the cell membrane also hinders the development of resistance (48). 
In addition, membrane stresses do not typically require cell growth to be active and 
can be effective at treating slow growing persistent infections like Mycobacterium 
tuberculosis (48). Structures of the membrane active agents discussed below are 
shown in Figure 1.3. 
 
Detergents 
Detergents are a universal source of membrane stress. Their amphiphilic nature 
allows them to integrate into the outer leaflet of the plasma membrane (40). This 
creates a positive curvature in the membrane which reduces membrane order, density, 
and thickness. These effects lead to a loss of membrane stability which can result in 
increased permeability or pore formation. At higher concentrations, detergents will 
completely solubilize the membrane into mixed micelles (42, 59). Common detergents 
include triton X-100, sodium dodecyl sulfate, and amitriptyline. In addition, many 
organisms employ detergents or detergent-like compounds as antibacterial agents. The 
bile salts produced by mammals and lipopeptides produced by bacteria are two 
prominent examples. 
 
Daptomycin 
Daptomycin is a lipopeptide consisting of a 10 cyclic amino acids and three exocyclic 
residues connected to a fatty acid moiety (3). It has a net charge of -3, but complexes 
with Ca
2+
 which increases its attraction toward the anionic cell envelope. When 
daptomycin encounters the cell envelope, its fatty acid side chain inserts into  
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Figure 1.3: Structures of membrane active agents A. triton X-100, B. sodium dodecyl 
sulfate (SDS), C. amitryptline, D. bile salts, E. polymyxin B, and F. daptomycin.  
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the plasma membrane leading to pore formation, depolarization and eventual cell 
death. It is believed to interact preferentially with PG over other membrane lipids (34). 
 
Polymyxins 
The polymyxins (eg. polymyxin B and colistin) are similar to daptomycin in 
that they consist of a peptide ring connected to a tripeptide side chain with a fatty acid 
tail but differ from daptomycin in that they are cationic (net charge = +5) (108). 
Although polymyxins are primarily used against Gram negative bacteria, they are 
active against B. subtilis (71). When Polymyxins interact with a bacterium, they 
damage the cell in two distinct ways. The peptide ring binds divalent cations that 
would otherwise aid in stabilizing the cell envelope and the fatty acid chain forms 
pores in the membrane. 
 
1.2.3: Antimicrobial peptides 
Antimicrobial peptides are a diverse group of molecules that contain an amino 
acid backbone and function as potent antibiotics. These compounds are synthesized by 
all forms of life as defensive mechanisms against pathogens or competing microbes 
(35). They exhibit diverse modes of action ranging from disruption the cell envelope 
(48, 95) to inhibition of cytoplasmic components (35). Despite this diversity, 
antimicrobial peptides tend to be cationic, which attracts them to the negatively 
charged bacterial cell envelope, and amphiphilic, which allows them to associate with 
membranes (35). The prevalence and broad spectrum activity of antimicrobial peptides 
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has led to considerable interest in developing them for clinical and industrial 
applications. 
Many of these antimicrobial compounds are bacteriocins, peptides produced by 
one bacteria that target another bacteria (15). They can include everything from small 
lipopeptides like polymyxin and daptomycin to large heat-labile proteins like 
peptidoglycan hydrolysases (15). A sub-group of bacteriocins called lantibiotics (class 
I bacteriocins) are the focus of Chapter 3 and will be reviewed in detail below. 
 
Lantibiotics  
The term lantibiotic refers to antimicrobial peptides that contain thioether-
bridged amino acids called lanthionines. These lanthionine residues arise from the 
posttranslational dehydration of serines and/or threonines followed by cyclization with 
a cystine residue which introduces intramolecular rings within a peptide. Lantibiotics 
are ribosomally synthesized by Gram positive bacteria and are primarily involved in 
interspecies competition against other Gram positive microbes (84). They have 
become promising candidates for clinical applications because they are effective 
against numerous pathogens (6, 18, 27, 66) and share similarities with defensins and 
other human antimicrobial peptides (83, 91, 97). 
The most widely used and extensively studied lantibiotic is nisin, which is 
produced by Lactococcus lactis. It is 34 amino acids long, has a charge of +5, and 
contains 5 lanthionine rings (Figure 1.4, Table 1.1). This lantibiotic is active against a 
broad spectrum of Gram positive bacteria and has been used as a food preservative for 
almost 60 years (15, 19). The extensive history of nisin has led researchers to  
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Figure 1.4: Structures of the lantibiotics A. nisin, B. subtilin, C. gallidermin, and D. 
mersacidin. Abu refers to -aminobutyric acid, Dha refers to 2,3-didehydroalanine, and 
Dhb refers to 2,3-didehydrobutyrine. Red residues are basic, blue residues are acidic.
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Table 1.1 Characteristics of select lantibiotics 
 
 
 
a.
 Although gallidermin does not readily form pores in the membrane, it still inserts its 
C-terminal end into the membrane  
b.
 Mersacidin complexes with Ca
2+
, so its functional net charge is higher than its actual 
charge. 
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acknowledge that it is a prototypical lantibiotic that serves as a model antimicrobial 
peptide (4). 
Nisin is an effective lantibiotic because it employs a potent mechanism of 
action. The cationic residues of nisin initially attract this molecule towards the anionic 
cell membrane. Upon reaching the membrane, the N-terminal region of nisin functions 
as a pyrophosphate cage that binds to lipid II with high affinity (39). The lanthionine 
rings are essential for forming this lipid II binding motif (45). Since lipid II is required 
for peptidoglycan synthesis, nisin binding inhibits cell wall synthesis. While the N-
terminal region of nisin is bound to lipid II, its C-terminal end inserts into the 
membrane. At high enough concentrations of nisin, multiple nisin and lipid II 
molecules will combine into a complex that forms pores in the membrane (106). A 
flexible hinge region in the middle of the peptide allows both membrane insertion and 
lipid II binding to occur at the same time (4). Since nisin damages cells in two distinct 
ways, by inhibiting cell wall synthesis and disrupting cell membrane, it is referred to 
as having a dual mechanism of action. 
Most lantibiotics share all or part of this dual mechanism of action. Those that 
bind lipid II and form pores in the membrane are usually type A (I) lantibiotics like 
subtilin, ericin, gallidermin, epidermin and entianin (106). This class of lantibiotic 
consists of linear peptides synthesized by separate dehydratase and cyclase enzymes. 
Most other lantibiotics are classified as type B lantibiotics. They are globular peptides, 
dehydrated and cyclized by a single enzyme, that typically bind lipid II, but do not 
integrate into membranes (49). Mersacidin and actagardine fall under this category. 
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However, not all lantibiotics function similarly to nisin. Some, like duramycin, do not 
bind to lipid II, and others, like SapB from Streptomyces coelicolor, lack antibacterial 
activity and perform alternative functions (4). 
The lantibiotics nisin, subtilin, gallidermin, and mersacidin are all involved in 
Chapter 3 of this thesis. The structures of these lantibiotics are shown in Figure 1.4, 
and Table 1.1 compiles their relevant characteristics. 
 
1.3: The cell envelope stress responses of B. subtilis 
B. subtilis encounters a diverse array of antimicrobial compounds produced by 
competing microbes in nature. Since these compounds often target components of the 
cell envelope, B. subtilis has evolved numerous resistance mechanisms against cell 
envelope stress and even low levels of cell envelope active compounds can induce 
complex CESR (51). In B. subtilis, these CESR consists primarily of two component 
regulatory systems (TCS) and extracytoplasmic function sigma (ECF ) factors 
(Figure 1.5) (51). 
 
1.3.1: Two component systems 
TCS are phosphotransfer signal transduction pathways that consist of a 
membrane-bound histidine kinase (HK) and its corresponding response regulator (RR) 
(98). The HK typically contains an extracellular N-terminal sensing domain that can 
detect environmental stimuli. Once a stimulus is detected, the cytoplasmic C-terminal 
domain phosphorylates a specific RR. The phosphorylated RR then modifies the  
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Figure 1.5. Model of B. subtilis CESR regulated by ECF  factors (left) and TCS 
pathways (right). (HK = histidine kinase; RR = response regulator). Adapted from 
(51). 
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expression of specific genes. The simplicity of this system has allowed bacteria to 
evolve numerous TCS to respond to a variety of stresses (105). 
Although B. subtilis has at least 35 putative TCSs (57), only the LiaRS TCS 
will be discussed in detail (Chapter 3). In this system, the HK LiaS detects stresses 
that interfere with the undecaprenol cycle (bacitracin, nisin, vancomycin, etc) and 
phosphorylates the RR LiaR (72). LiaR will then activate the expression of the 
liaIHGFSR and the yhcYZyhdA operons by binding to a conserved palindromic DNA 
sequence (52). In addition, LiaF negatively regulates this system. Since TCS are not a 
focus of this thesis, the rest of this section will review ECF  factors. 
 
1.3.2: Extracytoplasmic function sigma factors 
Sigma () factors are dissociable subunits of the bacterial RNA polymerase 
holoenzyme that are required for transcription initiation. Their primary role in 
transcription initiation is to recognize the -10 and -35 elements of DNA promoters (5, 
78). All bacteria contain at least one primary sigma factor responsible for expressing 
the genes that maintain housekeeping functions (A in B. subtilis). In addition, many 
bacteria utilize alternative  factors to activate a specific set of genes in response to 
particular stimuli. 
This dissertation focuses on a subfamily of alternative  factors called the 
extracytoplasmic function (ECF)  factors. The term “extracytoplasmic function” is 
used to describe this group of  factors because they all activate the expression of 
genes associated with the cell envelope (44). Most ECF  factors are inactive under 
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normal conditions due to sequestration by corresponding membrane-bound anti- 
factors. However, specific environmental stresses can trigger a CESR in which 
conformational changes or regulated intramembrane proteolysis of the anti- factor 
result in the release of the ECF  factor (41). Once released, the  factor is free to 
activate the transcription of genes that will presumably resist the stress that originally 
activated it. 
The B. subtilis genome contains seven known ECF  factors: M, W, V, X, 
Y, Z, and YlaC. Of these seven, the most active and best characterized are M, W, 
and X. Together, these three  factors protect against numerous environmental 
stresses including antibiotics and detergents that interfere with cell envelope synthesis 
or function (44). M, W, and X exhibit a moderate level of basal activity under 
normal growing conditions and can be induced by a variety of cell envelope stresses. 
Some stresses only activate one  factor (moenomycin & M) (92), while other 
stresses can stimulate a strong response from all three ECF  factors (Triton X-100, 
vancomycin) (13, 44). Their known regulons, or the genes activated by a specific ECF 
 factor, consist of ~30-70 genes each (10, 12, 24, 110), but the three  factors only 
regulate a total of ~120 known genes because they exhibit a significant amount of 
regulatory overlap. Certain genes are activated by multiple ECF  factors, and 
resistance to some cell envelope stresses like D-cycloserine, polymyxin B, and nisin 
can only be completely abrogated by deleting multiple  factors from B. subtilis (71). 
Despite this overlap, each of these  factors have specialized functions. M 
activates a numerous genes involved in cell envelope synthesis and confers resistance 
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to cell wall antibiotics like moenomycin, aztreonam, and cefuroxime (24, 65). The W 
regulon includes genes encoding proteins that can modify the cell membrane and 
defend against antimicrobial compounds produced by other bacteria like fosfomycin 
and sublancin (7, 12, 43). Finally, many of the genes activated by X alter cell surface 
properties to prevent antimicrobial compounds from penetrating the cell envelope 
(10). 
The other four ECF sigma factors, V, Y, Z, and YlaC are thought to play 
relatively minor roles in the CESR of B. subtilis. They are inactive under normal 
conditions and deleting them has little effect on cell envelope stress sensitivity (64, 
71). The most well understood of these four is V which is primarily activated by, and 
provides resistance to, lysozyme (31). Previous studies have implicated Y in 
preventing the loss of the SPβ prophage (75) and YlaC in resistance against reactive 
oxygen species (90). In addition, Y is induced by nitrogen starvation and may affect 
sporulation. The inducers and functions of Z are unknown, and it is the only ECF  
factor in B. subtilis that lacks a corresponding anti- factor and cannot autoregulate its 
own expression. 
Although many of the genes activated by each ECF  factor have been 
identified, we may be unaware of additional ECF -activated genes that play critical 
roles in CESR. One strategy for uncovering novel ECF -regulated genes is a 
promoter consensus search. As mentioned previously, ECF  factors activate 
transcription by binding to specific recognition elements called promoters (71). 
Computational analysis of each known promoter for the three most active ECF  
 24 
 
factors (M, W, and X) has given a consensus sequence that exhibits high 
conservation in both the -35 and -10 elements (Figure 1.6). We can search the B. 
subtilis genome for this sequence to identify novel ECF  activated loci. In fact, one 
of the candidate ECF  binding sites identified by this type of search is P5, a novel 
promoter within fabHA and upstream of fabF that will be analyzed in Chapter 2.  
 
1.3.3: Membrane Stress adaptations 
One of the major goals of this work is to elucidate resistance pathways that 
adapt B. subtilis to cell membrane stress. This aspect of CESR is often overlooked 
because most of the antibiotics currently used to combat pathogens target the cell wall 
(95). However, bacteria naturally encounter many cell envelope active compounds that 
affect the biophysical properties of the phospholipid bilayer and have evolved 
numerous mechanisms to acclimatize to these stresses (109). The study of these 
mechanisms is becoming increasingly important as we begin to rely more on 
developing novel membrane targeting antibiotics (48). 
Many membrane-oriented forms of CESR directly modify the plasma 
membrane to aid in resistance (109). Some modifications affect its net charge while 
others adjust its fluidity (21, 88). These adjustments are critical for maintaining the 
desired biophysical properties of the plasma membrane such as permeability of the 
lipid bilayer, protein mobility, protein-protein interactions and active transport 
processes (62). Changes in membrane composition are often exerted at the level of 
membrane synthesis (63). For example, B. subtilis has two FabH isozymes, that differ 
in their substrate specificities (14). Chapter 2 of this thesis explains how these  
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Figure 1.6: Consensus promoter sequences recognized by M, W, and X 
individually, and a MWX consensus sequence recognized all three of these ECF  
factors. The -10 and -35 elements are indicated. The degree of sequence conservation 
is represented by the height of the nucleotide(s) at that position. Created using the 
Weblogo service (http://weblogo.berkeley.edu/logo.cgi) and adapted from (71).
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differences are exploited by B. subtilis to adjust the iso:anteiso ratio of lipids in the 
membrane. Bacteria can also influence membrane composition by modifying existing 
phospholipids which is more efficient and faster than de novo synthesis (17). A 
common example of this type of CESR in B. subtilis is the DesRK two component 
system which contributes to the universally conserved tendency of bacteria to maintain 
a constant membrane fluidity throughout changes in temperature (2, 63, 109). A 
decrease in temperature will lower membrane fluidity causing B. subtilis to trigger the 
activation of the DesK histidine kinase. This kinase will phosphorylate its cognate 
response regulator DesR which then activates the expression of desA encoding an 
acyl-desaturase that introduces a double bond into the fatty acid chains of existing 
phospholipids (69). Unsaturated FAs have greater steric hindrance than saturated FAs 
which help raise membrane fluidity to normal levels. 
Proteins can also contribute to membrane stress resistance through interactions 
with the phospholipid bilayer. This kind of interaction is evident in the phage shock 
proteins of Gram negative bacteria. Psp systems are activated by agents that dissipate 
the proton motive force such as ethanol, temperature shifts, and organic solvents (18). 
Activated phage shock proteins then bind to the inner membrane and help reestablish 
proton motive force by blocking leakage (50). The keystone of this stress response is 
PspA which forms an oligomeric ring hypothesized to act as a scaffold that enhances 
the rigidity of the membrane. Another example of proteins that can influence the 
biophysical properties of the membrane through direct interaction is bacterial flotillins 
and NfeD proteins. As explained in section 1.1, these enzymes functionally organize 
the bacterial membrane and have been shown to affect membrane fluidity (58), protein 
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secretion (61), cell shape (20), and antibiotic resistance (7).  
In B. subtilis, ECF  factors and membrane stress adaptations are 
fundamentally connected. A central tenant of this connection is that a significant 
portion of the signaling pathways that activate ECF  factors occur in the membrane. 
Anti- factors are membrane bound, as are many of the enzymes involved in releasing 
a sequestered  factor, such as the proteases PrsW and RasP that activate W through 
regulated intramembrane proteolysis of its anti- factor RsiW (41). This association 
with the membrane suggests that ECF  factor activity can be affected by membrane 
perturbations or changes in lipid composition. Indeed, Both M and V are activated 
when the phosphatidylglycerol content of the membrane is reduced (38) confirming a 
connection between lipid composition and ECF  factor activity. This may explain 
why membrane stresses like triton X-100, polymyxin B, and daptomycin stimulate an 
ECF  response as well (43, 71, 103).  
ECF  factors are also known to activate genes involved in membrane 
synthesis and modification. The M regulated ytpAB operon encodes the 
phosphatidylglycerol hydrolysis enzyme YtpA (24, 100), and the tetraprenyl-β-
curcumene synthase YtpB which synthesizes unique membrane lipids known as 
sesquarterpenes (93). Both of these proteins have the capacity to alter membrane 
composition, but their roles are largely unexplored. W regulates many proteins with 
membrane associated functions including the phage shock proteins PspA and YvlC (a 
PspC homolog), membrane proteases SppA YqeZ, and YjoB, fatty acid synthase 
enzymes FabHA and FabF (12), NfeD proteins (YuaF and YqeZ) (61) and flotillin 
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homologs (FloT and YqfA). Several studies have already hinted at some of the 
functions of these enzymes. The W regulon limits membrane proteins overproduction 
which could be related its control over the membrane proteases SppA, YqeZ, and 
YjoB (111), W-dependent regulation the Fab proteins, NfeD proteins, and flotillins 
has been shown to influence membrane fluidity (46, 54), and the Psp proteins may 
enhance membrane stability as evidenced by the contribution of PspA to resistance 
against the pore forming antibiotic daptomycin (33). Finally, PE synthesis genes pssA, 
ybfM, and psd are upregulated by X which may represent a resistance mechanism that 
reduces the net negative charge of the bilayer to repel cationic antimicrobial 
compounds (10). Some of these membrane-associated genes have already been shown 
to contribute to cell envelope stress resistance. FloT resists cefuroxime (58), FloA 
protects against sublancin (7), and YtpB affects bacitracin sensitivity (personal 
observation). Furthermore, Chapters 2 and 3 attribute detergent and lantibiotic 
resistance mechanisms to several of these genes and future studies will likely uncover 
additional roles for them in mediating membrane stress. 
 
1.3.4: Cell wall and teichoic acid stress adaptations 
 
Cell envelope stress adaptations are not limited to those affecting the cell 
membrane. ECF  factors activate many genes encoding proteins with cell wall- or 
TA-associated functions. Although these resistance pathways are not a primary focus 
of this work, they still merit discussion because modifications to the cell wall or TAs 
can indirectly affect the cell membrane and its ability to resist stress. 
Numerous studies have shown that ECF  factors and TAs are strongly 
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connected. LTA depletion in B. subtilis produces a strong ECF  response with M 
and X induced under mild LTA depletion followed by induction of W and ylaC and, 
subsequently, V and Y as depletion becomes more severe (37). A similar response to 
WTA depletion in Staphylococcus aureus has been observed as well (8). In B. subtilis, 
several ECF  factor-mediated stress responses alter TA synthesis or directly modify 
TAs. X activates the dlt operon which increases the net charge of TAs via D- 
alanination. The alternative LTA synthase LtaSa is activated by M (24) and is capable 
of producing LTA polymers that are different from those produced by the primary 
LTA synthase (107). Additionally, tagT (formerly, ywtF) and tagU (formerly, lytR), 
which encode two of the three enzymes in B. subtilis responsible for attaching WTAs 
to peptidoglycan (53), are partially regulated by M and X respectively (24, 47). 
Changes in TAs may prevent membrane stressors from reaching the bilayer. 
Activation of the dlt operon has been shown to repel membrane stressing cationic 
antimicrobial peptides in multiple Gram positive bacteria including B. subtilis (10), 
Clostridium difficile (74), Lactococcus lactis (56), Staphylococcus aureus (83). In 
Streptococcus bovis, a nisin resistant strain was found to produce longer and denser 
LTAs than WT cells (70). It should also be noted that LTAs have the potential to 
affect bilayer properties because they are embedded in the membrane and LTA 
synthesis consumes phosphatidylglycerol from the cell membrane thereby contributing 
to fatty acid turnover (109). 
Direct connections between cell wall stress adaptations and membrane 
integrity are less clear, but both cell envelope components are dependent upon each 
other. A stable membrane requires a healthy cell wall since the cell membrane will 
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lyse without its support, and several essential steps in cell wall synthesis require a 
functional membrane. In addition, some stresses target both the cell wall and the cell 
membrane, and both targets must be taken into account to fully understand the CESR 
of B. subtilis to these stresses. 
ECF  factors are integral in mediating resistance against many cell envelope 
stresses. Most common cell wall antibiotics stimulate an ECF  response which 
upregulates a number of cell wall associated genes. M activates the cell shape 
determining proteins MreBCD & RodA, the MurB & MurF ligases, Ddl (D-alanine-D-
alanine ligase), and the MinCD & DivIB proteins involved in septum formation while 
X and W induce the penicillin binding proteins PbpX and PbpE, respectively (10, 12, 
24). Some ECF  factor dependent proteins confer resistance against specific cell wall 
stresses. The UPP phosphatase BcrC (M) resists bacitracin (11), bacillithiol-S-
transferase FosB (W) inactivates fosfomycin (9), and MurNAc specific O-
acetyltransferase OatA (V) reduces the affinity of lysozyme for peptidoglycan (31). 
ECF  factors confer resistance against many other cell envelope stresses as well 
including moenomycin, azetreonam, D-cycloserine, cephalosporins, and penicillins, 
but precise resistance mechanisms for these stresses have yet to be defined (64, 72). 
 
1.4: Assays to analyze membranes  
Proper analysis of membrane stress responses requires specialized assays that 
can evaluate various properties of the cell membrane. Assays of this nature that will be 
employed in subsequent chapters are described in this section. 
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1.4.1 Fluorescence anisotropy 
Fluorescence anisotropy is frequently used to analyze membrane fluidity. In 
this assay, a fluorescent probe is excited with polarized light and the intensities of 
polarized and depolarized light that are emitted from the molecule are measured (1). 
The key principle behind fluorescence anisotropy is that during the period between the 
excitation and emission of polarized light, a molecule can rotate to emit depolarized 
light (101). The faster that the probe rotates, the greater the proportion of emitted light 
that will be depolarized (29). To assess membrane fluidity with this technique, a 
fluorescent probe like 1,6-diphenyl-1,3,5-hexatriene (DPH) is used (79). This probe 
localizes to the hydrophobic core of the lipid bilayer and orients itself parallel to fatty 
acid side chains (101). In this orientation, the molecule’s rotational freedom and hence 
depolarization levels are affected by changes in membrane dynamics (21, 85, 101) 
which can be observed with fluorescence anisotropy. 
 
1.4.2: FAME and ESI-MS 
Membrane composition can be accurately quantified with a combination of 
fatty acid methyl ester (FAME) analysis and electrospray ionization tandem mass 
spectrometry (ESI-MS). FAME analysis consists of the esterification of lipids, and 
their subsequent separation, identification, and quantification of esterified fatty acids 
by gas chromatography/mass spectrometry (23, 32, 77). It specifically provides 
information on iso:anteiso ratios, fatty acid chain lengths, and the degree of saturation 
within a membrane. However, FAME analysis is limited in that it does not distinguish 
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between different phospholipid and glycolipid species. To identify relative proportions 
of these species, ESI-MS is employed. ESI-MS is a common technique in which an 
electric field ionizes larger molecules with minimal fragmentation and subsequent 
mass spectrometry or tandem mass spectrometry provides enough information to 
identify them (36). 
 
1.5: Content of this dissertation 
This dissertation investigates CESR pathways with an emphasis on ECF  
factor mediated responses to membrane stress. The majority of the work presented 
here will be split up into two main chapters. 
Chapter 2 focuses on P5, a 
W
-dependent promoter located within fabHa and 
upstream of fabF. Activation of this internal promoter downregulates FabHa and 
upregulates FabF. Reduced FabHa levels increase the utilization of the FabHb paralog 
leading to a greater proportion of straight chain fatty acids in the membrane. Higher 
FabF production improves the probability that the synthesis of a fatty acid will include 
additional elongation cycles which raises the average fatty acid chain length. These 
changes in fatty acids reduce membrane fluidity which resists detergents and 
antimicrobial compounds produced by other bacteria. 
Chapter 3 identifies and analyzes the ECF  factor dependent lantibiotic 
resistance mechanisms in B. subtilis. Using nisin as a model, we showed that M, W, 
and X all contribute to innate lantibiotic resistance. X activates the dlt operon which 
D-alanylates TAs and M upregulates ltaSa which increases the size and density of 
LTA. Both of these teichoic acid alterations decrease access of lantibiotics to its lipid 
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II target. The W-regulated lantibiotic resistance genes principally protect against 
membrane permeabilization and include a signal peptide peptidase (SppA), phage 
shock proteins (PspA and YvlC), and proteins related to tellurite resistance (YceGHI). 
These two chapters identify and characterize multiple physiologically relevant 
membrane stress resistance mechanisms in Bacillus subtilis that are mediated by ECF 
 factors. In addition, the appendices cover several experiments that analyze ECF  
factor-dependent mechanisms that modify the plasma membrane but don’t fit into a 
full story. Appendix A shows that the yuaFGI operon encoding both the NfeD protein 
YuaF and the flotillin YuaG (FloT) can reduce membrane fluidity when activated by 
W, Appendix B presents evidence suggesting that the phospholipase YtpA resists 
daptomycin by reducing PG levels, and Appendix C identifies resistance mechanisms 
associated with the tetraprenyl-β-curcumene synthase YtpB. Overall, this work 
advances our knowledge of how Gram positive bacteria mediate cell envelope stress 
which adds to our understanding of interspecies competition and may contribute to the 
development of novel antibiotics.  
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CHAPTER 2 
A W-DEPENDENT STRESS RESPONSE IN BACILLUS SUBTILIS THAT 
REDUCES MEMBRANE FLUIDITY
1 
 
2.1 Summary 
Bacteria respond to physical and chemical stresses that affect the integrity of the cell 
wall and membrane by activating an intricate cell envelope stress response. The ability 
of cells to regulate the biophysical properties of the membrane by adjusting fatty acid 
composition is known as homeoviscous adaptation. Here, we identify a homeoviscous 
adaptation mechanism in Bacillus subtilis regulated by the extracytoplasmic function 
 factor W. Cell envelope active compounds, including detergents, activate a sense-
oriented, W-dependent promoter within the first gene of the fabHa fabF operon. 
Activation leads to a decrease in the amount of FabHa coupled with an increase in 
FabF, the initiation and elongation condensing enzymes of fatty acid biosynthesis, 
respectively. Down-regulation of FabHa results in an increased reliance on the FabHb 
paralog, leading to a greater proportion of straight chain fatty acids in the membrane, 
and the up-regulation of FabF increases the average fatty acid chain length. The net 
effect is to reduce membrane fluidity. The inactivation of the W-dependent promoter 
within fabHa increased sensitivity to detergents and to antimicrobial compounds 
produced by other Bacillus spp. Thus, the W stress response provides a mechanism to 
conditionally decrease membrane fluidity through the opposed regulation of FabHa 
and FabF. 
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The results of this study were published in Kingston AW, Subramanian C, Rock CO, 
and Helmann JD. Molecular Microbiology. 2011 Jul; 81(1):69-79. C.S. and C.O.R 
performed the lipid analysis. All other experiments were performed by A.W.K.  
A.W.K and J.D.H wrote the manuscript. 
 
2.2 Introduction 
Bacillus subtilis, like other soil microbes, produces a wide variety of secondary 
metabolites, many of which have antibacterial activity. Many of these compounds 
affect the integrity of the cell envelope and elicit specific stress responses. B. subtilis 
is a model system for studying cell envelope stress responses in Gram positive bacteria 
mediated by a complex network of two-component regulatory systems (TCS) and 
extracytoplasmic function (ECF)  factors (22). B. subtilis encodes seven ECF  
factors, several of which are induced by, and confer resistance to, antibiotics targeting 
the cell envelope (19). Many cell envelope active compounds are detergents or 
otherwise affect the biophysical properties of the phospholipid bilayer. As a result, 
cells have evolved the ability to modify membrane lipid composition to acclimatize to 
membrane stress (46). Some modifications affect the net membrane charge, while 
others adjust fluidity by changing the fatty acid (FA) composition (13, 34). 
Adjustments in membrane fluidity, known as homeoviscous adaptation, are critical for 
maintaining the desired biophysical properties such as permeability of the lipid 
bilayer, protein mobility, protein-protein interactions and active transport processes 
(26). A clear example of homeoviscus adaptation is the response of B. subtilis to cold-
temperature stress (1, 27, 46). The decrease in membrane fluidity associated with a 
rapid decrease in temperature triggers the activation of the DesK histidine kinase that 
phosphorylates its cognate response regulator (DesR), which activates the expression 
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of des encoding an acyl-desaturase that increases membrane fluidity by introducing a 
double bond into the FA chains of existing phospholipids (12) .  
 Several ECF  factors of B. subtilis are involved in stress responses elicited by 
compounds that affect membrane integrity and/or fluidity. A strain lacking all seven 
ECF  factors displays increased susceptibility to antibiotics and detergents that affect 
the cell membrane (28). The X regulon includes the phosphatidylethanolamine 
synthesis genes pssA and psd (8) while the M regulon includes the 
phosphatidylglycerol hydrolysis enzyme YtpA (14, 41) and numerous proteins 
involved in cell wall synthesis and cell division (14). Both the M and V stress 
responses are activated when the phosphatidylglycerol content of the membrane is 
reduced (18). The W regulon includes numerous membrane-localized proteins (20) 
and is activated under conditions of membrane stress, such as the presence of 
detergents or when membrane proteins are overproduced (14).  
 Here, we report a W-dependent pathway that contributes to homeoviscous 
adaptation in B. subtilis by modifying the membrane phospholipid structure. In 
contrast with the DesRK pathway, which responds to conditions that decrease 
membrane fluidity, W responds to compounds that increase membrane fluidity. 
Activation of a W-dependent promoter within the fabHa fabF operon downregulates 
FabHa and upregulates FabF leading to a higher proportion of straight chain FA and a 
longer average chain length for membrane phospholipids. These membrane 
compositional changes reduce bilayer fluidity and increase resistance to detergents and 
antimicrobial compounds produced by other Bacillus species. 
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2.3 Materials and methods 
Strains, plasmids, and growth conditions. All B. subtilis strains, plasmids, and 
oligonucleotides (oligos) used in this study are listed Table S2. Bacteria were grown in 
liquid Luria-Bertani (LB) medium at 37°C with vigorous shaking or on solid LB 
medium containing 1.5% Bacto agar (Difco) with appropriate selection. Plasmids were 
amplified in Escherichia coli DH5 before transformation of B. subtilis strains. 
Ampicillin (amp; 100 g ml-1) was used to select E. coli transformants. For B. subtilis, 
antibiotics used for selection were: spectinomycin (spec; 100 g ml-1), kanamycin 
(kan; 15 g ml-1), chloramphenicol (cat; 10 g ml-1), and macrolide-lincosoamide-
streptogramin B (MLS; contains 1 g ml-1 erythromycin and 25 g ml-1 lincomycin).  
Genetic techniques. Chromosomal and plasmid DNA transformations were 
performed as described previously (17). Unless otherwise stated, all PCR products 
were generated using W168 chromosomal DNA as a template and all strains were 
verified by sequence analysis (Cornell University Life Sciences Core Laboratories 
Center).  
To create HB13069 (P5-lacZ), a DNA fragment containing P5 was PCR-
amplified with primers 4577 and 4852 and cloned into pDG1661 (16). The resulting 
plasmid (pTK022) was linearized by digestion with ScaI and integrated into the amyE 
locus. To create HB13001 (PfabHaF-P5-lacZ), the same protocol was used except that 
the DNA fragment was synthesized using primers 4576 and 4577 and the resulting 
plasmid was pTK001. 
To create HB13054 (thrC::PfabHaF-fabHa-FLAG), the fabHa ORF and the 
PfabHaF promoter were PCR-amplified (primers 4778 and 4780) to generate a product 
 48 
with a BamH1 site upstream of PfabHaF and a flag tag followed by an EcoRI site at the 
3’ end of fabHa. The PCR fragment was cloned into pDG1664 (16) and integrated into 
W168 at thrC. To create HB13058 (thrC::PfabHaF-fabHa-fabF-FLAG), the same 
procedure was used with primers 4778 and 4781.  
The Quikchange site-directed mutagenesis kit (Stratagene) and primers 4883 
and 4884 were used to change the -10 element of P5 from CGTA in pTK001, pTK013, 
pTK015, pTK022, and pTK043 to CGGA (designated P5*) in plasmids pTK033, 
pTK045, pTK046 pTK031, and pTK044, respectively. To incorporate P5* at the 
genomic locus in B. subtilis, a 525 bp fragment containing P5, PfabHaF, and the FapR 
binding site was PCR-amplified (primers 4576 and 4577) and cloned into pMUTIN4 
(42) to create pTK043. P5* was generated with site-directed mutagenesis as described 
above to create pTK044. Uncleaved pTK044 was inserted into W168 at the fabHa 
locus through Campbell integration to create HB13118 in which P5 is changed to P5* 
at the genomic locus. Note that the upstream regulatory elements remain unchanged. 
Since this integration vector also incorporated ~8.6 kb of plasmid DNA upstream of 
PfabHaF, we created a control strain (HB13117) with pMUTIN4 inserted upstream of 
fabHa while maintaining wild type P5.   
 Gene deletions were generated using long-flanking homology PCR (LFH-
PCR) as described previously (30). To create HB13118 (fabHb::kan), 800 bp DNA 
fragments flanking fabHb were amplified using primers 5059 and 5060 for the 
upstream (24) fragment and 5061 and 5062 for the downstream (DO) fragment. 
Extensions of ~25 nucleotides were added to the 5’ end of the UP-reverse and the DO-
forward primers that were complementary (opposite strand and inverted sequence) to 
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the ends of the kanamycin cassette. 100-150 ng of the UP and DO fragments and 250-
300 ng of the resistance cassette were used together with the specific UP-forward and 
DO-reverse primers in a second joining PCR and the product used to transform B. 
subtilis. To generate a fabHa null mutant, while retaining fabF under control of PfabHaF 
(HB13127), an ~800 bp UP fragment was amplified with primers 5164 and 5174. The 
DO fragment (a PfabHaF-fabF fusion) required the fusion of two PCR product 
encompassing the PfabHaF promoter (primers 5165 and 5166) and fabF (primers 5167 
and 5169). The UP and DO fragments were joined with an MLS cassette by PCR and 
used to transform B. subtilis. These extra steps were taken to insert the MLS resistance 
cassette upstream of PfabHaF instead of between PfabHaF and fabF to minimize the effect 
of deleting fabHa on fabF expression.
 
To generate HB13128 (Pxyl-fabF), a PCR-amplified fragment (primers 5168 
and 5169) containing a ribosome binding site followed by fabF was cloned into 
pSWEET-bgaB (4) and the resulting plasmid (pTK047) was cleaved with PstI and 
integrated into W168 at amyE. 
5'-RACE. The start site of the P5 transcript was determined using 5’ rapid 
amplification of cDNA ends (5’-RACE) (35). The W168 strain was grown to an OD600 
of 0.4 and treated with 0.004% triton X-100 for 30 minutes at 37 
o
C with aeration. 2 
g of extracted RNA was reverse-transcribed to cDNA using TaqMan reverse 
transcription reagents (Applied Biosystems) and oligo P5-GSP1 (4520) as a primer. 
The 3’ end of the cDNA was tailed with poly(dC) using dCTP and terminal 
deoxynucleotidyl transferase (New England Biolabs). The tailed cDNAs were 
amplified by PCR with primers AAP (3314) and P5-GSP2 (4521) and sequenced. 
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Disk diffusion assays. Disk diffusion assays were performed as described (29). 
Briefly, strains were grown to an OD600 of 0.4. A 100 μl aliquot of these cultures was 
mixed with 4 ml of 0.7% LB soft agar (kept at 50°C) and directly poured onto LB 
plates (containing 15 ml of 1.5% LB agar). The plates were dried for 20 min in a 
laminar airflow hood. Filter paper disks containing the chemicals to be tested were 
placed on the top of the agar and the plates were incubated at 37°C overnight. The 
distances between the edge of the inhibition zones and the edge of the filter paper 
disks were measured. For promoter-lacZ strains, 80 g ml-1 Xgal (5-bromo-4-chloro-
3-indolyl-β-D-galactopyranoside) was added to the agar and the plates were analyzed 
for the appearance of a blue ring around the edge of the zone of inhibition. The 
following chemicals and quantities were used in the disk diffusion assays: Triton X-
100 10 μl of a 25% solution, amitriptyline 200 μg, polymyxin B 100 μg, vancomycin 
100 μg, daptomycin 100 μg, D-cycloserine 1 mg, cephalosporin C 10 μg. 
-galactosidase assays. Strains carrying promoter-lacZ fusions were grown to an 
OD600 of 0.4 in LB. Cultures were then treated with alkali shock (24 mM NaOH) or a 
control (H2O) and samples were taken 30 min after treatment. -galactosidase assays 
were performed as described by Miller (32).  
Western Blots.  Strains expressing FLAG-tagged copies of FabHa or FabF were 
grown to an OD600 of 0.4 and treated with either 2% xylose, 24 mM NaOH, or 200 μL 
H2O for 30 minutes at 37 
o
C with aeration. Cells were lysed and subjected to Western 
blot analysis using anti-FLAG antibodies to detect the fusions as described (39). 
Relative levels of each FLAG-tagged protein were compared using densitometry 
analysis with ImageJ. 
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Spot-on-lawn assays. Spot-on-lawn assays were performed as described (6). Briefly, 
lawn cells were grown to an OD600 of 0.4 in LB. A 100 μl aliquot of these cultures was 
mixed with 4 ml of 0.7% LB soft agar (kept at 50°C) and directly poured onto LB 
plates (containing 15 ml of 1.5% LB agar). Plates were dried for 20 min in a laminar 
flow hood, and 2 l of the producer strain (OD600 of 0.6) was spotted on top of the 
agar. Plates were incubated at 37°C overnight (18 h) before observation.  
Fluorescence Anisotropy.  We analyzed fluorescence anisotropy of B. subtilis strains 
treated with 1,6-diphenyl-1,3,5-hexatriene (DPH) using a modification of described 
methods (40). Strains were grown to early-log phase (OD600 of 0.2+0.01) in 5 ml LB 
medium. Cultures were treated with or without 2% xylose and/or 2.5 M DPH (from a 
2.5 mM stock in acetone) and incubated at 37°C with aeration for 30 minutes. For 
each culture, a 1 ml sample was washed once and suspended in 2 mL phosphate buffer 
(100 mM, pH 7.0). Fluorescence anisotropy measurements (ex=358 nm, slit width=10 
nm; em=428 nm, slit width=15 nm) were performed with a PerkinElmer LS55 
luminescence spectrometer. The correction for the fluorescence intensity of non-
labeled cells was calculated according to (24).  
Lipid analysis.  Cells were grown in M9 minimal medium supplemented with 0.05% 
casamino acids, 10 g ml-1 tryptophan, 0.1% glutamate, 1 mM MgSO4, 0.1 mM 
CaCl2, 500 nM MnCl2, 10 M FeCl3, 0.5% glucose and 2% xylose. Cells were 
harvested and lipids extracted as described by Bligh and Dyer (5). FA methyl esters 
were prepared using methanol-HCl and were identified and quantified using a 
Hewlett-Packard model 5890 gas chromatograph equipped with a flame ionization 
detector as described (11). FA compositions are expressed as weight percent. Samples 
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for molecular species analysis were dried and resuspended in 
chloroform:methanol:formic acid (50:50:1). Mass spectra were obtained using a 
Thermo Finnigan TSQ Quantum Ultra triple quadrupole mass spectrometer (Thermo 
Fisher Scientific) operated in the positive ESI mode using neutral loss scanning for 
141 m/z corresponding to the loss of the phosphoryl headgroup of 
phosphatidylethanolamine (25). Ion source parameters were: spray voltage 3000 V, 
capillary temperature 270°C, capillary offset 35 V, and tube lens offset set by infusion 
of the polytyrosine tuning and calibration solution (Thermo Electron, San Jose, CA) in 
electrospray mode. Acquisition parameters for phosphatidylethanolamine were: scan 
range 600-900 m/z, scan time 0.5 s, neutral loss mass 141.0 m/z, collision energy 30 V, 
peak width Q1 and Q3 0.7 FWHM, and Q2 CID gas 0.5 mTorr. The sample was 
injected into the loop using a syringe pump at a flow rate of 5 l min-1 and the data 
were collected for 3 min. and analyzed using QuantumTune software version 1.2 
(Thermo Fisher Scientific). 
Statistical analysis. All experiments were performed with a minimum of three 
biological replicates.  Unless otherwise noted, data is presented as mean ± standard 
error.  Statistical evaluation of the data was performed
 
by the use of unpaired 
Student's t tests. 
 
A value of P < 0.05 was considered statistically significant. 
 
2.4 Results and discussion: 
Identification of an active W-dependent promoter within fabHa. Because ECF  
promoters are, as a class, highly conserved (19, 23), computer-based searches have 
been effective in identifying candidate promoters. The first efforts to identify regulons 
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controlled by ECF  factors relied on promoter consensus sequence searches directed 
to intergenic regions (20, 21). Subsequently, the search was expanded to incorporate 
microarray-based methods to detect mRNAs produced by ECF  factors in vivo 
(transcriptional profiling) and in vitro (ROMA; run-off transcription microarray 
analysis) (8-10, 14). In the M regulon, several promoter sites are located within genes 
(14), a finding consistent with whole genome chromatin immunoprecipitation studies 
in other systems (43). We therefore performed a computer search of the B. subtilis 
genome to determine if other candidate ECF  promoters were present within 
annotated genes. Here, we focus on one such element, arbitrarily designated P5, within 
the fabHa gene. P5 matches the 
W
 consensus in both the -35 (TGAAAC) and -10 
(CGTA) elements (19, 29) (Figure 2.1A). A 5′-RACE analysis of detergent-treated 
wild type cells confirmed the presence of a transcript with a 5 end corresponding to 
transcription from P5 that ROMA and microarrays failed to detect.  
Several of the seven ECF  factors in B. subtilis overlap in their promoter 
recognition properties (28, 29). To determine which ECF  factors activate the P5 
promoter we used a strain with an ectopic P5-lacZ fusion inserted at the amyE locus 
(HB13069). Using a disk diffusion assay, P5-promoted β-galactosidase activity was 
observed with activators of W such as polymyxin B, vancomycin, cephalosporin C, 
D-cycloserine, and triton X-100 (Table 2.1, Figure S2.1) (10). A sigW null mutant 
(HB13099) exhibited no induction of β-galactosidase. Moreover, a strain deleted for 
all ECF  factor genes except for sigW behaved like wild-type. Therefore, W is both 
necessary and sufficient for activating P5 in response to antibiotics and detergents. 
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Figure 2.1:  A W dependent promoter (P5) in fabHa.   
A.  Schematic map of P5, PfabHaF, FabHa, FabF, and the associated FapR binding site 
(black triangle). The -35 and -10 elements of P5 are in bold. The locations of the P5 
and PfabHaF transcriptional start sites (+114 and -68 respectively) are described relative 
to the first base of the FabHa translation initiation codon. The ‡ indicates a putative 
terminator.  The DNA regions included in the PfabHaF-P5-lacZ and P5-lacZ fusions are 
also illustrated.  
B. The -galactosidase activity of the P5-lacZ (HB13069), P5*-lacZ (HB13080), 
PfabHaF-P5-lacZ (HB13001), and PfabHaF-P5*-lacZ (HB13082) strains grown to mid-log 
phase in LB with and without alkaline shock. This experiment was performed in 
biological triplicate and repeated at least three times. Bars represent mean values with 
error bars indicating standard error. Student’s t tests were performed, and a 
statistically significant difference (P value > 0.05) between the control and alkaline 
shocked cells is denoted as * above the bar graph while a non-significant difference is 
denoted as NS.  
C. Detection of FLAG-tagged FabHa and FabF by Western blot with anti-FLAG 
antibodies in the strains fabHa-FLAG (HB13054),  fabF-FLAG (HB13056),  fabHa-
FLAG Pxyl-sigW (HB13058), and fabF-FLAG Pxyl-sigW (HB13060) with and without 
xylose treatment.  This experiment was performed in biological triplicates and 
repeated at least three times.  The numbers below each band represent the average 
intensity of that band (± standard error) relative to the non-xylose treated control for 
that strain.  Using Student’s t-tests, a statistically significant difference (P value < 
0.05) between the control and xylose treated cells was found in strains containing the 
Pxyl-sigW construct but not in strains lacking this construct. 
D. Overview of FA biosynthesis. Chain initiation requires either FabHa or FabHb. 
FabHb has a greater ability to accept straight chain precursors than FabHa. Increased 
abundance of the FabF elongation enzyme can increase the chain length of the 
resulting FA (Choi et al., 2000; (37). 
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Table 2.1:  Summary of disk diffusion assays to monitor induction of P5-lacZ by cell 
envelope antibiotics 
 
Stress P5-lacZ 
P5-lacZ         
M, V, X, Y, ylaC, Z 
P5-lacZ         
W 
Triton X-100 +++ +++ - 
Vancomycin ++ ++ - 
Polymyxin B + + - 
Cephalosporin + + - 
D-cycloserine + + - 
 
a 
The induction ability of the listed antibiotics was measured in the reporter strains 
HB13069 (P5-lacZ), HB13151 (P5-lacZ sigM sigY sigZ sigV ylaC sigX), and 
HB13099 (P5-lacZ sigW::MLS) using disk diffusion assays with various stresses to 
induce the promoter (see Fig. S1 for examples).  Blue halos were observed after 
overnight incubation:  +++ (strong blue) > ++ (blue) > + (light blue) > - (white after 7 
days, no induction).  Each disk diffusion assay was performed at least three times with 
biological triplicates.  Data shown is representative of all experiments.   
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W regulates transcription of the fabHa-fabF operon. To obtain a more quantitative 
assessment of P5 activity, we performed -galactosidase assays on a strain carrying an 
ectopically located P5-lacZ fusion after induction by alkaline shock as described (45). 
P5 displayed a low basal activity that increased ~3-fold in response to alkaline shock 
(Figure 2.1B). To verify that this activity was due to P5, a P5*-lacZ strain was 
constructed in which the -10 element was changed from CGTA to CGGA (HB13082). 
No known W promoters have a G at this position (9, 19), and as predicted this P5*-
lacZ strain expressed no detectable -galactosidase activity either with or without 
alkaline shock.  
 The fabHaF operon expressed from the promoter PfabHaF is negatively 
regulated by FapR, a repressor of genes involved in membrane lipid biosynthesis (37). 
-galactosidase activity in strain HB13001 containing an ectopically located PfabHaF -
P5-lacZ fusion (Figure 2.1B) inserted at amyE increased by ~2-fold in response to 
alkaline shock, whereas no induction was noted for the corresponding PfabHaF -P5*-
lacZ fusion strain. Thus, W-dependent activation of P5 has a measurable impact even 
in the presence of PfabHaF.  
Activating W increases FabF and reduces FabHa. To determine how P5 affects 
FabHa and FabF protein levels, strains with ectopic copies of fabHa and fabF 
containing C-terminal FLAG sequences (HB13054 and HB13056, respectively) were 
constructed. The fabHa-flag and fabF-flag constructs were expressed under the control 
of both native promoters (PfabHaF and P5) to ensure that the amount of FabHa-FLAG 
and FabF-FLAG within the cell approximated wild type levels and was appropriately 
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influenced by P5. Since P5 is part of the 
W
 regulon, it was activated using a xylose-
inducible copy of sigW. Induction of W reduced FabHa-FLAG (HB13058) levels by 
~4-fold and increased FabF-FLAG (HB13060) by ~3-fold compared to uninduced 
control cells (Figure 2.1C). In contrast, expression was unaffected in control strains 
lacking the Pxyl-sigW fusion (Figure 2.1C) or containing the inactive P5* promoter 
(Figure S2.2A). Analogous experiments using alkaline shock to activate W resulted in 
similar effects, albeit of reduced magnitude: FabHa decreased by 53% while FabF 
increased by 25% (Figure S2.2B). Thus, P5 activation directly downregulates FabHa 
and upregulates FabF protein levels. 
Activation of W alters membrane composition. B. subtilis has two initiating 
condensing enzymes, FabHa and FabHb, that have been biochemically characterized 
(Figure 2.1D): Both enzymes utilize branched-chain primers (that become branched 
fatty acids) but FabHb is significantly more capable of utilizing the straight chain 
precursor acetyl-CoA (11). The function of the two condensing enzymes in vivo was 
assessed by determining the FA composition of knockout strains. The inactivation of 
FabHa (HB 13127) led to a significant increase in the proportion of straight-chain FA 
(Table 2.2) with a concomitant increase in 31:0-carbon phosphatidylethanolamine 
species (Figure 2.2A & 2.2B) compared to W168. The phosphatidylglycerol molecular 
species profiles were the same as phosphatidylethanolamine (not shown), consistent 
with phosphatidic acid being a common precursor to both phospholipids. The fabHB 
deletion strain (HB13115) had a FA composition (Table 2) and molecular species 
composition (2.2A & 2.2C) similar to strain W168, although there was a small 
decrease in the proportion of straight-chain FA. These data are consistent with the  
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Figure 2.2:  Phosphatidylethanolamine molecular species of genetically modified 
strains.  The phosphatidylethanolamine molecular species fingerprint was obtained by 
ESI mass spectrometry of cells grown under inducing conditions (+ xylose). Data 
shown are representative of least three separate experiments performed in biological 
triplicates. 
A. Wild-type control strain (W168) 
B.  fabHa::MLS  (HB13127) 
C.  fabHb::kan (HB13115) 
D.  PfabHaF-fabHa(P5)fabF Pxyl-sigW (HB13121) 
E. PfabHaF-fabHa(P5*)fabF Pxyl-sigW (HB13122) 
F.  fabHa::MLS Pxyl-fabF (HB13132).  
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Table 2.2:  The effect of W on membrane composition and fluidity 
 
Strain W168 
PfabHaF-
fabHa(P5)-
fabF Pxyl-
sigW 
PfabHaF-
fabHa(P5*)- 
fabF Pxyl-
sigW 
fabHa::MLS fabHb::kan Pxyl-fabF 
fabHa::MLS 
Pxyl-fabF 
% C15:0 iso a 9.6 ± 0.6 6.5 ± 0.8 10.7 ± 1.4 1.8 ± 0.8 15.6 ± 0.3 6.5 ± 0.9 1.9 ± 0.2 
% C15:0 
anteiso a 
40.0 ± 3.1 31.8 ± 3.2 42.2 ± 2.4 30.3 ± 1.9 39.0 ± 2.8 32.4 ± 3.1 30 .0 ± 2.7 
% C16:0 iso a 3.6 ± 0.4 2.3 ± 0.5 1.7 ± 0.5 5.2 ± 0.4 4.8 ± 0.8 3.5 ± 1.1 4.3 ± 0.4 
% C16:0 a 8.3 ± 1.6 8.3 ± 0.5 7.5 ± 1.1 22.2 ± 1.8 6.8 ± 1.2 8.5 ± 1.6 16.8 ± 1.2 
% C17:0 iso a 10.3 ± 2.0 9.0 ± 1.7 8.1 ± 0.7 4.8 ± 0.7 10.6 ± 2.2 11.9 ± 2.4 5.4 ± 1.0 
% C17:0 
anteiso a 
26.0 ± 1.8 32.5 ± 0.8 24.8 ± 2.1 27.7 ± 0.7 20.3 ± 0.4 34.0 ± 2.0 35.4 ± 2.2 
% C18:0 a 2.2 ± 0.6 9.6 ± 1.0 2.8 ± 0.8 7.8 ± 1.1 2.0 ± 0.7 3.3 ± 0.4 6.0 ± 0.9 
% straight FAs a 
10.5 ± 1.0 17.9 ± 1.2 10.3 ± 1.1 29.3 ± 0.7 8.8 ± 1.0 11.8 ± 1.8 22.0 ± 0.7 
% iso FAs a 
23.5 ± 2.9 17.8 ± 2.9 20.6 ± 1.6 11.4 ± 1.1 31.0 ± 2.0 21.9 ± 3.9 12.0 ± 1.3 
% anteiso FAs a 
66.0 ± 3.5 64.3 ± 3.9 67.0 ± 2.1 58.0 ± 1.5 59.3 ± 2.5 66.4 ± 4.0 65.7 ± 0.9 
17:15 FA ratio a 
0.73 ± 0.07 1.08 ± 0.09 0.62 ± 0.08 1.03 ± 0.11 0.57 ± 0.08 1.18 ± 0.12 1.32 ± 0.22 
Fluorescence 
anisotropy 
analysisb 
0.185 ± 
0.005 
0.217 ± 
0.003 
0.202 ± 
0.004 
ND ND ND ND 
 
a 
Data derived from FAME analysis of the following strains under xylose inducing conditions: W168, 
PfabHaF-fabHa(P5)fabF Pxyl-sigW (HB13121), PfabHaF-fabHa(P5*)fabF Pxyl-sigW (HB13122) fabHa::MLS  
(HB13127), fabHb::kan (HB13115), Pxyl-fabF (HB13128), and fabHa::MLS Pxyl-fabF (HB13132).  
Data is presented as the average of three trials (± standard error).
 
b 
Data derived from fluorescence anisotropy analysis of the wild type (W168), PfabHaF-fabHa(P5)fabF 
amyE::Pxyl-sigW (HB13121), and PfabHaF-fabHa(P5*)fabF amyE::Pxyl-sigW (HB13122) strains under xylose 
inducing conditions. Data is presented as the average of three trials (± standard error).  Student’s t-tests 
were performed, and all three values were found to be statistically different (P value < 0.05) from each 
other. 
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biochemical properties of the two enzymes and indicate that FabHa is the principal 
condensing enzyme responsible for the initiation of FA synthesis in non-stressed B. 
subtilis cells. A decrease in branched-chain FA synthesis is seen following W 
activation when P5 is present (in strain PfabHaF-fabHa(P5)fabF Pxyl-sigW; HB13121), 
but not in the strain with the mutant P5* promoter (PfabHaF-fabHa(P5*)fabF Pxyl-sigW; 
HB13122) consistent with the observed downregulation of FabHa expression and an 
increased reliance on FabHb (Table 2; Figure 2.2D & 2.2E). 
 Activation of W (HB13121) also led to an increase in average FA chain 
length. As measured by the ratio of 17 to 15 carbon length FA (17:15 ratio), activation 
of W led to an increase from 0.73 (wild-type) to 1.08. This increase was not observed 
(ratio of 0.62) in the strain containing the inactive P5* promoter (HB13122, Table 2.2). 
An increase in FabF expression is sufficient to account for the increase in 17:15 ratio 
since overexpression of FabF led to a ratio of 1.18 in strain HB13128. However, an 
increase in FabF levels alone does not account for all effects of W on FA chain 
length: a hallmark of W activation is the appearance of the C33:0 
phosphatidylethanolamine species (Figure 2.2D) that reflects a significant increase in 
18 carbon FA (Table 2.2). Overexpression of FabF (HB13128) led to only a modest 
increase in 18 carbon FA chains which was substantially increased when combined 
with a fabHa null mutation (HB13132) (Table 2.2, Figure 2.2F). Thus, an increase in 
the supply of 16 carbon acyl-ACP due to the down-regulation of FabHa provides the 
substrate for FabF elongation to an 18 carbon acyl-ACP. We conclude that the 
influence of W on FA synthesis results from both the down-regulation of FabHa and 
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the up-regulation of FabF protein levels. The net effect is an increase in both the 
proportion of straight-chain FA and the average FA chain length leading to an altered 
phospholipid molecular signature indicative of a less fluid bilayer. 
The W-dependent changes in membrane composition reduce membrane fluidity. 
To determine whether these W-dependent changes in FA composition were sufficient 
to significantly alter membrane fluidity we monitored the fluorescence anisotropy of 
B. subtilis cells using 1,6-diphenyl-1,3,5-hexatriene (DPH). For this analysis we used 
isogenic strains expressing the intact fabHa-fabF operon containing either P5 
(HB13121) or the inactive P5* point mutation (HB13122) following treatment with 
xylose to induce W for 30 minutes. Induction of W led to a substantially higher 
anisotropy (a lower degree of rotational freedom) consistent with alterations in 
membrane composition that reduce fluidity (Table 2.2). The control strain carrying the 
inactive P5* promoter exhibited a smaller increase in anisotropy indicating that 
although P5 reduces membrane fluidity, other 
W
-dependent pathways may also 
contribute to this reduction. The magnitude of the change in anisotropy dependent on a 
functional P5 promoter was comparable to that previously reported for a shift in 
growth temperature from 37
o
C to 25
o
C (3), consistent with the hypothesis that P5 can 
have a physiologically relevant impact on membrane fluidity. 
W contributes to detergent resistance by activating P5. Activation of 
W
 confers 
resistance to numerous cell envelope active antibiotics and detergents such as 
vancomycin and triton X-100 (29). The resistance to antibiotics and detergents in 
strains containing the intact fabHa-fabF operon with either P5 (HB13117) or the 
inactive P5* promoter (HB13118) was compared to a sigW null mutant (HB6208) 
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using disk diffusion assays. All of the detergents tested (triton X-100, N-lauryl 
sarcosine, DTAB, amitriptyline, and bile salts) had larger zones of inhibition in the 
P5* strain than in the strain containing active P5, although the effects were not as 
pronounced as in the sigW null mutant (Figure 2.3). Therefore, W-dependent 
alteration of membrane fluidity via activation of P5 contributes to detergent resistance. 
In contrast, activation of P5 did not affect resistance to either the membrane-active 
antibiotic daptomycin or the cell wall antibiotic vancomycin (Figure S2.3). 
To determine whether detergent resistance is due to downregulation of FabHa, 
up-regulation of FabF, or both, we monitored detergent resistance in the fabHa::MLS 
(HB13127), fabHb::kan (HB13115), and xylose-inducible Pxyl-fabF (HB13128) 
strains. Although inactivating fabHa had little effect on detergent susceptibility, 
inactivating fabHb increased detergent susceptibility (Figure 2.3). The increased 
susceptibility of the fabHb null strain underscores the importance of FabHb-initiated 
straight-chain fatty acids in detergent resistance which is driven by FabHa 
downregulation. The absence of a resistance phenotype in the fabHa::MLS strain 
could be attributed to the fact that deleting fabHA also removes P5 which renders the 
strain incapable of upregulating FabF in response to stress. Finally, the FabF-
overexpressing strain was more resistant to all detergents tested illustrating the 
contribution of chain length to resistance (Figure 2.3). We conclude that both effects 
of W activation contribute to the detergent resistance phenotype. 
W contributes to resistance to antimicrobials made by other Bacillus spp. by 
activating P5. The 
W
 regulon also confers resistance to antimicrobial compounds 
produced by other Bacillus species (6). We used a spot-on-lawn assay in which an 
 64 
 
Figure 2.3: Disk diffusion assays of detergent sensitivity for the PfabHaF-
fabHa(P5)fabF control (HB13117), PfabHaF-fabHa(P5*)fabF (HB13118),  sigW::spec 
(HB6208), fabHa::MLS  (HB13127), fabHb::kan (HB13115), and Pxyl-fabF 
(HB13128) strains. Each bar represents the average zone of inhibition of at least three 
assays performed with three independent clones of each strain.  The y axis shows the 
zone of inhibition (in millimeters), expressed as total diameter minus diameter of the 
filter paper disk (5.5 mm). Note that the scales of individual compounds vary for 
clarity. Error bars represent standard error.  Student’s t tests were performed, and P5*, 
sigW::spec, fabHb::kan, and Pxyl-fabF were found to be significantly different (P 
value < 0.05) from the wild-type control for all four stresses.  The P5* and sigW::spec 
strains were also significantly different from each other under triton X-100, N-lauryl 
sarcosine, and amitriptyline treatment. 
A. triton X-100 
B. N-lauryl sarcosine  
C. bile salts  
D. amitriptyline 
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antibiotic producing strain is spotted at high cell density on a lawn of the target strain 
to test whether W activation of P5 affects interspecies competition. The six Bacillus 
species tested are known to produce compounds to which W confers resistance (6). 
When the reporter (lawn) strain contained the inactive P5* promoter there was an 
increased sensitivity to compound(s) produced by three strains: B. amyloliquefaciens, 
B. subtilis ssp. spizizenii 2A8
T
, and B. atrophaeus ESM rplV str (Figure 2.4). No 
significant P5-dependent differences in sensitivity were observed with B. subtilis ssp. 
spizizenii 2A9 (Figure 2.4), B. licheniformis, or B. atrophaeus NRS-213 (Figure S2.4) 
as the producer strains. In those strains where P5-dependent modulation of membrane 
composition may be important, the P5* strain was not as sensitive as the sigW null 
strain (Figure 2.4), consistent with the previous demonstration that other W-
dependent operons contribute to antimicrobial resistance (6).  
 
2.5 Conclusion 
Our study uncovers a novel ECF  factor dependent pathway that protects against 
environmental insults to the cell membrane by altering FA synthesis to produce a more 
rigid phospholipid bilayer. A unique aspect of the system is the presence of an 
internal, sense-oriented W promoter that reduces the expression of the gene it is 
within (fabHa) and elevates expression of the downstream gene (fabF). The 
coordinate decrease in FabHa and increase in FabF protein levels combine to produce 
a bilayer with a different constellation of phospholipid species that leads to decreased 
fluidity. This biophysical response contributes to adaptation to membrane active 
compounds like detergents and some, yet uncharacterized, antimicrobial compounds  
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Figure 2.4: Spot on lawn assays depicting the sensitivity of the pMUTIN-P5 
(HB13117), pMUTIN-P5* (HB13118), and sigW::spec (HB6208) lawn strains to spots 
of B. amyloliquefaciens FZB42, B. subtilis subsp. spizizeni 2A8
T
, B. atrophaeus ESM 
rplV str, and B. subtilis subsp. spizizenii 2A9. The relative sensitivity of the lawn 
strains to each spotted strain is reflected by the size of the spot and the zone of 
inhibition surrounding it after 24 hours growth.  A larger spot size and zone of 
inhibition represents increased sensitivity of the lawn strains to the metabolites 
produced by the spotted strains.  Pictures are representative of at least three assays 
performed with three independent clones of each strain. 
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produced by other Bacilli. The alterations of membrane phospholipid composition 
observed upon genetic manipulations of FabHa, FabHb and FabF expression further 
illustrate the relative importance of each of these enzymes in modulating membrane 
FA composition and thereby the resistance of cells to environmental insults.   
The mechanism by which changes in FabHa and FabF protein levels affect FA 
composition are understood based on prior enzymological analysis in this and other 
systems.  FabH condenses an acyl-CoA with malonyl-ACP to form a 3-ketoacyl-ACP 
that initiates new cycles of FA elongation (44). The two B. subtilis FabH isozymes, 
FabHa and FabHb (27), catalyze the same reaction although FabHb has a higher 
specific activity for straight chain FA substrates than FabHa (11). Thus, 
downregulation of FabHa by W increases the proportion of straight chain FAs by 
increasing the cell's reliance on FabHb (Figure 2.1D). The other enzyme affected by 
P5 is FabF, the elongation condensing enzyme that adds two carbons to the growing 
FA chain in each round of elongation (44). As the only elongation condensing enzyme 
in B. subtilis, FabF activity plays a determining role in the final chain length of the 
acyl-ACP (31, 36). The acyl-ACPs have 3 possible fates: 1) conversion to acyl-PO4 by 
PlsX; 2) acylation of lysophosphatidic acid by PlsC; or 3) elongation by another 2 
carbons by FabF. Therefore, the W-dependent upregulation of FabF alters the 
competitive balance between these 3 fates to increase the average FA chain length, as 
illustrated in strains where FabF is conditionally induced under xylose control. 
Together, these increases in the proportion of straight chain FA and average FA chain 
length reduce membrane fluidity. Sequence comparisons suggest that this regulatory 
mechanism is likely conserved in those Bacillus spp. containing two FabH paralogs, 
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but conservation of the P5 promoter is not apparent in more distantly related bacteria 
that contain neither fabHb nor an obvious sigW ortholog (Table S1). In Streptococcus 
pneumoniae a similar regulatory effect is exerted instead by the essential YycFG TCS 
which downregulates fabH, upregulates fabF, and increases the average FA chain 
length of phospholipids in the plasma membrane (33). The physiological role for this 
homeoviscous adaptation could be similar to that of the P5 pathway. Unlike the 
situation in B. subtilis, Listeria monocytogenes has only a single FabH which displays 
an altered substrate specificity at different temperatures and thereby contributes to 
temperature-dependent adjustments in membrane fluidity (38). 
One of the best characterized mechanisms of homeoviscous adaptation is the 
DesRK TCS of B. subtilis that regulates expression of a FA desaturase to conditionally 
increase membrane fluidity (Aguilar & Mendoza, 2006). This system is initiated by 
the sensor kinase DesK which becomes activated in response to an increase in 
membrane thickness due to a temperature decrease (12). In contrast with DesRK, 
which is activated by conditions that decrease membrane fluidity, the W-dependent 
response can be activated, either directly or indirectly, by conditions that increase 
membrane fluidity. The W regulon mediates resistance to antimicrobial compounds 
by activating expression of detoxification enzymes, immunity proteins, and efflux 
pumps. Here, we extend this suite of mechanisms to include chemical alterations to the 
membrane that contribute to resistance against the action of membrane-destabilizing 
compounds. Since the W regulon is induced by detergents and related membrane-
active compounds, this system provides a novel mechanism of homeoviscous 
adaptation. 
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2.7 Supplementary information 
Table S2.1:  Consensus P5 nucleotide sequences in B. subtilis and related species  
 
a
 For each sequence, the region corresponding to the P5 -35 and -10 elements is underlined.  
b
 Bacillus subtilis subsp. subtilis str. 168, Bacillus subtilis subsp. spizizenii str. W23, Bacillus 
licheniformis ATCC 14580, Bacillus atrophaeus 1942, Bacillus pumilus SAFR-032, and Bacillus 
amyloliquefaciens DSM7 
c
 Bacillus anthracis str. Sterne, Bacillus thuringiensis str. Al Hakam, Bacillus cereus ATCC 14579, and  
Bacillus cereus subsp. cytotoxis NVH 391-98 
d 
Includes all 17 listeria/Staphylococcus genomes on the U Chicago SEED server 
(http://www.theseed.org) 
 
Note:  Residues W38, R42, and T43 are part of the FabH substrate binding site.  W38 
and T43 (last residue shown) are highly conserved with R42 showing some variability 
(15).  
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Table S2.2: Bacterial strains, plasmids, and oligos used in Chapter 2. 
 
Strain, 
plasmid, 
or oligo 
Genotype or description 
Source, reference, or 
construction1 
        B. subtilis strains   
W168 trpC2 Lab Stock 
HB0020 CU1065 sigW::MLS (7) 
HB6208 W168 sigW::spec (6) 
HB13001 W168 amyE::PfabHaF-P5-lacZ
 pTK001 --> W168 
HB13042 W168 amyE::Pxyl-sigW pVG003 --> W168 
HB13054 W168 thrC::PfabHaF-fabHa-FLAG
 pTK013 --> W168 
HB13056 W168 thrC::PfabHaF-fabHa-fabF-FLAG
 pTK015 --> W168 
HB13058 W168 thrC::PfabHaF-fabHa-FLAG amyE::Pxyl-sigW HB13042 chrDNA --> HB13054 
HB13060 W168 thrC::PfabHaF-fabHa-fabF-FLAG amyE::Pxyl-sigW HB13042 chrDNA --> HB13056 
HB13069 W168 amyE::P5-lacZ
 pTK022 --> W168 
HB13077 W168 thrC::PfabHaF-fabHa-FLAG sigW::kan HB0020 chrDNA --> HB13054 
HB13078 W168 thrC::PfabHaF-fabHa-fabF-FLAG  sigW::kan HB0020 chrDNA --> HB13056 
HB13080 W168 amyE::P5*-lacZ
 pTK031 --> W168 
HB13082 W168 PfabHaF-P5*-lacZ
 pTK033 --> W168 
HB13099 W168 amyE::P5-lacZ sigW::MLS  HB0020 chrDNA --> HB13069 
HB13115 W168 fabHb::kan LFH-PCR --->168 
HB13117 W168 PfabHaF-fabHa(P5)fabF pTK043 --> W168 
HB13118 W168 PfabHaF-fabHa(P5*)fabF
 pTK044 --> W168 
HB13121 W168 PfabHaF-fabHa(P5)fabF amyE::Pxyl-sigW HB13042 chrDNA --> HB13117 
HB13122 W168 PfabHaF-fabHa(P5*)fabF amyE::Pxyl-sigW
 HB13042 chrDNA --> HB13118 
HB13123 W168 thrC::PfabHaF-fabHa(P5*)-FLAG 
 pTK045 --> W168 
HB13124 W168 thrC::PfabHaF-fabHa(P5*)-fabF-FLAG 
 pTK046 --> W168 
HB13125 W168 thrC::PfabHaF-fabHa(P5*)-FLAG amyE::Pxyl-sigW HB13042 chrDNA --> HB13123 
HB13126 
W168 thrC::PfabHaF-fabHa(P5*)-fabF-FLAG amyE::Pxyl-
sigW HB13042 chrDNA --> HB13124 
HB13127 W168 fabHa::MLS 
 LFH-PCR --->168 
HB13128 W168 amyE::Pxyl-fabF 
 pTK047 --> W168 
HB13132 W168 fabHa::MLS amyE::Pxyl-fabF HB13128 chrDNA --> HB13127 
BSU2006 W168 sigM sigY sigZ sigV ylaC sigX (2) 
HB13151 W168 sigM sigY sigZ sigV ylaC sigX P5-lacZ HB13069 chrDNA --> BSU2006 
      
Plasmids     
pdg1661 Vector for integration of lacZ fusions at amyE  (16) 
pdg1664 Vector for integration at thrC locus (16) 
pMUTIN Vector for allelic replacement (42) 
pVG003 pSWEET-sigW (cat) 
Veronica Guariglia-Oropeza  
(unpublished results) 
pTK001 pDG1661-PfabHaF-P5-lacZ (cat) This work 
pTK013 pDG1664-PfabHaF-fabHa-FLAG (MLS) This work 
pTK015 pDG1664-PfabHaF-fabHa-fabF-FLAG (MLS) This work 
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pTK022 pDG1661-P5-lacZ (cat) This work 
pTK031 pDG1661-P5*-lacZ (cat) This work 
pTK033 pDG1661-PfabHaF-P5*-lacZ (cat) This work 
pTK043 pMUTIN- PfabHaF-P5 (MLS) This work 
pTK044 pMUTIN- PfabHaF-P5* (MLS) This work 
pTK045 pDG1664-PfabHaF-fabHa(P5*)-FLAG (MLS) This work 
pTK046 pDG1664-PfabHaF-fabHa(P5*)-fabF-FLAG (MLS) This work 
pTK047 pSWEET-fabF (cat) This work 
 
Oligos Name Sequence 
4520 P5 GSP1 CGTACATGAAGCCCGCACA 
4521 P5 GSP2 CCGAGTTGTTCTTGAATCATA 
4549 AAP GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG 
4778 FabHa UP BamHI AGCTGGATCCCAACTGCATACGCCTCCTT 
4780 FabHa Flag DO EcoRI 
AGCTGAATTCTTATTATTTATCATCATCATCTTTATAA
TCCGGCCGAACGACCACATCGCCGTCT 
4781 FabF Flag DO EcoRI 
AGCTGAATTCTTATTATTTATCATCATCATCTTTATAA
TCCGGCCGGAATCCTAATGAGTTGCTGA 
4883 P5 Fwd cgGa -10 element 
TCTGACGAGTGGATTCGGACAAGAACAGGAATAGAA
G 
4884 P5 Rev cgGa -10 element TCTATTCCTGTTCTTGTCCGAATCCACTCGTCAGAAG 
4576 PfabHaF-P5 UP EcoRI AGTCGAATTCCAACTGCATACGCCTCCT 
4577 P5 DO BamHI AGTCGGATCCCGTACATGAAGCCCGCACA 
4852 P5 UP EcoRI AGTCGAATTCAGGATAGAATTAGTACCTGATA 
5059 fabHb up-fwd CGTACAAAACAAGCAGAGACA 
5060 fabHb up-rev (kan) 
CCTATCACCTCAAATGGTTCGCTGTCACTCCTTATGG
TCAGATTA 
5061 fabHb do-fwd (kan) 
CGAGCGCCTACGAGGAATTTGTATCGGATTAACCTAT
ACAGGATTGCT 
5062 fabHb do-rev GACAGGAAGCAGCCAAGTAT 
5164 PfabHaF-up-rev (MLS) 
GAGGGTTGCCAGAGTTAAAGGATCGATGTGTTTTCAA
GAATGATGT 
5165 PfabHaF-do-fwd (MLS) 
CGATTATGTCTTTTGCGCAGTCGGCCAACTGCATACG
CCTCCTT 
5166 PfabHaF-do-rev TTAGTCATTAGGGAAGACTCCTTTATATCT 
5167 fabF-do-fwd 
AGATATAAAGGAGTCTTCCCTAATGACTAAAAAAAG
AGTAGTTGT 
5168 fabF UP RBS PacI 
AGTCTTAATTAAAGGAGGACACAAGATGACTAAAAA
AAGA 
5169 fabF DO BamHI AGTCGGATCCTCATGTGATCGCCTCCTCT 
   
Other Bacillus Strains Bacillus Genetic Stock Center (BGSC) # 
B. subtilis ssp. spizizenii NRRL B-23049 2A8T 
B. subtilis ssp. spizizenii NRRL B-14472  2A9 
B. licheniformis ATCC14580  5A36T 
B. amyloliquefaciens FZB42 NA 
B. atrophaeus NRS-213  11A2T 
B. atrophaeus ESM rplV str  12A1 
1  
Abbreviations used:  --> indicates transformation;  chrDNA indicates chromosomal DNA.  
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Figure S2.1: Disk diffusion assays to monitor induction of P5-lacZ by cell envelope 
antibiotics. Representative results are shown for HB13069 (P5-lacZ), HB13151 (P5-
lacZ sigM sigY sigZ sigV ylaC sigX), and HB13099 (P5-lacZ sigW::MLS) 
under triton X-100 (top disk), vancomycin (bottom left disk), and polymyxin B 
(bottom right disk) treatments.  Pictures are representative of at least three independent 
experiments performed with biological triplicates.   
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Figure S2.2:  Supplementary Western blot quantification.   
A. Change in expression of FabHa-FLAG in fabHa(P5*)-FLAG Pxyl-sigW (HB13125) 
and of FabF-FLAG in fabHa(P5*)-fabF-FLAG Pxyl-sigW (HB13126) upon xylose 
treatment. This experiment was performed in biological triplicate and repeated at least 
three times. Bars represent the relative levels of FabHa-FLAG or FabF-FLAG 
compared to an untreated control (error bars indicate standard error). Student’s t tests 
showed no statistically significant difference (P value > 0.05) between the xylose and 
non-xylose treated cells for both FabHa-FLAG and FabF-FLAG expression.  
B. Change in expression of FabHa-FLAG and FabF-FLAG levels following alkaline 
shock in strains fabHa-FLAG (HB13054),  fabF-FLAG (HB13056),  fabHa-FLAG 
sigW::kan (HB13077), and fabF-FLAG sigW::kan (HB13078). Bars represent the 
relative levels of FabHa-FLAG or FabF-FLAG compared to an untreated control with 
error bars indicating standard error.   Student’s t tests showed a statistically significant 
difference (P value < 0.05) between the fabHa-FLAG and fabHa-FLAG sigW::kan 
strains, but a non-significant difference (P value > 0.05) between the fabF-FLAG and 
fabF-FLAG sigW::kan strains. 
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Figure S2.3: Disk diffusion assays of vancomycin (A) and daptomycin (B) sensitivity 
in the PfabHaF-fabHa(P5)fabF (HB13117), and PfabHaF-fabHa(P5*)fabF (HB13118) 
strains.  Each bar represents the average zone of inhibition of at least three assays 
performed with three independent clones of each strain. Error bars represent standard 
error. Student’s t tests were performed, and the zones of inhibition for the two strains 
were not significantly different (P value > 0.05) under vancomycin or daptomycin 
treatment. 
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Figure S2.4: Spot on lawn assays showing the sensitivity of the PfabHaF-
fabHa(P5)fabF (HB13117), PfabHaF-fabHa(P5*)fabF (HB13118), and sigW::spec 
(HB6208) lawns to B. licheniformis ATCC14850 and B. atrophaeus NRS-213.  
Pictures are representative of at least three assays performed with three independent 
clones of each strain. 
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CHAPTER 3 
CONTRIBUTIONS OF THE W, M, AND X REGULONS TO THE 
LANTIBIOTIC RESISTOME OF BACILLUS SUBTILIS
1
 
 
3.1 Summary 
In Bacillus subtilis, the extracytoplasmic function (ECF)  factors M, W, and X all 
contribute to resistance against lantibiotics. Nisin, a model lantibiotic, has a dual mode 
of action: it inhibits cell wall synthesis by binding lipid II, and this complex also forms 
pores in the cytoplasmic membrane. These activities can be separated in a nisin hinge-
region variant (N20P M21P) that binds lipid II, but no longer permeabilizes 
membranes. The major contribution of M to nisin resistance is expression of ltaSa, 
encoding a stress-activated lipoteichoic acid synthase, and X functions primarily by 
activation of the dlt operon controlling D-alanylation of teichoic acids. Together, M 
and X regulate cell envelope structure to decrease access of nisin to its lipid II target. 
In contrast, W is principally involved in protection against membrane 
permeabilization as it provides little protection against the nisin hinge region variant. 
W contributes to nisin resistance by regulation of a signal peptide peptidase (SppA), 
phage shock proteins (PspA and YvlC, a PspC homolog), and tellurite resistance 
related proteins (YceGHI). These defensive mechanisms are also effective against 
other lantibiotics such as mersacidin, gallidermin, and subtilin and comprise an 
important subset of the intrinsic antibiotic resistome of B. subtilis.  
1
The results of this study are pending publication in Molecular Microbiology. Authors: 
Kingston AW, Liao X, and Helmann JD.  X.L. contributed to some disk diffusion 
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assays and β-galactosidase assays.  All other experiments were performed by A.W.K. 
A.W.K and J.D.H wrote the manuscript. 
 
3.2 Introduction 
As a normal resident of the soil and rhizosphere, B. subtilis encounters a 
diverse array of antimicrobial compounds produced by competing microbes, including 
other Bacilli. Typically, gene clusters involved in antibiotic production encode 
specific immunity functions that protect the producer organism against self-imposed 
toxicity. However, non-producers also display significant intrinsic antibiotic 
resistance, imparted by genes collectively known as the antibiotic resistome (89). In 
many cases, key components of the resistome are induced when cells encounter 
antibiotics and, as explored here, this induction may be mediated by extracytoplasmic 
function (ECF)  factors. 
 Antimicrobial compounds often target the cell envelope by inhibiting the 
synthesis or impairing the function of the peptidoglycan cell wall (74) and the 
phospholipid membrane (35). Upon encountering cell envelope active antibiotics, B. 
subtilis activates the expression of one or more cell envelope stress responses 
(CESRs), often including genes that protect against antibiotic-mediated killing (40). 
Here, we focus specifically on the responses to a subset of bacterially produced 
peptide antibiotics (bacteriocins) known as lantibiotics (14) and the corresponding 
lantibiotic resistance determinants.  
Lantibiotics (class I bacteriocins) are antimicrobial peptides containing 
lanthionine, thioether bridged amino acids that introduce intramolecular rings within 
the peptide. They play critical roles in interspecies competition (64) and share 
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similarities with cationic antimicrobial peptides (CAMPs) produced by the immune 
systems of humans and higher organisms (63, 79) (72). In addition, lantibiotics show 
promise for clinical applications because they are effective against a wide spectrum of 
Gram positive bacteria including known pathogens (7) (16) (20) (50). The most widely 
used and extensively studied lantibiotic is nisin, a 34 amino acid cationic antimicrobial 
peptide produced by Lactococcus lactis. This bacteriocin is active against a broad 
range of Gram-positive bacteria and has been used as a food preservative for almost 
60 years (14, 17, 20). Partly because of its ubiquity, nisin serves as a model for 
studying lantibiotics (5). 
Nisin employs a potent mechanism of action that is shared by many 
lantibiotics. Nisin binds with high affinity to lipid II (30), a membrane bound cell wall 
precursor essential for peptidoglycan synthesis. Once bound, nisin permeabilizes the 
membrane through lipid-II-dependent pore formation. Pore formation is made possible 
by a flexible hinge region in the middle of the peptide that allows the C-terminus to 
insert into the membrane while the N-terminus remains bound to lipid II (5). Thus, 
nisin has a dual mechanism and acts both by inhibiting cell wall synthesis and 
disrupting cell membrane integrity. Other lantibiotics that share this dual mechanism 
of action (such as subtilin, ericin, gallidermin, epidermin and entianin) are usually type 
A(I) lantibiotics (linear peptides) whereas type B lantibiotics (globular peptides), such 
as mersacidin and cinnamycin typically bind lipid II, but do not insert into membranes 
(37). 
In the presence of nisin, B. subtilis activates multiple CESR pathways 
including those controlled by ECF  factors (collectively, ECF) and two component 
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systems (9, 65). B. subtilis encodes seven ECF  factors, among which four (σM, σW, 
σX, and V) are known to be activated by, and confer resistance against, cell envelope 
active compounds (18, 23, 31). These four ECF  factors are activated by overlapping 
sets of cell envelope stresses and subsequently up-regulate distinct, but overlapping, 
sets of genes that confer resistance (53). 
In this study, we demonstrate that M, W, and X contribute to intrinsic nisin 
resistance through their collective activation of six operons: pspA, yvlC, sppA, ltaSa, 
dltABCD, and yceGHI. The M and X controlled operons contribute broadly to 
lantibiotic resistance including compounds that bind lipid II, but do not permeabilize 
the membrane. In contrast, W regulated genes function primarily to protect against 
the membrane-permeabilization activity of lantibiotics. These same resistance 
determinants protect against related lantibiotics, such as gallidermin and mersacidin, 
and against competing Bacillus strains that produce lantibiotics and other 
antimicrobial compounds.  
 
3.3 Materials and methods 
Strains, plasmids, and growth conditions. All B. subtilis strains, plasmids, and 
oligonucleotides (oligos) used in this study are listed Table S7. Bacteria were grown in 
liquid Luria-Bertani (LB), penassay broth (PAB), Belitsky minimal (MM) (78) or 
Mueller Hinton (MH)  medium at 37°C with vigorous shaking or on solid LB or MH 
medium containing 1.5% Bacto agar (Difco) with appropriate selection. Plasmids were 
amplified in Escherichia coli DH5 before transformation of B. subtilis strains. 
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Ampicillin (amp; 100 g ml-1), kanamycin (kan; 30 g ml-1), chloramphenicol (cat; 34 
g ml-1) were used to select E. coli transformants. For B. subtilis, antibiotics used for 
selection were: spectinomycin (spec; 100 g ml-1), kanamycin (kan; 15 g ml-1), 
chloramphenicol (cat; 10 g ml-1), tetracycline (20 g ml-1), neomycin (neo; 10 g ml-
1
), and macrolide-lincosoamide-streptogramin B (MLS; contains 1 g ml-1 
erythromycin and 25 g ml-1 lincomycin).  
Genetic techniques. Chromosomal and plasmid DNA transformations were 
performed as described previously (29). Unless otherwise stated, all PCR products 
were generated using WT168 chromosomal DNA as a template and all strains were 
verified by sequence analysis (Cornell University Life Sciences Core Laboratories 
Center). Gene deletions were generated using long-flanking homology PCR (LFH-
PCR) as described previously (54). 
Disk diffusion assays. Disk diffusion assays were performed as described (53). 
Briefly, strains were grown to an OD600 of 0.4. A 100 μl aliquot of these cultures was 
mixed with 4 ml of 0.7% MH soft agar (kept at 50°C) and directly poured onto MH 
plates (containing 15 ml of 1.5% MH agar). The plates were dried for 20 min in a 
laminar airflow hood. Filter paper disks containing the chemicals to be tested were 
placed on the top of the agar and the plates were incubated at 37°C overnight. The 
distances between the edge of the inhibition zones and the edge of the filter paper 
disks were measured. For IPTG treated cells, the indicated concentration of IPTG was 
added only to the soft agar except for 1 mM IPTG treatments which contained 1 mM 
IPTG in the MH plates as well.  For promoter-lacZ strains, 80 g ml-1 X-gal (5-bromo-
4-chloro-3-indolyl-β-D-galactopyranoside) was added to the agar and the plates were 
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analyzed for the appearance of a blue ring around the edge of the zone of inhibition. 
Unless otherwise noted, the following chemicals and quantities were used in the disk 
diffusion assays: Triton X-100 10 μl of a 10% solution, sodium dodecyl sulfate 500 
μg, bile salts 1 mg, colistin 100 μg, protamine 1 mg, Clofazimine 1 mg, poly-L-lysine 
5 μg, ethylenediaminetetraacetic acid 365 μg,  polymyxin B 50 μg, novobiocin 50 μg, 
vancomycin 50 μg, daptomycin 100 μg, D-cycloserine 500 μg, mersacidin 10 μg, 
gallidermin 5 μg,  nisin 20 μg. For Nisin assays, a 2.5 mg ml-1 nisin stock solution was 
prepared by dissolving a 2.5% nisin mixture balanced with sodium chloride and 
denatured milk solids (Sigma-Aldrich Co. St. Louis, MO USA) in 0.02 M HCl.   For 
daptomycin and mersacidin assays, the media was supplemented with 1.25 mM CaCl2. 
Broth Dilution Assays 
We determined the minimal inhibitory concentration (MIC) and the 50% inhibition 
concentration (IC50) of B. subtilis strains to nisin using a variation of the broth dilution 
assay described previously (48). Briefly, strains were grown to an OD600 of 0.4 in MH 
media.  For MIC determination, strains were diluted 1:200 in MH broth, and 200 µl 
aliquots of the diluted cultures were dispensed in a Bioscreen 100-well microtitre 
plate. Each strain was grown in nisin concentrations ranging from 0.0625 to 10 µg ml
-1 
with concentrations near the MIC of a specific strain increasing by increments of 10% 
or less.  For (IC50) determination, 200 µl aliquots of the undiluted culture were 
dispensed into the wells of a Bioscreen 100-well microtitre plate. Each strain was 
grown in nisin concentrations ranging from 0.25 to 2.5 µg ml
-1
 with concentrations 
increasing by increments of 25% or less. Growth was measured 
spectrophotometrically (OD600) every 15 min for 24 h using a Bioscreen C incubator 
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(Growth Curves USA, Piscataway, NJ) at 37 °C with continuous shaking. MIC was 
defined as the lowest concentrated that prevented growth (OD600 < 0.2) at the 10 h 
time point and IC50 was defined as the lowest concentration that reduced cell density 
to OD600 < 0.2 (a 50% reduction). 
-galactosidase assays. Strains carrying promoter-lacZ fusions were grown to an 
OD600 of 0.4 in LB. Cultures were then treated with the indicated concentrations of 
nisin or control (H2O) and samples were taken 60 min after treatment. -galactosidase 
assays were performed as described by Miller (57). 
Western Blots. LTA detection in B. subtilis was adapted from Wörmann et al. (88). 
Wild-type and ltaSa::spec strains were grown to an OD600 of 0.6 in PAB media and 
treated with or without 0.5 µg ml
-1 
nisin for 60 minutes at 37 
o
C with aeration. 
Bacteria from 4.5 mL culture was pelleted by centrifugation and resuspended in 150 
µL 2x protein sample buffer per mL culture of OD600 = 3. Samples were boiled for 45 
min, centrifuged for 5 min, and a volume containing 100 ug of protein from each 
supernatant was analyzed on a 15% SDS PAGE gel.  Blocking was performed with 
3% BSA. LTA detection was accomplished with an overnight incubation in 1:250 
Gram positive bacteria LTA monoclonal antibody (Thermo Fisher Scientific Inc.; 
Rockford, IL USA) followed by a 5 hour incubation in 1:2000 anti-mouse IgG 
alkaline phosphatase (Sigma-Aldrich Co. St. Louis, MO USA). Relative levels of each 
LTA were compared using densitometry analysis with ImageJ. 
Spot-on-lawn assays. Spot-on-lawn assays were performed as described (8). Briefly, 
lawn cells were grown to an OD600 of 0.4 in LB. A 100 μL aliquot of these cultures 
was mixed with 4 mL of 0.7% LB soft agar (kept at 50°C) and directly poured onto 
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LB plates (containing 15 ml of 1.5% LB agar). Plates were dried for 20 min in a 
laminar flow hood, and 3 l of the producer strain (OD600 of 0.6) was spotted on top of 
the agar. Plates were incubated at 37°C overnight (18 h) before observation. 
Nisin production and purification. Production and purification of nisin and the 
N20PM21P nisin variant was adapted from (25) with some modifications. HE13090 
(DE3 pRSFDuet-1-His6nisAB pACYCDuet-1-NisC) and HE13091 (DE3 pRSFDuet-
1-nisAB-N20PM21P pACYCDuet-1-NisC) were each grown to an OD600 of 0.6 in 1 L 
terrific broth media containing 30 g ml-1 kan and 34 g ml-1 cat at 37 oC. The media 
was then supplemented with 0.5 mM IPTG and grown at 18 
o
C for 18 hours with 
continuous shaking. Each culture was pelleted, resuspended in 25 mL LEW buffer (50 
mM NaH2PO4, 300 mM NaCl, pH 8.0), and incubated at 4 
o
C for 30 minutes with 1 
mg ml
-1 
lysozyme. The samples were then lysed by sonication and subsequently 
centrifuged for 30 minutes at 5000 g. The resulting supernatants were each incubated 
with 0.75 g PrepEase his-tagged high yield purification resin (Affymetrix) for 30 
minutes. The resins were loaded onto columns and washed with 50 mL LEW buffer 
containing 10 mM imidazole. Prenisin was eluted from each resin with three 4 mL 
fractions of LEW buffer containing 250 mM imidazole. The eluents were concentrated 
to 0.5 mL and desalted with Amicon Ultra-4 centrifugal filtration units, 3K MWCO 
(Millipore). Concentrated prenisin was treated with 2.5 µg trypsin (Sigma) in 100 mM 
tris at pH 8.0 and incubated for 18 hours @ 37 
o
C to generate mature nisin.  At each 
step, the presence of prenisin or mature nisin was confirmed with a coomassie-stained 
tris-tricine gel. For disk diffusion assays, 10 µL of mature nisin or mature 
(N20PM21P)-nisin was used.   
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Statistical analysis. All experiments were performed with a minimum of three 
biological replicates. Unless otherwise noted, data is presented as mean ± standard 
error. Statistical evaluation of the data was performed
 
by the use of unpaired 
Student's t tests. 
 
A value of P < 0.05 was considered statistically significant. 
 
3.4 Results and discussion: 
Three ECF  factors (M, W, and X) contribute to intrinsic nisin resistance.  We 
previously reported that a B. subtilis NCIB3610 strain lacking M, W, and X (the 
MXW strain) displayed a significant increase in sensitivity to cell envelope active 
compounds and, in the case of nisin, the effects of these three  factors were additive 
(53). In subsequent studies, we analyzed a B. subtilis W168 in which all seven genes 
encoding ECF  factors were replaced by unmarked deletions (7) (3). For most 
tested compounds, the 7 strain was not significantly more sensitive than an isogenic 
MXW strain, although lantibiotics were not tested in that study (47).  
 Here, we have investigated nisin sensitivity in the B. subtilis 168 strain 
background and, consistent with previous results (53), we find that M, W, and X 
contribute additively to nisin resistance (Figure 3.1A). Removal of the four remaining 
ECF  factor genes, in the 7 strain, does not further increase nisin sensitivity. We 
also quantified the contribution of ECF  factors to nisin resistance with a broth  
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Figure 3.1: Disk diffusion assays that led to the identification of extracytoplasmic 
function sigma factor regulated nisin resistance genes. For all graphs representing disk 
diffusion assays, the y-axis shows the zone of inhibition (in millimeters), expressed as 
total diameter minus diameter of the filter paper disk (5.5 mm).  Each bar represents 
the average zone of inhibition of at least three assays performed with three 
independent clones of each strain with error bars representing standard error.  
Statistically significant differences in zone of inhibition were determined with a 
Student’s t-test (P-value 0.05).  A. Nisin sensitivity for the WT (168), M 
(HB10216), W (HB10102), X (HB10103), MW (HB13218), MX (HB13217), 
WX (HB13219), MWX (HB10107), and 7ECF (BSU2007) strains. All mutant 
strains had significantly larger zones of inhibition than the WT strain, and the MWX 
zone of inhibition was significantly larger than that of the single or double ECF  
deletion strains. B. Nisin sensitivity for the WT (168), pspA (HB13243),  yvlABCD 
(HB13242), sppA (HB13251), ltaSa (HB13210), dltA (HB12084), yceH 
(HB13281), ltaSa dltA yceH (HB13287), and MWX (HB10107) strains. All 
single gene deletion strains exhibited significantly larger zones of inhibition than the 
WT strains.  The zone of inhibition of the ltaSa dltA yceH strain was significantly 
lower than that of the MWX strain.  
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dilution assay. The MXW mutant had a 7-fold lower MIC than that of wild-type 
(0.45 ± 0.04 µg ml
-1
 vs. 3.25 ± 0.11 µg ml
-1
).    
 This ECF-mediated nisin resistance is augmented by the LiaRS two component 
system (TCS). In B. subtilis, nisin strongly activates LiaRS which upregulates the 
nisin resistance determinants LiaIH (28, 87). Our disk diffusion assays confirmed that 
liaIH null strain was significantly more sensitive to nisin than WT cells, and when  
liaIH was deleted from the MXW strain, the nisin MIC further decreased to over 11 
times its original value (0.29 ± 0.03 µg ml
-1
). 
Identification of ECF-dependent operons that confer nisin resistance. Presumably, 
the MXW strain is more susceptible to nisin because it is unable to activate the 
expression of specific, ECF-dependent resistance genes. Previous studies have defined 
the regulons activated by each of these ECF factors (9, 10, 18). Each regulon 
contains ~30-60 target genes, including several that can be activated by more than one 
ECF  factor. As a result of this regulon overlap, the total number of genes activated 
by M, W, and X is ~80 (9, 10, 18). Within these regulons, the only operon known to 
confer nisin resistance is dltABCD which encodes a pathway (Dlt) for D-alanylation of 
teichoic acids (9, 62). However, a dltA strain, previously shown to inactivate Dlt 
function (62), is not as sensitive to nisin as the MXW strain (Figure 3.1), indicating 
that there are additional ECF-activated genes that confer nisin resistance.  
To identify ECF-dependent operons that contribute to nisin resistance, we 
screened a library of strains containing mutations in operons activated by M, W, 
and/or X, with a focus on genes that are associated with the cell envelope. Although 
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many of the mutant strains did not display increased nisin sensitivity (Table S1), there 
were generally small but measurable effects for the singly mutant strains lacking pspA, 
yvlABCD, sppA, ltaSa, or yceH (Figure 3.1B). Among these mutants, the strongest 
phenotypes were observed upon inactivation of ltaSa, yceH, or dltA (Figure 3.1B), and 
a triple mutant was almost as sensitive to nisin as the MXW strain. These results 
indicate that ltaSa, yceH, and the dlt operon are each major contributors to ECF-
dependent nisin resistance in B. subtilis.  
ECF regulation of nisin resistance operons. The M, W, and X factors are all 
moderately active in growing cells, depending on growth medium and growth phase 
(47, 53, 92). However, their activities can be induced in response to a variety of cell 
envelope stress conditions. To explore the contributions of each ECF factor to both the 
basal and induced expression of these operons, we fused the promoter regions for each 
resistance determinant (PyvlA, PsppA, PpspA, PdltA, PltaSa, and PyceC) to the lacZ reporter 
gene and integrated the resulting promoter-lacZ fusions into both WT and various 
ECF backgrounds. Initial studies were done using disk diffusion assays which 
provide a gradient of antibiotic concentrations and thereby allow a clear qualitative 
visualization of promoter induction. Strong induction was noted in response to both 
vancomycin and triton X-100, consistent with prior studies (10, 18, 65). More modest 
induction was seen in response to nisin (Table 3.1, and Figure S3.1). In the sigW 
background, the PpspA-lacZ, PsppA-lacZ, and PyvlA-lacZ strains had no detectable 
activity, consistent with the assignment of these promoters to the W regulon (10). The 
activity of the PyceC-lacZ fusion was substantially reduced in sigW, but was only 
 93 
 
completely abolished in theMXW background. PyceC is therefore primarily driven by 
W but can be partially activated by M and/orX.  A similar analysis with PdltA 
showed that this promoter is primarily activated by X and weakly activated by M, 
which is in agreement with previous results (9). The PltaSa-lacZ fusion displayed 
diminished activity in the sigM background, but still retained a small level of basal 
activity even in the MXW strain. Thus, ltaSa can be activated by M, but is also 
controlled by other transcriptional factors.   
These induction results were corroborated with β-galactosidase assays on cells 
grown in liquid culture (Figure 3.2). Nisin concentrations ranged from low levels that 
did not affect growth (25 and 125 ng ml
-1
), moderate levels that inhibited growth (250 
and 375 ng ml
-1
), to high levels (500 and 625 ng ml
-1
) that induce cell lysis. The W-
dependent promoters PpspA, PsppA, PyvlA, and PyceH were only upregulated by high nisin 
concentrations with a maximal induction of ~2 fold above their basal activity. PdltA, 
which is primarily activated by X, was significantly upregulated by moderate nisin 
stress and was induced ~3.5 fold by high nisin levels. The M-activated PltaSa had 
significant basal activity and was activated ~1.75 times by nisin. These assays 
demonstrate that the nisin resistance genes are expressed even in the absence of nisin 
stress, and this basal activity is due largely or entirely to the basal activity of ECF 
factors in growing cells (Table 3.1). Addtionally, the promoters regulating these genes 
can by upregulated by nisin stress, but their induction is modest compared to PliaI 
which can be induced over 400 by fold nisin (55). 
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Table 3.1: Detailed summary of the inducing activity of the nisin resisting ECF 
promoters in WT  and ECF backgrounds.a 
 
Strain Stress WT W 
 
Strain Stress WT M W X MW MX WX MWX 
PpspA-
lacZ  
Triton X-100 ++ - 
 PltaSa-
lacZ  
 Triton X-100 ++++ + ++++ ++++ + + ++++ + 
Vancomycin  ++ - 
 
 Vancomycin  ++++ + ++++ ++++ + + ++++ + 
Nisin  + - 
 
 Nisin  ++ + ++ ++ + + ++ + 
PyvlA-
lacZ  
Triton X-100 +++ - 
 PdltA-
lacZ  
 Triton X-100 ++++ ++++ NA + NA - NA NA 
Vancomycin  +++ - 
 
 Vancomycin  ++++ ++++ NA + NA - NA NA 
Nisin  + - 
 
 Nisin  ++ ++ NA + NA - NA NA 
PsppA-
lacZ  
Triton X-100 +++ - 
 PyceC-
lacZ  
 Triton X-100 ++++ +++ + ++++ + ++ + - 
Vancomycin  +++ - 
 
 Vancomycin  ++++ +++ + ++++ + ++ + - 
Nisin  + - 
 
 Nisin  ++ + + ++ + + + - 
 
a.
 The induction ability of PpspA-lacZ, PyvlA-lacZ, PpspA-lacZ, PltaSa-lacZ, PdltA-lacZ, and 
PyceC-lacZ gene fusions in WT and 
ECF
 backgrounds to triton X-100, vancomycin, 
and nisin as measured by disk diffusion assays.  The reported activity of each strain 
represents intensity of the blue halos induced by each stress after overnight incubation: 
++++ (dramatic blue) > +++ (strong blue) > ++ (blue) > + (light blue) > -(white after 3 
days, no induction). A sample image of a disk diffusion assay can be found in Figure 
S3.2.  
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Figure 3.2: Nisin-dependent induction of the ECF promoters regulating nisin 
resistance genes. β-galactosidase activity of the A. PsppA-lacZ (HB13308), B. PyvlA-
lacZ (HB13310), C. PpspA-lacZ (HB13306), D. PyceC-lacZ (HB13298), E. PdltA-lacZ 
(HB12060), and F. PltaSa-lacZ (HB13225) strains grown to mid-log phase and treated 
with varying concentrations of nisin for 1 hour.  This experiment was performed with 
at least three biological replicates. Bars represent mean values with error bars 
indicating standard error. Error bars represent standard error. 
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ECF factors confer nisin resistance by the activation of five operons (dltABCDE, 
sppA, yceCDEFGHI, ltaSa, and yvlABCD). We used genetic epistasis to determine if 
these ECF-regulated operons are sufficient to account for the roles of these three ECF 
factors in nisin resistance. Indeed, the unique contribution of M is mediated largely, if 
not entirely, by ltaSa: Inactivation of sigM in the ltaSa mutant does not further 
increase nisin sensitivity (Figure 3.3A). Similarly, the dlt operon is sufficient to 
account for the unique role of X: Inactivation of sigX in a dlt mutant strain does not 
further increase nisin sensitivity (Figure 3.3B). In contrast, W contributes to nisin 
resistance by activation of several resistance determinants. Among the W-regulated 
loci, pspA had the smallest effect (Figure 3.1B). We therefore focused our attention on 
a triple mutant in the remaining three (largely) W-dependent loci (yvlABCD sppA 
yceH). This mutant is at least as sensitive as a sigW mutant and, importantly, does 
not exhibit an increase in nisin sensitivity upon deletion of sigW (Figure 3.3C).  
Collectively, these results suggest that the nisin sensitivity of the MXW mutant 
strain is due, in large part, to decreased transcription of these five operons encoding a 
total of 18 genes. 
Mechanisms of nisin resistance: Modification of the cell envelope. The dlt operon 
and ltaSa represent two distinct ECF activated nisin resistance mechanisms that affect 
teichoic acids (TAs). TAs are long chains of glycopolymers that can either be 
anchored to the cell membrane (lipoteichoic acid or LTA) or covalently attached to 
peptidoglycan (wall-teichoic acid or WTA) (59).  LTA and WTA are synthesized by 
distinct pathways, but share many of the same functions (85). The cell can modulate  
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Figure 3.3:  Nisin disk diffusion assays to confirm that the identified nisin resistance 
genes account for the entirety of ECF mediated nisin resistance.  Each graph compares 
nisin sensitivity between A. sigM (HB10216), ltaSa (HB13210) and ltaSa sigM 
(HB13215); B. sigX (HB10103), dltA (HB12084) and dltA sigX (HB13337); and 
C. sigW (HB10102), yceH sppA yvlC  (HB13289) and yceH sppA  yvlC 
sigW (HB13290). For all comparisons, no significant difference in nisin sensitivity 
was found when the gene encoding an ECF  factor was deleted from a strain lacking 
the nisin resistance gene(s) activated by that  factor. Error bars represent standard 
error  
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the protective effects of the cell envelope by altering the chemical composition of 
LTA and WTA. To investigate the roles of teichoic acids in nisin resistance, we 
analyzed the effects of deletion mutations affecting LTA synthesis, WTA synthesis, or 
D-alanylation of teichoic acids.  
LTA protects cells against nisin. LTA is synthesized on a glycolipid (Glc2-
diacylglycerol) anchor by transfer of glycerophosphate (GroP) head groups from the 
membrane lipid phosphatidylglycerol. In B. subtilis, the LTA primase, YvgJ, or one of 
three distinct lipoteichoic acid synthases (LtaS, LtaSa, or YqgS) are responsible for  
creating the initial GroP-Glc2-DAG product that is then elongated by one or more 
LTA synthases (88). LtaS is the primary synthase responsible for the bulk of LTA 
synthesis, LtaSa (formerly YfnI) is a M-regulated and stress-induced LTA synthase, 
and YqgS may play a specific role in sporulation (73).  The chemical differences in 
the LTA produced by these three synthases, and the implications for CAMP 
resistance, are not fully understood.  
 Because of their polyanionic nature, LTA and WTA adsorb cations from the 
environment, including cationic antimicrobial peptides (CAMPs) such as nisin. 
Binding of cations to LTA and WTA may inhibit their transit through the cell wall, 
and thereby increase resistance. Indeed, ltaS mutants display an increased sensitivity 
to Mn
2+
 (73). To dissect the contribution of LTA to nisin resistance, we measured the 
nisin susceptibility of strains lacking one, two, or all three of the LTA synthases 
(Figure 3.4A). Deleting ltaS greatly increased nisin susceptibility, consistent with its 
role as the primary LTA synthase. As noted (Figure 3.1B & 3.4A) an ltaSa mutant 
also displays a small but significant increase in nisin susceptibility. Both LtaS and 
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LtaSa contribute to nisin resistance and their effect is additive, as evidenced by the 
increased sensitivity of the ltaS ltaSa double mutant strain. Inactivation of yqgS had no 
effect on nisin susceptibility (Table S2), presumably because it was not active under 
the growth conditions tested. The high level of nisin sensitivity exhibited by the ltaS 
ltaSa double mutant can be complemented fully by ectopic expression of LtaS (Figure 
3.4B). Curiously, induction of LtaSa increased nisin resistance in wild-type cells 
(Figure S3.7A), but failed to complement the ltaS ltaSa mutant strain and actually 
increased sensitivity in this background (Figure 3.4B). The reason for this latter effect 
could be due to the synthesis of LTAs that are so long that they impair the cell. 
 LtaS and LtaSa have been previously shown to produce distinct LTA polymers 
as visualized by immunoblotting: The LTA synthesized by the M-regulated LtaSa is 
substantially longer than that produced by LtaS or YqgS (88). We have confirmed this 
general effect in our background. An ltaS mutant has greatly decreased staining in the 
region corresponding to LTA, and induction of ltaSa leads to an increase in the 
average molecular weight of LTA as visualized by immunoblotting (Figure S3.2). 
Moreover, our results indicate that treatment of wild-type cells, but not the ltaSa 
mutant, with nisin leads to an apparent increase in average LTA chain length. (Figure 
S3.2). These results are reminiscent of a previous study which found that a nisin 
resistant Streptococcus bovis strain produces longer and denser LTAs than the 
corresponding WT strain (51). Collectively, these data are consistent with the notion 
that LTA plays a role in the general defense mechanism of B. subtilis against nisin, 
presumably by limiting access of this cationic antimicrobial to its target in the cell 
membrane.  
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Figure 3.4: LTA synthesis influences nisin resistance. A. Nisin disk diffusion assays 
for WT (168), ltaSa (HB13210), ltaS (HB13255), ltaS ltaSa (HB13258).  
Significant increases in sensitivity are observed upon deletion of ltaSa and ltaS. B. 
Nisin disk diffusion assays for WT (168), ltaS ltaSa (HB13258), ltaS ltaSa 
Pspac(hy)-ltaS (HB13264), ltaS ltaSa Pspac(hy)-ltaSa (HB13261), and ltaS ltaSa 
Pspac(hy)-yqgS (HB13265) strains on media with varying concentrations of IPTG. * 
indicates prior growth in IPTG for one hour before nisin treatment.  All strains 
containing a IPTG induicible LTA synthase exhibited a significant change in zone of 
inhibition due to IPTG treatment with the exception of the 100 mM treatment for 
ltaS ltaSa Pspac(hy)-ltaSa. Error bars represent standard error. 
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WTA protects cells against nisin. Like LTA, WTA is a major constituent of the 
anionic cell envelope, but it is unknown whether WTA also contributes to lantibiotic 
resistance. We note that a strain unable to synthesize WTA (due to a tagO deletion) 
was extremely susceptible to nisin (Table S3). This suggests that, like LTA, WTA 
may contribute to an anionic barrier that impedes the permeation of cations through 
the cell wall to targets in the membrane. WTA may not be a permeability barrier for 
all CAMPs, however. It is also possible that, by facilitating accumulation of CAMPs 
from the medium, WTA and other anionic polymers could sensitize cells to their 
antimicrobial action. Indeed, in S. aureus depletion of WTA has been shown to confer 
resistance to mammalian phospholipase A2 and -defensin 3 (Koprivnjak et al., 2008). 
 As noted above for LTA synthesis, the final steps of WTA synthesis can be 
catalyzed by any of several functionally overlapping enzymes. Specifically, three 
LytR-Cps2A-Psr (LCP) family proteins (TagTUV) were recently identified as 
encoding enzymes that attach the WTA polymer to peptidoglycan (41). Interestingly, 
two of the three B. subtilis genes that encode WTA attaching enzymes are regulated by 
ECF factors: tagT (formerly, ywtF) and tagU (formerly, lytR) are partially regulated 
by M and X, respectively (18) (34). This led to the hypothesis that one mechanism 
by which ECF factors might contribute to nisin resistance is by modulating the extent 
or the nature of the attachment between WTA and peptidoglycan. However, deleting 
these genes did not affect nisin resistance (Table S3). Thus, these enzymes are either 
complemented by TagV, or have only a minor role in mediating resistance to nisin. 
We conclude that WTA itself is an intrinsic resistance determinant for nisin, but the 
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role (if any) of ECF-mediated modulation of WTA synthesis and attachment is not yet 
clear.  
D-alanylation of LTA and WTA contributes to nisin resistance. The dlt operon 
encodes proteins that esterify D-alanine residues to the glycerol backbone of WTA 
and LTA (62). The D-alanyl esters introduce positively charged free amino groups that 
partially compensate for the negative charge of the phosphodiester linkages, thereby 
reducing the net negative charge of the TAs.  
 The contribution of teichoic acid D-alanylation to nisin resistance had been 
recognized in multiple Gram-positive bacteria including B. subtilis (9), Clostridium 
difficile (56), Lactococcus lactis (45), Staphylococcus aureus (63), and Streptococcus 
pneumoniae (44).  Originally, it was proposed that the anionic TAs attracted CAMPs 
and thus sensitized the cells to their action, and the Dlt system reduced this 
electrostatic attraction. The finding that LTA and WTA both serve to decrease, rather 
than increase, nisin sensitivity challenges this interpretation. Recently, an alternative 
model was proposed that suggests that D-alanylation allows LTA to form a more 
compact and less permeable barrier that serves to physically restrict the access of 
CAMPs to the membrane (71). Thus, the key role of the Dlt pathway may be to 
decrease CAMP permeation by altering the structure of TAs, rather than by reducing 
the extent of CAMP binding.  
 We sought to investigate whether the contribution of the Dlt pathway to nisin 
resistance was dependent upon LTA, WTA, or both. DltABCD has only been shown 
to directly attach D-alanine to LTA (83), and one model suggests that a separate 
enzyme, encoded outside the dlt operon, transfers the D-alanyl residues from LTA to 
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WTA (26, 69). A recent study supporting this model has shown that a strain lacking 
LTAs exhibits significantly less D-alanylated WTA in Staphylococcus aureus (68).  If 
this were the case in B. subtilis, the dlt operon would be primarily dependent upon 
LTAs to resist nisin. We noted that a dltA mutation only slightly increased nisin 
sensitivity in an ltaS ltaSa double mutant background that synthesizes little LTA 
(Table S3.4). This agrees with the hypothesis that LTA is needed to efficiently transfer 
D-alanine to WTA, but also indicates that WTA can still be D-alanylated in the 
absence of LTA. 
 
Mechanisms of nisin resistance: W activates multiple resistance pathways. The 
above results indicate that X and M play a major role in defending the cell against 
nisin by activation of an alternative LTA synthase (LtaSa) and by increasing the D-
alanylation of teichoic acids, which collectively serve to decrease permeation of nisin 
through the envelope to the membrane. In contrast, W regulated resistance genes have 
a variety of functions that are linked to membrane homeostasis. These are encoded by 
the sppA, pspA, yvlABCD, and yceCDEFGHI operons.  
The SppA signal peptide peptidase protects against nisin. The W activated nisin 
resistance gene sppA encodes a signal peptide peptidase, SppA. Signal peptide 
peptidases are ubiquitous enzymes present in eukaryotic, bacterial, and archaeal cells 
(42). Their proposed function is to cleave signal peptides left behind in the membrane 
after they have been cleaved by signal peptidases. However, the regulation of sppA by 
the antibiotic-inducible W presents an alternative hypothesis: SppA may serve to bind 
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and possibly cleave peptide antibiotics that insert into the membrane and thereby 
provide protection.  This hypothesis is supported by the fact that lantibiotics and Gram 
positive signal peptides share similar structures (both are small peptides with a 
hydrophobic core and cationic residues (4)) and thus may have similar affinities for 
SppA. Additionally, a recent report has shown that B. subtilis SppA is capable of 
digesting folded proteins other than signal peptides in vivo (58). 
 Other examples of bacterial proteases that degrade antimicrobial peptides have 
been described (66), including the digestion of LL-37 by the metalloprotease 
aureolysin from S. aureus (77) and the cleavage of nisin by the nisin resistance protein 
NSR in some Lactococcus lactis strains (82). Moreover, an SppA homolog is encoded 
within the enterocin A gene cluster in Enterococcus faecium (60), suggesting a 
possible role in immunity.  
In addition to SppA, B. subtilis contains two other signal peptide peptidase 
homologs, TepA, and YqeZ (6, 31). To determine whether these SppA paralogs also 
influence nisin resistance, the nisin susceptibility of single, double, and triple mutants 
lacking sppA, tepA, and/or yqeZ was analyzed with disk diffusion assays. Deleting 
tepA and/or yqeZ had no effect on nisin susceptibility, even in an sppA mutant 
background (Table S3.5). Since only sppA deletion increased sensitivity to nisin, we 
conclude that SppA is the only signal peptide peptidase in B. subtilis that contributes 
to nisin resistance. 
PspA, YvlC, and LiaH are phage shock proteins that confer nisin resistance. Two 
additional W-regulated resistance genes encode homologs of the phage shock protein 
(Psp) system originally described in Gram negative bacteria (36) (39). In E. coli, the 
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key phage shock proteins are PspA, PspB, PspC, and PspF (15).  The Psp response is 
inactive under non-stressed conditions due to PspA binding and inhibiting the 
transcriptional activator PspF. When activated by membrane stress, PspB and/or PspC 
sequester PspA to the inner membrane (90) leaving PspF free to activate the 
expression of all phage shock proteins (36). Membrane disruption is ameliorated by 
accumulated PspA at the cell membrane, but other phage shock proteins contribute to 
membrane stress resistance as well (39).  
 B. subtilis encodes two PspA homologs, PspA and LiaH, and one PspC 
homolog, YvlC.  Both PspA and YvlC are expressed from W-dependent promoters, 
whereas LiaH is activated by the antibiotic-sensing LiaRS TCS (55). LiaR activates 
transcription of an autoregulatory promoter driving expression of the liaIHGFSR 
operon. However, we find that nisin resistance only requires liaH (Figure S3.7). 
Purified LiaH has been previously shown to form oligomeric rings similar to those 
formed by active E. coli PspA (87). In addition, both PspA and LiaH have been 
implicated in resistance to daptomycin  (27) (Figure S3.6), which, like nisin, damages 
cells by depolarizing the membrane. These observations suggest that the Psp 
homologs of B. subtilis may function similarly to their E. coli orthologs: YvlC may 
function to recruit PspA and LiaH to the membrane where they prevent or repair 
membrane damage.    
 Here, we show that all three B. subtilis Psp proteins contribute to nisin 
resistance. We first showed that within the yvlABCD operon, yvlC is necessary and 
sufficient for nisin resistance (Fig S3 & supplemental text). We then analyzed mutants 
lacking pspA, liaIH, and/or yvlABCD with nisin disk diffusion assays (Figure 3.5). The  
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Figure 3.5: Nisin resistance among psp deletion strains. Nisin disk diffusion assays 
for WT (168), liaH (HB13245), pspA (HB13243), yvlABCD (HB13242), liaIH 
pspA (HB13247), liaIH yvlABCD (HB13246), pspA yvlABCD (HB13244), and 
liaIH pspA yvlABCD (HB13248) strains.  The liaIH strain has a higher zone of 
inhibiton than the WT strain, the liaH pspA strain has a higher zone of inhibition 
than the liaH or pspA strains, and the triple mutant has a higher zone of inhibition 
than the liaH yvlABCD or pspA yvlABCD strains. These differences are modest 
yet statistically significant. Error bars represent standard error. 
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pspA liaIH double mutant was significantly more sensitive than either of the single 
gene deletions. Deleting pspA or liaIH from a yvlABCD background did not 
significantly increase sensitivity, but the triple mutant (pspA liaIH yvlABCD) was 
significantly more sensitive than the yvlABCD null strain. Thus, pspA, yvlC, and liaH 
all independently contribute to nisin resistance, but the PspA homologs may partially 
complement each other. These findings are consistent with a previous report that liaIH 
contributes to nisin resistance (28). 
Our genetic studies indicate the the PspA and PspC pathways are at least 
partially independent and contribute additively to nisin resistance. This is consistent 
with reports that E. coli PspA is capable of repairing proton leakage of damaged 
membranes independent of PspC (43), and that PspC can function independently of 
PspA in Yersinia enterocolitica (32). Previous studies have also identified roles for the 
Psp system in nisin resistance in Gram positive bacteria. Mutations in Listeria 
monocytogenes leading to increased expression of a yvlC homolog (lmo2485) or a liaS 
homolog (lmo1021) decreased nisin sensitivity, while interrupting the operon 
containing the yvlC homolog or the liaS homolog increased sensitivity (22). In 
addition, Psp proteins are activated by Lipid II interacting antibiotics in Lactococcus 
lactis (52) and Streptococcus pneumonia (19), and by membrane perturbing agents in 
Streptomyces lividans (84). Although the functions of Psp proteins may be broadly 
conserved, the regulatory pathways that activate expression in response to cell 
envelope stress appear quite diverse involving, depending on the bacterium, one or 
more two-component systems, ECF  factor(s), or RpoN-dependent regulation.  
The YceGHI proteins contribute to nisin resistance.  Of all the ECF-activated nisin 
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resistance loci identified in this paper, a yceH::pMUTIN insertion mutation had the 
single largest effect (Figure 3.1B). Since yceH is the penultimate gene in the 
yceCDEFGHI operon, we first set out to determine which gene(s) from this operon 
were important for nisin resistance. Expression of yceH from an IPTG inducible 
promoter was able to restore nisin resistance to a yceH strain, but not to a 
yceCDEFGHI strain, indicating that an additional component within this operon is 
necessary for yceH-mediated nisin resistance (Figure S3.4A). Our studies to date 
indicate that YceGHI are likely sufficient for wild-type levels of nisin resistance 
(Figure S3.4 & accompanying text).  
 The roles of the YceGHI proteins are not entirely clear. YceI, also known as 
NiaP, is a nicotinate transporter (70) (38), YceH is classified as a tellurite resistance 
protein (TelA) homolog  (2), and YceG is largely uncharacterized. YceH shares 
significant homology with Listeria monocytogenes  TelA, which also contributes to 
innate nisin and gallidermin resistance (13).  The B. subtilis genome encodes a second 
TelA homolog, YaaN, which is also activated by a ECF-dependent promoter (2). 
However, deleting yaaN from either WT cells or a yceH mutant background did not 
affect nisin sensitivity (Table S6). A recent study of TelA domain architecture 
concluded that TelA proteins likely function as part of a membrane associated sensory 
complex (2). Additionally, TelA homologs likely interact with YceG because the 
genes encoding these proteins often co-occur. 
Finally, we looked at the nicotinate transporter YceI. Nicotinate is primarily 
used by B. subtilis as a substrate for NAD synthesis. One hypothesis is that YceG 
and/or YceH are NAD-dependent enzymes and YceI increases the amount of NAD 
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available to these proteins. This would explain why yceI contributes to, but is not 
essential for, this nisin resistance mechanism.  To test this hypothesis, we performed a 
nisin disk diffusion assay on WT and yceCDEFGHI cells grown on minimal media 
supplemented with or without 4 µM nicotinate (Figure S3.5).  The addition of 
nicotinate resulted in a small increase in nisin resistance in the WT cells, but had no 
effect on the yceCDEFGHI or yceI strain, suggesting that the yceI-dependent 
import of nicotinate into the cell benefits this nisin resistance mechanism. 
Mechanistic inferences from analysis of a nisin hinge region mutant. To better 
understand the origins of nisin resistance, we assessed the susceptibility of gene 
knockout strains to the N20PM21P nisin variant hinge-region variant (N20PM21P-
nisin). This variant can still bind lipid II and inhibit cell wall synthesis, but no longer 
forms membrane pores (21).   
 Disk diffusion assays using (N20PM21P)-nisin, purified as described (25, 76), 
revealed that ltaSa, dltA, and yceH still functioned as resistance determinants (Figure 
3.6A). This is consistent with the roles of LtaSa and the Dlt pathway in reducing the 
permeation of nisin through the cell envelope. In contrast, comparison of wild-type 
and singly mutant strains failed to show any role for pspA, yvlABCD, liaH, or sppA in 
resistance against the (N20PM21P)-nisin. This supports the notion that the Psp 
proteins (PspA, YvlC, and LiaH) and SppA only defend against the membrane-
perturbing and pore forming activities of nisin.  
Mechanistic inferences from comparison of nisin and other antibiotics.  Nisin, 
gallidermin and mersacidin are all lipid II-binding lantibiotics that inhibit cell wall 
synthesis. As noted above, nisin binds lipid II and this complex nucleates pore 
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formation and membrane permeabilization. Gallidermin binds lipid II and inserts its 
N-terminal region into the membrane, possibly leading to some membrane 
perturbation, but the N-terminal tail does not readily form pores (86). Mersacidin 
binds lipid II but does not integrate into the membrane.  
 In support of the mechanistic inferences described above, susceptibility to 
gallidermin and mersacidin was only increased in the ltaSa, dltA, and yceH knockout 
strains, which mimic the results seen with the non-pore forming N20PM21P nisin 
variant (Figure 3.6B, 3.6C). Conversely, the pspA, yvlC, and liaH genes do not 
provide resistance against those compounds (N20PM21P nisin, mersacidin, and 
gallidermin) which cannot form pores in the membrane (Figure 3.6). However, the 
sppA strain was more sensitive to gallidermin, even though it was not more sensitive 
to mersacidin or (N20PM21P)-nisin.  Since the major difference between gallidermin 
and mersacidin/(N20PM21P)-nisin is that gallidermin can insert into the membrane, it 
is likely that SppA only resists lantibiotics that integrate into the membrane. SppA 
may be targeting gallidermin directly (perhaps by degradation) once it enters the 
membrane where the active site of the SppA protease resides (58).   
To determine if the effects of these nisin resistance genes were specific for 
lantibiotics, we also tested the sensitivity of various mutant strains to other antibiotics 
including polymyxin B, vancomycin, bacitracin, triton X-100, daptomycin, D-
cycloserine, novobiocin, and ampicillin.  These stresses were chosen since, in each 
case, an increased susceptibility was noted in the MXW triple mutant (53).  
Daptomycin, polymyxin B, novobiocin, and triton X-100 disrupt different aspects of 
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Figure 3.6: Comparison of A. WT- and N20PM21P-Nisin, B. mersacidin, and C. 
gallidermin sensitivity for the WT (168), pspA (HB13243), yvlABCD (HB13242), 
liaH (HB13245), sppA (HB13251), ltaSa (HB13210), dltA (HB12084), and 
yceH (HB13281) strains. The ltaSa, dltA, and yceH strains exhibit significantly 
larger zones of inhibition than WT cells to these stresses.  Additionally, sppA 
exhibits significantly increased sensitivity to gallidermin.  
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the cell membrane, while vancomycin, ampicillin, D-cycloserine, and bacitracin 
inhibit various steps of cell wall synthesis.  Like nisin, vancomycin binds to lipid II.  
However, these nisin resistance gene knockout strains were not more sensitive to the 
stresses tested, with the exception of slight increases in sensitivity to daptomycin for 
the pspA mutant, to novobiocin for yceH, and to polymyxin B and novobiocin for dltA 
(Figure S3.6). Thus, the resistance mechanisms described here seemed to have 
evolved to help resist the actions of bacteriocins such as nisin and related lantibiotics. 
Creating a nisin resistant B. subtilis strain. Our identification of ECF-activated 
genes that contribute to nisin resistance provided us with an opportunity to engineer a 
nisin resistant B. subtilis strain. Such a strain could be useful in developing a cost-
effective method of producing nisin or other lantibiotics for industrial, clinical, or 
research purposes (28). Previous efforts to create such a strain relied on the 
introduction of nisin immunity genes from Lactococcus lactis or overexpression of a 
single resistance determinant, liaIH (28, 80).   
To artificially increase nisin resistance, we fused each resistance gene or 
operon to the IPTG inducible promoter Pspac(hy) and assessed nisin sensitivity for 
these strains with and without 1 mM IPTG using disk diffusion assays (Figure S3.7A). 
Induction slightly increased nisin resistance in the Pspac(hy)-yvlC, Pspac(hy)-liaH, and 
Pspac(hy)-ltaSa strains, but did not affect sensitivity in the Pspac(hy)-pspA and Pspac(hy)-
dltABCDE strains. In contrast with our hypothesis, induction increased nisin 
sensitivity in the Pspac(hy)-sppA and Pspac(hy)-yceGHI strains. These results highlight 
the fact that high level overexpression of resistance determinants (as obtained with the 
strong Pspac promoter) is not necessarily beneficial compared to the normal expression 
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level and, in some cases, can be detrimental.   
Based these results, we decided to create a B. subtilis strain that could 
moderately upregulate all ECF -dependent nisin resistance genes.  We first deleted 
the genes encoding the anti- factors to W and X, rsiW and rsiX respectively, 
thereby creating a strain in which W and X constitutively upregulate their target 
genes (including pspA, yvlC, sppA, yceGHI, and dltABCD).  To increase expression of 
LtaSa, we included a Pspac(hy)-ltaSa fusion in the rsiW rsiX strain. A disk diffusion 
assay confirmed that this Pspac(hy)-ltaSa rsiW rsiX strain was significantly more nisin-
resistant than WT cells on MH media, and this resistance was increased by the 
addition of 1 mM IPTG (Figure S3.7B).   
To quantify the increase in nisin resistance achieved by these mutations, we 
determined the minimal inhibitory concentration (MIC) of this strain with a broth 
dilution assay. The MIC of the Pspac(hy)-ltaSa rsiW rsiX  to nisin in MH media + 1 
mM IPTG was 1.3x higher than wildtype (4.16 ± 0.21 µg ml
-1
 vs. 3.25 ± 0.11 µg ml
-1
).  
This modest increase may be limited by the use of very low density cultures in the 
MIC assay (OD600 = 0.002). As an alternative, we determined the concentration of 
nisin required to kill 50% of cells at OD600 = 0.4 (50% inhibition concentration). In 
this assay, we observed a ~3.8 fold increase for the Pspac(hy)-ltaSa rsiW rsiX  over the 
WT strain in MH media + 1 mM IPTG (1.72 ± 0.16 µg ml
-1
 vs. 0.45 ± 0.02 µg ml
-1
). 
Nisin resistance genes defend against competing microbes. Since the nisin 
resistance genes identified in this study presumably evolved through interspecies 
competition, we reasoned that they might also play a role in protection against 
lantibiotics, peptide antibiotics, and other antimicrobial compounds made by other 
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Bacillus spp. We therefore analyzed the sensitivity of strains lacking one or more nisin 
resistance genes to other Bacilli using spot on lawn assays in which an antibiotic 
producing strain is spotted at high density on lawns of B. subtilis. We tested six 
Bacillus strains known to produce compounds to which B. subtilis ECF factors confer 
resistance (8) (49) (75) (Table 3.2, Figure 3.7 and Figure S3.8A). In general, the lawns 
lacking individual nisin resistance genes showed little differences in sensitivity to the 
Bacilli tested, but progressively deleting these potential resistance genes led to 
increased sensitivity. For example, the dltA ltaSa double mutant was more sensitive to 
B. atrophaeus ESM, and B. atrophaeus NRS-213 than either single mutant.  In 
addition, while the pspA, yvlABCD, yceH, liaIH and sppA strains displayed little to no 
sensitivity to B. subtilis ssp. spizizenii W23 and B. subtilis ssp. spizizenii ATCC 6633, 
sensitivity was evident in double mutant strains (pspA yvlABCD, sppA yvlABCD, and 
sppA yceH), and even more apparent in triple mutant strains (sppA yceH yvlABCD and 
pspA yvlABCD liaIH). A quadruple mutant (dltA ltaSa yceH yvlABCD) exhibited still 
higher sensitivity to B. atrophaeus ESM and B. amyloliquefaciens (Table 3.2). Thus, 
we conclude that each of these nisin resistance loci protects B. subtilis W168 from at 
least one of these Bacillus species, and therefore likely contributes to fitness in the 
complex microbial community of the soil. 
Many of the antimicrobial compounds produced by Bacillus species have been 
identified (1). We can therefore make inferences regarding the likely active compound 
in these intermicrobial competition studies. For example, B. subtilis subsp. spizizenii 
ATCC 6633 and 2A9 generated the largest growth inhibition phenotypes in B. subtilis 
 116 
 
Table 3.2: The contribution of liaIH, pspA, yvlABCD, sppA, ltaSa, dltA, and yceH  to 
resistance against other Bacilli
a
  
 
 
liaIH pspA yvlABCD sppA ltaSa dltA yceH 
B. licheniformis ATCC 14580  - - - - - - - 
B. atrophaeus NRS-213  - - - - + +++ - 
B. atrophaeus ESM rplV str  + + + + ++ +++ + 
B. amyloliquefaciens FZB42 - - + - + + + 
B. spizizenii W23 + ++ +++ +++ + + ++ 
B. spizizenii ATCC 6633 +++ ++ +++ +++ + + +++ 
 
a
. The contribution of each gene or operon to resistance against a specific strain is 
determined by the increase in zone of inhibition and spot size of the competing 
microbe due to gene deletion in the B. subtilis lawn strain: Representative images of 
all spot on lawn assays can be found in Figure S6.  
- : Gene deletion has no visible effect on the spot.  
+: Gene deletion increases spot size, but not the zone of inhibition.  The effect is only 
visible in strains lacking multiple nisin resistance genes.  
++: Gene deletion increases spot size and zone of inhibition, but the effect is visible 
only in strains lacking multiple nisin resistance genes. 
+++: Gene deletion increases spot size and zone of inhibition in a WT background.  
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Figure 3.7: Spot on lawn assays depicting the sensitivity of the WT (168), liaIH 
pspA yvlABCD (HB13248) sppA yceH yvlABCD (HB13289), and yceH dltA 
ltaSa yvlABCD (HB13335)  lawn strains to spots of B. licheniformis ATCC 14580, 
B. atrophaeus NRS-213, B. atrophaeus ESM, B. amyloliquefaciens FZB42, B. subtilis 
ssp. spizizenii W23, and B. subtilis ssp. spizizenii ATCC 6633. The relative sensitivity 
of the lawn strains to each spotted strain is reflected by the size of the spot and the 
zone of inhibition surrounding it after 18 h growth at 37 
o
C. A larger spot size and 
zone of inhibition represents increased sensitivity of the lawn strains to the metabolites 
produced by the spotted strains. Pictures are representative of at least three assays 
performed with three independent clones of each strain.  
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strains lacking nisin resistance genes. Although these B. subtilis subsp. spizizenii 
strains are closely related to B. subtilis W168, one key difference is that their genomes 
contain a subtilin biosynthesis gene cluster (91). Subtilin is a type A lantibiotic with a 
size, structure, and mechanism of action that is similar to nisin (61).  Indeed, the 
antimicrobial activity of unpurified supernatant from a ATCC 6633 culture is 
considered to derive primarily from subtilin when assayed against other B. subtilis 
strains (79). Since all of the B. subtilis W168 nisin resistance genes protect the cell 
from B. subtilis subsp. spizizenii, it is likely that these genes are specifically providing 
protection against subtilin.   
B. amyloliquefaciens FZB42 synthesizes numerous lipopeptides and 
polyketides, the dipeptide antibiotic bacilysin, and a recently discovered cationic 
thiazole/oxazole-modified microcin called plantazolicin (12). We compared the 
sensitivity of wild-type B. subtilis and the quadruple mutant (dltA ltaSa yceH 
yvlABCD) to various B. amyloliquefaciens mutants, including an spf null strain that 
only produces bacilysin and plantazolicin (Figure S3.8B). Since B. subtilis is immune 
to bacilysin, these nisin resistance genes are probably defending against plantazolicin. 
This conclusion is supported by the fact that a B. subtilis sigW mutant is known to be 
more sensitive to plantazolicin than a WT strain (75).  
Collectively, these results demonstrate that although the resistance loci 
described here were defined with respect to their ability to confer resistance to nisin (a 
natural product of Lactococcus spp.), their role in the environment is broadly related to 
protection against lantibiotics and other antimicrobial peptides made by common co-
habitating soil microorganisms including other Bacillus spp. Indeed, our results, and 
 119 
 
those of others (86), indicate that nisin itself is a weak inducer of the ECF stress 
responses and these same resistance genes are induced more strongly by other 
compounds including the lantibiotics mersacidin and gallidermin. 
 
3.5 Conclusion 
We have here explored ECF  factor-mediated resistance mechanisms that protect 
against the model lantibiotic nisin. Intrinsic nisin resistance is primarily mediated by 
the pspA, yvlC, sppA, dltABCD, ltaSa, and yceGHI genes (Table 3.3). The W-
regulated pspA and yvlC genes encode phage shock protein homologs postulated to 
enhance membrane stability and thereby provide resistance specifically against the 
membrane-perturbing and pore forming activity of nisin. This resistance mechanism 
overlaps with that provided by a second PspA homolog, LiaH, which is activated by 
the lantibiotic inducible LiaRS TCS. The W-regulated signal peptide peptidase 
(SppA) may function by degrading those lantibiotics that integrate into the membrane. 
The mechanism by which YceG and its co-expressed proteins protects against nisin is 
unclear, but a homolog (TelA) functions in nisin resistance in L. monocytogenes  (13). 
X activates expression of the dlt operon, encoding proteins that attach D-alanine 
residues to teichoic acids, while the M-activated ltaSA encodes an alternative 
lipoteichoic acid synthase. Activation of these genes alters teichoic acids in the cell 
envelope and is postulated to reduce permeation of nisin through the envelope to 
access its binding partner in the membrane, lipid II. Collectively, these operons play a 
role in the intermicrobial competition amongst closely related Bacillus strains, and 
their regulation further highlights the role of ECF  factors in antimicrobial resistance.  
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Table 3.3: Summary of the B. subtilis nisin resistance genes identified in this paper  
 
Gene or 
operon 
Regulationa Function 
Resistance 
Contributionb 
Resistance 
Targetc 
Hypothesized Resistance 
Mechanism 
yceGHI  W(MX) 
YceG - Unknown  
+++ 
Inhibits 
nisin-lipid II 
binding 
Unknown, but nicotinate 
dependent 
YceH - Tellurium resistance 
homolog 
YceI - Nicotinate transporter 
dltABCD  X(M) 
D-alanylation of teichoic 
acids 
+++ 
Increases net charge of 
TAs 
ltaSa  M Lipoteichoic acid synthase ++ 
Increases length and 
quantity of LTAs 
sppA  
W 
Signal peptide peptidase ++ 
Resists 
nisin's pore 
forming 
activity 
Nisin degradation 
yvlC  
Phage shock protein C 
homolog 
++ 
Enhances membrane 
integrity 
pspA  Phage shock protein A + 
liaH  LiaRS 
Phage shock protein A 
homolog 
+ 
 
a.
 Identifies which ECF  factor(s) or TCS activate each nisin resistance gene based on 
disk diffusion and β-galactosidase assays in Table 3.1, Fig 2, and Figure S2. 
b.
 Indicates degree to which nisin sensitiviy increases upon deletion of the gene or 
operon based on the disk diffusion assays in Figure 1. 
c.
 Infers whether the nisin resistance genes contribute to resistance against nisin’s pore 
forming activity or its lipid II binding activity based on sensitivity assays in Figure 6.   
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3.7 Supplementary information 
Table S3.1: ECF  activated genes that don’t influence nisin resistance.a  
 
Strain Zone of Inhibition (mm) 
  WT 2.6 ± 0.1 
  ydbST  2.8 ± 0.3 
  yjoB  2.8 ± 0.1 
  yknWXYZ  2.8 ± 0.3 
  yfhLM  3.1 ± 0.5 
  ythPQ  2.9 ± 0.5 
  yuaFGI  2.9 ± 0.2 
  pssA  2.7 ± 0.1 
  xpaCyaaN  2.7 ± 0.1 
 
a.
 Data from nisin disk diffusion assays for WT (CU1065), ydbST (HB6196), yjoB 
(HB6158), yknWXYZ (HB6127), yfhLM (HB6123), ythPQ (HB6132), yuaFGI 
(HB6156), pssA (HB), tagU (HB10193), and tagT (HB13357) strains. The zone 
of inhibition was not significantly different from WT cells for all mutant strains tested. 
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Table S3.2: The alternative LTA synthase gene yqgS does not contribute to nisin 
resistance.
a 
 
 
Mutations 
Zone of Inhibition (mm) 
WT yqgS 
  WT 2.4 ± 0.1 2.3 ± 0.1 
  ltaSA  3.7 ± 0.1 3.7 ± 0.1 
  ltaS  7.2 ± 0.1 7.2 ± 0.2 
  ltaS ltaSA  8.0 ± 0.1 8.0 ± 0.1 
 
a.
 Nisin disk diffusion assays for WT (168), yqgs  (HB13256), ltaSa (HB13210), 
yqgs  ltaSa (HB13257), ltaS (HB13255), ltaS yqgs (HB13259) ltaS ltaSa 
(HB13258), and ltaS ltaSa yqgS (HB13260).  Significant increases in sensitivity 
are observed upon deletion of ltaSa and ltaS, but not upon deletion of yqgS. 
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Table S3.3: WTA synthesis genes and nisin resistance.
a 
 
 
Strain Zone of Inhibition (mm) 
  WT 2.8 ± 0.1 
  tagT  2.6 ± 0.2 
  tagU  2.8 ± 0.3 
  tagT tagU  2.6 ± 0.1 
  tagO  25.8 ± 2.3 
 
a.
 Data from nisin disk diffusion assays for WT (168), tagT (HB13357), tagU 
(HB10193), tagT tagU (HB13425), and tagO (HB13386) strains.  The tagO 
strain is significantly more sensitive to nisin than WT cells, but the tagU, tagT, and 
tagT tagU strains are not. 
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Table S3.4: dltA does not require LTA synthesis genes to confer nisin resistance.
a  
 
Mutations 
Zone of Inhibition (mm) 
WT dltA 
  WT 2.7 ± 0.1 5.0 ± 0.1 
  ltaSA  3.9 ± 0.1 5.6 ± 0.1 
  ltaS  6.4 ± 0.1 7.2 ± 0.1 
  ltaS ltaSA  7.3 ± 0.1 8.0 ± 0.1 
 
a.
 Data from nisin disk diffusion assays for WT (168), ltaSa (HB13210), dltA 
(HB12084), ltaSa dltA (HB13216), ltaS (HB13255), ltaS dltA (HB13317), 
ltaS ltaSa (HB13258), and ltaS ltaSa dltA (HB13318) .  Deleting dltA from 
strains lacking ltaS and/or ltaSa significantly increases nisin sensitivity. 
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Table S3.5: The SppA homologs TepA and YqeZ don’t contribute to nisin resistance.a  
 
Mutations 
Zone of Inhibition (mm) 
WT sppA 
  WT 3.1 ± 0.1 3.9 ± 0.1 
  tepA  3.2 ± 0.1 3.9 ± 0.1 
  yqeZ  3.0 ± 0.1 3.7 ± 0.2 
  tepA yqeZ  3.1 ± 0.1 3.9 ± 0.1 
 
a.
 Data from nisin disk diffusion assays for WT (168), sppA (HB13251), tepA 
(HB13313), yqeZyqfAB (HB13566 ), sppA tepA (HB13314), sppA yqeZyqfAB 
(HB13312), tepA yqeZyqfAB (HB13315), and sppA tepA yqeZyqfAB 
(HB13316) strains.  Among the strains, the deletion of sppA caused the zone of 
inhibition to significantly increase, but the deletion of tepA and yqeZ had no 
significant effect on nisin zone of inhibition. 
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Table S3.6: The YceH homolog YaaN does not contribute to nisin resistance.
a  
 
Mutations 
Zone of Inhibition (mm) 
WT yceH 
  WT 2.6 ± 0.1 5.6 ± 0.1 
  xpaCyaaN  2.7 ± 0.1 5.6 ± 0.2 
 
a.
 Data from nisin disk diffusion assays for WT (168), yaaN (HB13280), yceH 
(HB13281), and yaaN yceH (HB13282) strains.  Among the strains tested, the 
deletion of yaaN did not significantly change nisin sensitivity. 
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Table S3.7: Bacterial strains, plasmids, and oligos used in Chapter 3.
a
 
Strain Genotype or description Source, reference, or construction 
      
        E. coli strains 
DE3 BL21 (DE3) Lab Stock 
HE13085 DE3 pRSFDuet-1-His6nisAB DE3 --> pRSFDuet-1nisAB 
HE13086 DE3 pRSFDuet-1-nisAB-N20PM21P 
DE3 --> pRSFDuet-1nisAB-
N20PM21P 
HE13090 DE3 pRSFDuet-1-His6nisAB pACYCDuet-1-NisC  HE13085 --> pACYCDuet-1nisC 
HE13091 DE3 pRSFDuet-1-nisAB-N20PM21P pACYCDuet-1-NisC  HE13086 --> pACYCDuet-1nisC 
           B. subtilis strains 
168 trpC2 Lab Stock 
BSU2007 
168 sigM sigY sigZ sigV ylaC sigX sigW 
(7ECF) (3) 
CU1065 trpC2 attsp Lab Stock 
HB0010 CU1065 risW::kan (11) 
HB0031 CU1065 sigM::kan (11) 
HB0047 CU1065 rsiX::spec  (48) 
HB0077 ZB307A SPβ[PpspA-cat-lacZ] (neo, MLS) (10) 
HB0100 CU1065 yceCDEF::spc (8) 
HB0101 CU1065 yceH-pMUTIN (MLS) M. Cao, unpublished 
HB0348 CU1065 sppA::cat (8) 
HB0919 CU1065 pspA::cat (8) 
HB0935 CU1065 liaIH::tet (54) 
HB5131 CU1065 sigM::kan sigW::MLS sigX::spec liaIH::tet (27) 
HB5361 CU1065 pssA::spec (9) 
HB6123 CU1065 yfhLM::kan (8) 
HB6127 CU1065 yknWXYZ::kan (8) 
HB6132 CU1065 ythPQ::kan (8) 
HB6153  CU1065 yvlABCD::kan (8) 
HB6156 CU1065 yuaFGI::kan (8) 
HB6158 CU1065 yjoB::kan (8) 
HB6168 CU1065 xpaCyaaN::kan (8) 
HB6196 CU1065 ydbST::kan (8) 
HB6208 168 sigW::spec (8) 
HB7007 CU1065 sigX::spec (33) 
HB8013 ZB307A SPβ[PsppA-cat-lacZ] (neo, MLS) (10) 
HB8060 ZB307A SPβ[PyvlA-cat-lacZ] (neo, MLS) (10) 
HB10016  168 sigM::tet (49) 
HB10102 168 sigW::MLS (49) 
HB10103 168 sigX::kan (49) 
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HB10107 168 sigM::tet, sigX::kan sigW::mls  (49) 
HB10193 168 lytR::mls (48) 
HB10216 168 sigM::kan (49) 
HB10352  168 yybT::MLS (48) 
HB12060 168 SPβ[PdltA-cat-lacZ] (neo, MLS) V. Guariglia-Oropeza unpublished 
HB12084 168 dltA::MLS V. Guariglia-Oropeza unpublished 
HB12088  168 sigX::spec HB7007 chrDNA --> 168 
HB13108 168 rsiW::kan HB0010 chrDNA --> 168 
HB13159 168 yuaFGI::kan (46) 
HB13185  168 sigM::kan HB0031 chrDNA --> 168 
HB13210 168 yfnI::spec LFH-PCR --> 168 
HB13215 168 sigM::kan yfnI::spec HB13210 chrDNA --> HB13185 
HB13216 168 yfnI::spec dltA::MLS HB12084 chrDNA --> HB13211   
HB13217 168 sigM::kan sigX::spec HB12088 chrDNA --> HB13185 
HB13218 168 sigW::MLS sigM::kan HB0031 chrDNA --> HB10102 
HB13218 168 sigW::MLS sigM::kan HB0031 chrDNA --> HB10102 
HB13219 168 sigW::MLS sigX::spec HB13088 chrDNA --> HB10102 
HB13219 168 sigW::MLS sigX::spec HB12088 chrDNA --> HB10102  
HB13222 168 amyE::yfnI (cat) pTK075 --> 168 
HB13223 168 yfnI::spec amyE::yfnI (cat) HB13222 chrDNA --> HB13210 
HB13225 168 amyE::PyfnI-lacZ (cat) pTK077 --> 168 
HB13241 168 amyE::PyfnI(hy)-lacZ (cat) sigM::kan HB0031 chrDNA --> HB13225  
HB13242 168 yvlABCD::kan HB6153 chrDNA --> 168 
HB13243 168 pspA::cat HB0919 chrDNA --> 168  
HB13244 168 yvlABCD::kan pspA::cat HB0919 chrDNA --> HB13242  
HB13245 168 liaIH::tet HB0935 chrDNA --> 168 
HB13246 168 yvlABCD::kan liaIH::tet HB0935 chrDNA --> HB13242 
HB13247 168 pspA::cat liaIH::tet HB0935 chrDNA --> HB13243 
HB13248 168 yvlABCD::kan pspA::cat liaIH::tet HB0935 chrDNA --> HB13244 
HB13249 168 amyE::Pspac(hy)-yfnI (cat) pTK078 --> 168 
HB13250 168 yfnI::spec amyE::Pspac(hy)-yfnI HB13249 chrDNA --> HB13210 
HB13251 168 sppA::cat HB0348 chrDNA --> 168  
HB13253 168 yvlABCD::kan sppA::cat HB0348 chrDNA --> HB13242 
HB13255 168 ltaS::MLS LFH-PCR --> 168 
HB13256 168 yqgS::cat LFH-PCR --> 168 
HB13257 168 yfnI::spec yqgS::cat HB13256 chrDNA --> HB13210 
HB13258 168 yfnI::spec ltaS::MLS HB13255 chrDNA --> HB13210 
HB13259 168 yqgS::cat ltaS::MLS HB13255 chrDNA --> HB13256 
HB13260 168 yfnI::spec yqgS::cat ltaS::MLS HB13255 chrDNA --> HB13259 
HB13261 168 yfnI::spec ltaS::MLS amyE::Pspac(hy)-yfnI (cat) HB13249 chrDNA --> HB13258 
HB13262 168 amyE::Pspac(hy)-ltaS (cat) pTK079 --> 168 
HB13263 168 amyE::Pspac(hy)-yqgS (cat) pTK080 --> 168 
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HB13264 168 yfnI::spec ltaS::MLS amyE::Pspac(hy)-ltaS (cat) HB13262 chrDNA --> HB13258 
HB13265 168 yfnI::spec ltaS::MLS amyE::Pspac(hy)-yqgS (cat) HB13263 chrDNA --> HB13258 
HB13266 168 yvlBCD::kan LFH-PCR --> 168 
HB13267 168 yvlCD::kan LFH-PCR --> 168 
HB13268 168 yvlD::kan LFH-PCR --> 168 
HB13269 168 amyE::Pspac(hy)-yvlC (cat) pTK081 --> 168 
HB13270 168 yvlABCD::kan amyE::Pspac(hy)-yvlC (cat) HB13266 chrDNA --> HB13243 
HB13274 168 dltA::cat ECE76 --> HB12084 
HB13280 168 xpaCyaaN::kan HB6168 chrDNA --> 168 
HB13281 168 yceH-pMUTIN (MLS) HB0101 chrDNA --> 168 
HB13282 168 xpaCyaaN::kan yceH-pMUTIN (MLS) HB0101 chrDNA --> HB13280 
HB13283 168 yybT::cat ECE76 --> HB10352 
HB13284 168 yybT::cat ltaS::MLS HB13255 chrDNA --> HB13283 
HB13285 168 yceH-pMUTIN (MLS) dltA::cat HB13274 chrDNA --> HB13281 
HB13286 168 yceH-pMUTIN (MLS) yfnI::spec HB13210 chrDNA --> HB13281 
HB13287 168 yceH-pMUTIN (MLS) dltA::cat yfnI::spec  HB13274 chrDNA --> HB132815 
HB13288 168 yceH-pMUTIN (MLS) sigW::spec HB6208 chrDNA --> HB13281 
HB13289 168 sppA::cat yvlABCD::kan yceH-pMUTIN (MLS) HB0101 chrDNA --> HB13253 
HB13290 
168 sppA::cat yvlABCD::kan sigW::spec yceH-pMUTIN 
(MLS) HB0101 chrDNA --> HB13278 
HB13291 168 ltaS::MLS yfnI::spec yybT::cat  HB13283 chrDNA --> HB13258 
HB13292 168 sigX::kan 168 amyE::PyfnI-lacZ (cat) HB13255 chrDNA --> HB12088 
HB13293 168 sigW::MLS 168 amyE::PyfnI-lacZ (cat) HB13255 chrDNA --> HB12087 
HB13294 168 sigM::kan  168 amyE::PyfnI-lacZ (cat) HB13255 chrDNA --> HB13218 
HB13295 168 sigM::kan sigX::spec 168 amyE::PyfnI-lacZ (cat) HB13255 chrDNA --> HB13217 
HB13296 168 sigW::MLS sigX::spec 168 amyE::PyfnI-lacZ (cat) HB13255 chrDNA --> HB13219 
HB13297 
168 sigM::tet sigW::MLS sigX::kan 168 amyE::PyfnI-lacZ 
(cat) HB13255 chrDNA --> HB12090 
HB13298 168 amyE::PyceC-lacZ (cat) pTK082 --> 168 
HB13299 168 sigM::kan amyE::PyceC-lacZ (cat) HB13298 chrDNA --> HB13185 
HB13300 168 sigX::kan amyE::PyceC-lacZ (cat) HB13298 chrDNA --> HB12088 
HB13301 168 sigW::MLS amyE::PyceC-lacZ (cat) HB13298 chrDNA --> HB12087 
HB13302 168 sigM::kan sigW::MLS amyE::PyceC-lacZ (cat) HB13298 chrDNA --> HB13218 
HB13303 168 sigM::kan sigx::spec amyE::PyceC-lacZ (cat) HB13298 chrDNA --> HB13217 
HB13304 168 sigW::MLS sigX::spec 168 amyE::PyceC-lacZ (cat) HB13298 chrDNA --> HB13219 
HB13305 
168 sigM::tet sigW::MLS sigX::kan 168 amyE::PyceC-lacZ 
(cat) HB13298 chrDNA --> HB12090 
HB13306 168 SPβ[PpspA-cat-lacZ] (neo, MLS) HB0077 spβ--> 168 
HB13307 168 sigW::spec SPβ[PpspA-cat-lacZ] (neo, MLS) HB0077 spβ --> HB13206 
HB13308 168 SPβ[PsppA-cat-lacZ] (neo, MLS) HB8013 spβ --> 168 
HB13309 168 sigW::spec SPβ[PsppA-cat-lacZ] (neo, MLS) HB8013 spβ --> HB13206 
HB13310 168 SPβ[PyvlA-cat-lacZ] (neo, MLS) HB8060 spβ --> 168 
HB13311 168 sigW::spec SPβ[PyvlA-cat-lacZ] (neo, MLS) HB8060 spβ --> HB13206 
HB13312 168 yqeZyqfAB::kan sppA::cat HB0348 chrDNA --> HB13231 
 131 
 
HB13313 168 tepA::MLS LFH-PCR --> 168 
HB13314 168 sppA::cat tepA::MLS HB13314 chrDNA --> HB13251 
HB13315 168 yqeZyqfAB::kan tepA::MLS HB13314 chrDNA --> HB13231 
HB13316 168 yqeZyqfAB::kan sppA::cat tepA::MLS HB13314 chrDNA --> HB13312 
HB13317 168 dltA::cat ltaS::MLS HB13255 chrDNA --> HB13274 
HB13318 168 ltaS::MLS yfnI::spec dltA::cat HB13274 chrDNA --> HB13258 
HB13322 168 amyE::Pspac(hy)-yceH(cat) pTK084 --> 168 
HB13323 168 yceCDEFGHI::MLS LFH-PCR --> 168 
HB13324 168 yceH-pPL82 yceC-I::MLS HB13323 chrDNA --> HB13322 
HB13325 168 yceH-pMUTIN (MLS) yceH-pPL82 HB13322 chrDNA --> HB13281 
HB13326 168 amyE::Pspac(hy)-dltABCDE (cat) pTK090 -->168 
HB13327 168  amyE::Pspac(hy)-liaH (cat) pTK091 -->168 
HB13328 168 amyE::Pspac(hy)-pspA (cat) pTK092 -->169 
HB13329 168 amyE::Pspac(hy)-sppA (cat) pTK093 -->169 
HB13330 168 amyE::Pspac(hy)-yceG (cat) pTK094 -->170 
HB13331 168 amyE::Pspac(hy)-yceI (cat) pTK095 -->170 
HB13332 168 amyE::Pspac(hy)-yceGH (cat) pTK096 -->171 
HB13333 168 amyE::Pspac(hy)-yceHI (cat) pTK097 -->171 
HB13334 168 amyE::Pspac(hy)-yceGHI (cat) pTK098 -->172 
HB13335 
168 yceH-pMUTIN (MLS) dltA::cat yfnI::spec 
yvlABCD::kan HB13242 chrDNA --> HB13287 
HB13337 168 dltA::MLS sigX::spec HB12088 chrDNA --> HB12084 
HB13338 168 amyE::Pspac(hy)-yceG (cat) yceCDEFGHI::MLS HB13323 chrDNA -->HB13330 
HB13339 168 amyE::Pspac(hy)-yceGH (cat) yceCDEFGHI::MLS HB13323 chrDNA -->HB13331 
HB13340 168 amyE::Pspac(hy)-yceHI (cat) yceCDEFGHI::MLS HB13323 chrDNA -->HB13332 
HB13341 168 amyE::Pspac(hy)-yceI (cat) yceCDEFGHI::MLS HB13323 chrDNA -->HB13333 
HB13342 168 SPβ[PdltA-cat-lacZ] (neo, MLS) sigX::spec HB12088 chrDNA --> HB12060  
HB13343 168 SPβ[PdltA-cat-lacZ] (neo, MLS) sigM::tet HB10016 chrDNA --> HB12060 
HB13344 168 SPβ[PdltA-cat-lacZ] (neo, MLS) sigX::spec sigM::tet HB10016 chrDNA --> HB13342 
HB13347 168 amyE::Pspac(hy)-yceGHI (cat) yceCDEFGHI::MLS HB13323 chrDNA -->HB13334 
HB13352 168 yceH-pMUTIN (MLS) sppA::cat HB0348 chrDNA --> HB13281 
HB13357 168 tagT::cat LFH-PCR --> 168 
HB13384 168 yceCDEFG::MLS LFH-PCR --> 168 
HB13385 168 yceI::MLS LFH-PCR --> 168 
HB13386 168 TagO::kan LFH-PCR --> 168 
HB13392 168 rsiX::spec HB0047 chrDNA --> 168 
HB13393 168 rsiW::kan rsiX::spec HB0047 chrDNA --> HB13108 
HB13394 168 rsiW::kan amyE::Pspac(hy)-yfnI (cat) HB13249 chrDNA --> HB13108 
HB13395 168 rsiW::kan amyE::Pspac(hy)-yfnI (cat) rsiX::spec  HB0047 chrDNA --> HB13394 
HB13425 168 tagU::MLS tagT::cat HB13357 chrDNA --> HB10193  
HB13566  168 yqeZyqfAB::kan (46) 
ZB307A  trpC2 SPβc2∆2::Tn917::pSK10∆6  Lab Stock 
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Other Bacillus Strains BGSC # 
B. subtilis ssp. spizizenii NRRL B-23049T 2A8T 
B. subtilis ssp. spizizenii W23 (NRRL B-14472) 2A9 
B. subtilis ssp. spizizenii  ATCC 6633 (NRRL B-765) 2A13 
B. licheniformis ATCC 14580  5A36T 
B. amyloliquefaciens FZB42 NA 
B. atrophaeus NRS-213  11A2T 
B. atrophaeus ESM rplV str  12A1 
B. amyloliquefacien bmyA::MLS AK1 
B. amyloliquefaciens fen::cat AK2 
B. amyloliquefaciens pks2KS1::cat pks3KS1::MLS CH12 
B. amyloliquefaciens sfp::MLS CH3 
 
Plasmids Genotype or description Source 
pdg1661 Vector for integration of lacZ fusions at amyE  (24) 
pdg1662 Vector for integration at amyE locus (24) 
pPL82 
Vector for IPTG-inducible control of gene expression with 
integration at the amyE locus 
(67) 
ECE76 
Vector for integration of a cat  resistance cassette into a MLS 
resistance cassette 
(81) 
pTK075 pDG1662-yfnI (cat) This work 
pTK077 pDG1661-PyfnI (cat) This work 
pTK078 pPL82-yfnI (cat) This work 
pTK079 pPL82-ltaS (cat) This work 
pTK080 pPL82-yqgS (cat) This work 
pTK081 pPL82-yvlC (cat) This work 
pTK082 pDG1661-PyceC (cat) This work 
pTK090 pPL82-dltABCDE (cat) This work 
pTK091 pPL82-liaH (cat) This work 
pTK092 pPL82-pspA (cat) This work 
pTK093 pPL82-sppA (cat) This work 
pTK094 pPL82-yceG (cat) This work 
pTK095 pPL82-yceI (cat) This work 
pTK096 pPL82-yceGH (cat) This work 
pTK097 pPL82-yceHI (cat) This work 
pTK098 pPL82-yceGHI (cat) This work 
pRSFDuet-1nisAB Vector for IPTG-inducible control of nisAB (76) 
pRSFDuet-1nisAB-
N20PM21P 
Vector for IPTG-inducible control of nisAB with mutations in 
nisA to produce N20PM21P nisin 
(25) 
pACYCDuet-1nisC Vector for IPTG-inducible control of nisC (76) 
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Oligos Name Sequence 
5535 yfnI up-fwd GATGAGCTTGAGCGGTTTGA 
5536 yfnI up-rev (spec) CGTTACGTTATTAGCGAGCCAGTCTTCATTCATATTTACCTGCTCTT 
5537 yfnI do-fwd (spec) CAATAAACCCTTGCCCTCGCTACGAAGACTTGCTGAGGTTCCATA 
5538 yfnI do-rev  CCATGCCATCCTCAACTGT 
5559 yfnI up EcoRI AGTCGAATTCGTATGTACGCTAAGGATGTCT 
5560 yfnI do BamHI AGTCGGATCCCCGCAGAGAATGACCGCTT 
5670 ltaS up-fwd AATAGTCGTTCCATCCCATCA 
5671 ltaS up-rev (MLS) GAGGGTTGCCAGAGTTAAAGGATCGACGACCGCAATTAAGAAGAA 
5672 ltaS do-fwd (MLS) CGATTATGTCTTTTGCGCAGTCGGCCCTTCTGATTATGATTACACAA 
5673 ltaS do-rev TTAATTCCGCTTGGCCTTCA 
5674 yqgS up-fwd CGGCAGGAGTGGTTTATGAA 
5675 yqgS up-rev (cat) CTTGATAATAAGGGTAACTATTGCCATCAGTCTATTCCCAACATTCT 
5676 yqgS do-fwd (cat) GGGTAACTAGCCTCGCCGGTCCACGGATCAGGCATCATAATCACAA 
5677 yqgS do-rev GTGCTGTCGGTTTTCGGTAT 
5678 yfnI up XmaI TCAGCCCGGGCAGGTAAATATGAATGAAGAACT 
5679 yfnI do XbaI AGTCTCTAGAGTAATGATATGAGAGAAAGCCA 
5687 yvlB up-fwd GCTGCTTACTTACACTCATTA 
5688 yvlB up-rev (kan) CTATCACCTCAAATGGTTCGCTGCTTGCTTCATTACGATCTCCT 
5689 yvlCD up-fwd GACACGCATTTCTTCAGCAT 
5690 yvlC up-rev (kan) CTATCACCTCAAATGGTTCGCTGCTTATTCATTCGATCACCTCT 
5691 yvlD up-rev (kan) CCTATCACCTCAAATGGTTCGCTGACTAAAATGCTGACTGCCCA 
5696 ltaS up XmaI TCAGCCCGGGCGCTCGAACTGGATCGGAA 
5697 ltaS do XbaI  AGTCTCTAGATGAGGAATTGAGGGCTGCT 
5698 yqgS up XmaI  TCAGCCCGGGTGAGCGTGCTGCATAGGAG 
5699 yqgS do XbaI  AGTCTCTAGATCACCGTAATAAACGCCATCA 
5700 yvlC up XmaI TCAGCCCGGGATCAAACTAAAGTACTCACAGA 
5701 yvlC do XbaI  AGTCTCTAGAGCTGCTGATATGGATGGAGT 
5792 PyceC up EcoRI AGTCGAATTCACCGAATGCTGGAGAGTTGT 
5793 PyceC do BamHI AGTCGGATCCCTCACAAGGAAAATAAGCCGTA 
5816 tepA up-fwd  GAATGGCAAACAAAGCTCACA 
5817 tepA up-rev (MLS)  GAGGGTTGCCAGAGTTAAAGGATCGGACGCTCTTCTTCTGTGTT 
5818 tepA do-fwd (MLS)  CGATTATGTCTTTTGCGCAGTCGGCGATGAAGCAAGGAAAGAAGAA 
5819 tepA do-rev  TTCTTGCAGCGAGCGTCCT 
5871 yceC up-fwd  ACCAAGACCGAGCACCCAT 
5872 yceC up-rev (MLS) GAGGGTTGCCAGAGTTAAAGGATCAGCCGAGACCGACCATCAA 
5873 yceI do-fwd (MLS)  CGATTATGTCTTTTGCGCAGTCGGCCTTTGCTCGTCGGAACCCT 
5874 yceI do-rev  TCGGTCATTCTGCTTGCCTA 
5875 yceH up XmaI  TCAGCCCGGGATGGTGTTTCAGCAGGACTA 
5876 yceH do XbaI  AGTCTCTAGATATAGGCTGTTGTTTTCCCATT 
5893 sppA up XmaI TCAGCCCGGGTGAATCGTATAATGAGAGAGTT 
5894 sppA do XbaI  AGTCTCTAGACAGGAAAGCCCAGAAACGAA 
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5895 pspA up XmaI  TCAGCCCGGGGTTACCGAATTAGCTTTAGGA 
5896 pspA do XbaI  AGTCTCTAGAATTACCGTTCCCTCTCACATT 
5897 liaH up XmaI TCAGCCCGGGTTTGATGACGAATGGGAAGAAT 
5898 liaH do XbaI  AGTCTCTAGAGGTTTCATCCTTCTCATTCATT 
5899 yceG up XmaI  TCAGCCCGGGCAAGGAGGGAGGTTCAATGT 
5900 yceG do XbaI  AGTCTCTAGACGCTTCACTTCTGGTTCCT 
5901 yceI up XmaI  TCAGCCCGGGTGTGTAAAGACAGGTGTAAACT 
5902 yceI do XbaI  AGTCTCTAGAAGCATAGGAGCGGACATTCA 
5903 dltA up XmaI  TCAGCCCGGGAAACCCGCTGTCAAGTGGA 
5904 dltE do XbaI  AGTCTCTAGATGGTCAATCTCCCTGCTGTT 
5932 tagT up-fwd  CAAGAGCAATGACGGCACA 
5933 tagT up-rev (cat) CTTGATAATAAGGGTAACTATTGCCCGGCAACAACTTTCACCCAT 
5934 tagT do-fwd (cat)  GGGTAACTAGCCTCGCCGGTCCACGCTGCCGGAGTCTATTATTTCA 
5935 tagT do-rev TTCAGTTCTTCCTTCGCTTGT 
5952 yceI up-fwd AGATGAGATGACGAAGACGAA 
5953 yceI up-rev (MLS)  GAGGGTTGCCAGAGTTAAAGGATCACGCTGGGATATAGGCTGTT 
5954 yceG do-fwd (MLS)  CGATTATGTCTTTTGCGCAGTCGGCTCAGCAGGACTACAAAGAGC 
5955 yceG do-rev  GACGGATTTGAGGTGCGGT 
 
a
 Abbreviations used:  --> indicates transformation;  chrDNA indicates chromosomal DNA   
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Figure S3.1: Sample image of the PyceC-lacZ gene fusion being induced by triton X-
100 (triton), vancomycin (van), and nisin in WT and ECF backgrounds.  + and – 
symbols represent the blue intensity and hence, promoter activity as indicated in Table 
3.1.  
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Figure S3.2: Nisin influences LTAs in B. subtilis in a ltaSa-dependent manner. A. 
Detection of lipoteichoic acid by Western blot with anti-LTA antibodies in the WT 
(168), ltaSa (HB13210), and LTA (ltaS ltaSa yqgS - HB13260) strains with 
and without nisin treatment (0.5 g ml-1). This experiment was repeated three times 
with independent biological replicates and the image shown is representative of typical 
results.   The staining between 10-18 Kda, which is not present in the LTA strain, 
represents teichoic acid. B & C. The relative intensities of LTA staining (B) and the 
average LTA length (C) as measured in apparent kDa (based on protein 
standards; note that this does not correspond to actual LTA mass) for the strains 
analyzed in panel A as determined by densitometry analysis.  D. Detection of 
lipoteichoic acid by Western blot with anti-LTA antibodies in the Pspac(hy)-ltaSa 
(HB13249) and ltaS ltaSa Pspac(hy)-ltaSa (HB13261) strains with and without 1 
mM IPTG treatment.  
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Figure S3.3: Within the yvlABCD operon, the yvlC gene is sufficient to confer nisin 
resistance.  A. Nisin disk diffusion assays for WT (168), yvlD (HB13268), yvlCD 
(HB13267), yvlBCD (HB13266), and yvlABCD (HB13242) strains. The WT and 
yvlD strains exhibit significantly lower zones of inhibition than the yvlCD 
(HB13267), yvlBCD (HB13266), and yvlABCD strains.  B. Nisin disk diffusion 
assays for WT (168), yvlABCD (HB13242), Pspac(hy)-yvlC (HB13269), and 
yvlABCD Pspac(hy)-yvlC (HB13270) strains on MH media with and without 1 mM 
IPTG.  The zones of inhibition for the yvlABCD Pspac(hy)-yvlC strain with and 
without IPTG are significantly different from each other.   
 
To determine which gene(s) within the yvlABCD operon contribute to nisin resistance, 
we assessed the nisin sensitivity of strains lacking one or more genes (Panel A). Nisin 
sensitivity was increased in those strains lacking yvlC, and expression of yvlC from an 
IPTG-inducible promoter was sufficient to complement a yvlABCD deletion strain 
(Panel B). We conclude that yvlC is necessary and sufficient for nisin resistance.  
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Figure S3.4:  yceGHI contributes to intrinsic nisin resistance A. Within the 
yceCDEFGHI operon, a gene other than yceH contrbutes to nisin resistance.  Nisin 
disk diffusion assays of WT (168), yceH (HB13281), yceCDEFGHI (HB13323), 
yceH Pspac(hy)-yceH (HB13325), and yceCDEFGHI Pspac(hy)-yceH (HB13324) 
strains  treated with and without 1 mM IPTG.  The IPTG treatment restores nisin 
susceptibility to WT levels only in the yceH Pspac(hy)-yceH strain.  B. YceG is 
necessary to this nisin resistance mechanism while YceI contributes to it. Nisin disk 
diffusion assays of WT (168), yceCDEF (HB0100), yceCDEFG (HB13384), 
yceCDEFGHI (HB13323), and yceI (HB13385), strains.  The yceCDEF strain is 
not more susceptible to nisin than the WT strain while the yceCDEFG strain is more 
susceptible. The yceI strain is significantly more susceptible than the WT strain, but 
is significantly less susceptible than the yceCDEFGHI strain. C. Nisin disk diffusion 
assays for WT (168), Pspac(hy)-yceG (HB13330), Pspac(hy)-yceH (HB13322), Pspac(hy)-
yceI (HB13331), Pspac(hy)-yceGH (HB13332), Pspac(hy)-yceHI (HB13333), and 
Pspac(hy)-yceGHI (HB13334) strains with and without 1 mM IPTG.  IPTG treatment 
significantly increased sensitivity in all the strains containing an IPTG induicible copy 
of yceG and reduced sensitivity in the Pspac(hy)-yceHI strain. D. yceGHI are all 
essential to this nisin resistance mechanism.  Nisin disk diffusion assays of WT (168), 
yceCDEFGHI (HB13323), yceCDEFGHI Pspac(hy)-yceG (HB13338), 
yceCDEFGHI Pspac(hy)-yceH (HB13324), yceCDEFGHI Pspac(hy)-yceI 
(HB13341), yceCDEFGHI Pspac(hy)-yceGH (HB13339), yceCDEFGHI Pspac(hy)-
yceHI (HB13340), and yceCDEFGHI Pspac(hy)-yceGHI (HB13347) strains  treated 
with and without 100 uM IPTG.  Among all strains and treatments tested, only the 
yceCDEFGHI Pspac(hy)-yceGHI  strain treated with 100 uM IPTG exhibited no 
significant difference in nisin sensitivity compared to WT cells.  
 
Figure S4 describes our analysis to determine which genes within the yceCDEFGHI 
operon contribute to nisin resistance. Since we originally detected a nisin sensitive 
phenotype for a yceH::pMUTIN insertion strain, we could assume that least yceH is 
implicated in resistance. Expression of yceH from an IPTG inducible promoter was 
able to restore nisin sensitivity in a yceH strain, but not in a yceCDEFGHI strain, 
indicating that an additional component within this operon is necessary for yceH-
mediated nisin resistance (Panel A). Deleting yceCDEF did not increase nisin 
sensitivity beyond WT levels, but deleting yceCDEFG  or yceI did increase nisin 
sensitivity which focused our attention on yceGHI (Panel B). We introduced the IPTG 
inducible Pspac(hy)-yceG, -yceH, -yceI, -yceGH, -yceHI, or -yceGHI gene fusions in a 
WT background and assessed these strains for nisin sensitivity (Panel C).  Full 
induction (1 mM IPTG) of yceHI increased nisin resistance, but all of the strains 
containing an IPTG inducible yceG displayed increased nisin sensitivity.  Thus, even 
though YceG is essential to this nisin resistance mechanism, it can be detrimental to 
the cell in excessive amounts.  We therefore tested moderate induction (100 µM 
IPTG) of these gene fusions in a yceCDEFGHI operon deletion strain (Panel D). Only 
the induction of yceGHI restored nisin resistance to wild-type levels suggesting that 
YceG, YceH, and YceI all contribute to nisin resistance.  
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Figure S3.5: yceI-mediated nisin resistance requires nicotinate. Nisin disk diffusion 
assays of WT (168), yceI (HB13385) and yceCDEFGHI (HB13281) strains grown 
on minimal media supplemented with and without 4 µM nicotinate.  Nisin sensitivity 
is significantly reduced by nicotinate treatment in the WT strain, but not in the yceI 
or yceCDEFGHI strains.  
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Figure S3.6: Sensitivity of nisin resistance gene knockout strains to various stresses. 
The WT (168), pspA (HB13243),  yvlABCD (HB13242), sppA (HB13251), ltaSa 
(HB13210), dltA (HB12084), and yceH (HB13281) strains were assessed for 
sensitivity to polymyxin B, vancomycin, bacitracin, triton X-100, daptomycin, D-
cycloserine, novobiocin, and ampicillin.  The only significant differences between a 
WT and mutant strain are observed for dltA::MLS to polymyxin B and novobiocin, for 
pspA to daptomycin, for yceH to novobiocin, and ltaSa to D-cycloserine, but in 
all cases these differences account for less than 10% of total zone of inhibition.  
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Figure S3.7: Creating a nisin resistant B. subtilis strain. A. Nisin disk diffusion assays 
for WT (168), Pspac(hy)-pspA (13328), Pspac(hy)-yvlC (HB13269), Pspac(hy)-liaH 
(13327), Pspac(hy)-sppA (13329), Pspac(hy)-ltaSa (HB13249), Pspac(hy)-yceGHI 
(HB13334), and Pspac(hy)-dltABCDE (HB13326) strains on media with and without 1 
mM IPTG.  Each disk contained 25 µg nisin instead of the usual 20 µg.  In Media 
without IPTG, none of the strains exhibit significant differences in nisin sensitivity.  In 
1 mM IPTG media, nisin sensitivity was significantly lower in Pspac(hy)-yvlC, 
Pspac(hy)-liaH, and Pspac(hy)-ltaSa strains, significantly higher in Pspac(hy)-sppA and 
Pspac(hy)-yceGHI  strains, and showed no significant difference in  Pspac(hy)-pspA and 
Pspac(hy)-dltABCDE strains compared to WT. B. Nisin disk diffusion assays for WT 
(168), rsiW rsiX  (HB13393), and rsiW rsiX Pspac(hy)-ltaSa (HB13394) strains 
on media with and without 1 mM IPTG.  The nisin sensitivity was significantly lower  
in rsiW rsiX compared to WT and in rsiW rsiX Pspac(hy)-ltaSa  + IPTG 
compared to rsiW rsiX.  
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Figure S3.8: A representative set of spot on lawn data for the complete set of mutant 
strains. A. Spot on lawn assays of WT (168), dltA (HB12084), liaH (HB13245), 
pspA (HB13243), sppA (HB13251), yceH (HB13281), ltaSa (HB13210), 
yvlABCD (HB13242), ltaSa dltA (HB13216), sppA yvlABCD (HB13253), 
sppA yceH (HB13352), pspA yvlABCD (HB13244), liaIH pspA yvlABCD 
(HB13248), sppA yceH yvlABCD (HB13289), yceH dltA ltaSa (HB13287), 
and yceH dltA ltaSa yvlABCD (HB13335)  lawn strains to spots of  B. 
licheniformis ATCC 14580,
 
B. atrophaeus NRS-213, B. atrophaeus ESM, B. 
amyloliquefaciens FZB42, and B. subtilis ssp. spizizenii W23, and B. subtilis ssp. 
spizizenii ATCC 6633. B. Spot on lawn assays of WT (168) and yceH dltA ltaSa 
yvlABCD (HB13335)  lawn strains to spots of B. amyloliquefaciens FZB42 (WT), 
bmyA (AK1), fenA (AK2), pks23 (CH12), and sfp (CH3). The relative sensitivity 
of the lawn strains to each spotted strain is reflected by the size of the spot and the 
zone of inhibition surrounding it after 18 h growth at 37 
o
C. A larger spot size and 
zone of inhibition represents increased sensitivity of the lawn strains to the metabolites 
produced by the spotted strains. Pictures are representative of at least three assays 
performed with three independent clones of each strain.  
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CHAPTER 4 
CONCLUSIONS AND PERSPECTIVES 
 
This work identified and characterized several physiologically relevant CESR 
pathways in Bacillus subtilis. These pathways all contribute to, or are indirectly 
related to, ECF  factor-mediated responses to membrane stress which serves as a 
unifying theme that binds this thesis together. 
In Chapter 2, I investigated P5, an internal 
W
-dependent promoter within 
fabHa and upstream of fabF that could influence membrane fluidity. This promoter 
was able to employ an unusual regulatory mechanism whereby its activation could 
simultaneously reduce the expression of the gene it was within while increasing 
downstream gene expression. Although this unique method of regulation was 
intriguing, I chose to study the physiological function of the promoter instead. Since 
this promoter affected the expression of genes involved in fatty acid biosynthesis, I 
hypothesized that it was a membrane stress adaptation and focused my research in that 
direction. My hypothesis proved to be correct, and I was eventually able to show that 
P5 reduces membrane fluidity with fluorescence anisotropy. Our collaborators were 
able to further show that this reduction in membrane fluidity is associated with 
specific changes in membrane composition using FAME and ESI-MS. Previous 
studies in the literature were extremely helpful as they provided sufficient information 
on the functions and characteristics of FabHa and FabF to explain how their regulation 
could affect membrane fluidity (1, 5, 6). I finally showed that P5 contributed to 
resistance against detergents and competing Bacilli to confirm that this membrane 
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stress adaptation was physiologically relevant. 
The goal of Chapter 3 was to uncover all of the ECF  factor mediated 
resistance mechanisms employed by B. subtilis to protect the cell against lantibiotics. 
To accomplish this goal, I used the prototypical lantibiotic nisin which binds lipid II 
and forms pores in the phospholipid bilayer. I discovered that the phage shock 
proteins, which had been thought to only function in Gram negative bacteria, resist 
lantibiotic pore forming activity in the Gram positive B. subtilis (4). I also showed that 
the membrane bound SppA (signal peptide peptidase) protects against lantibiotics that 
integrate into the membrane and proposed a novel hypothesis that SppA is directly 
degrading lantibiotics that it comes in contact with. yceGHI was discussed as well, and 
although I demonstrated that this operon prevents nisin from binding lipid II and may 
encode NAD-dependent enzymes, I was unable to determine a specific resistance 
mechanism. Finally, I characterized the roles of teichoic acids in preventing 
lantibiotics from reaching the cell membrane. This study had a very broad focus and 
included components of the lantibiotic resistome that were not directly related to ECF 
 factors, such as the liaRS TCS and the primary LTA synthase LtaS. It was also 
necessary to acknowledge the fact that lantibiotics inhibit cell wall synthesis by 
binding to lipid II, and some of the resistance mechanisms protect against this type of 
stress as well.  
Several strategies were employed to emphasize the importance of my findings 
in Chapter 3. I used the knowledge obtained from this study to generate a nisin-
resistant B. subtilis strain. Although the resistance of this strain was not particularly 
dramatic, it could potentially be further modified to be used for industrial nisin 
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production. Furthermore, I showed that these nisin resistance mechanisms contributed 
to resistance against other lantibiotics (gallidermin & mersacidin) and to competing 
bacteria commonly found in the soil. The chapter also contains numerous references 
that connect the resistance mechanisms I characterized to those in known pathogens. 
For example, B. subtilis YceH is a homolog of TelA Listeria monocytogenes which 
contributes to innate nisin resistance as well (2).  
Interestingly chapters 2 and 3 represent two distinct strategies for studying 
CESR. Chapter 2 analyzes a single resistance mechanism in extensive detail. It uses a 
wide range of assays, from basic experiments like western blots to specialized 
techniques like fluorescence anisotropy, to fully understand the P5-mediated CESR. 
On the other hand, Chapter 3 looks at a single stress and characterizes all of the 
resistance mechanisms that confer resistance to that stress. Since multiple mechanisms 
are analyzed simultaneously, they individually receive less attention than the P5 
mechanism in Chapter 2. Despite these differences, both chapters make significant 
contributions to the field.  For future studies, I would like to investigate several of the 
lantibiotic resistance mechanisms in more detail.  My hypothesis that SppA inactivates 
lantibiotics through direct interaction is quite intriguing and should be confirmed with 
additional experiments.  In addition, it would be worthwhile to further analyze the 
resistance mechanism associated with YceGHI because so little is known about it.   
Appendices A, B, and C further supplement this thesis by summarizing several 
minor ECF  factor-mediated mechanisms that affect the cell membrane. Appendix A 
confirms that some of the NfeD and SPFH protein homologs in B. subtilis, which have 
previously been shown to contribute to lipid raft formation (3), can influence 
 157 
 
membrane fluidity. Appendix B proposes the hypothesis that the phospholipase YtpA 
resists daptomycin by reducing PG levels and begins to verify this hypothesis with 
some preliminary findings. The evidence presented in Appendix C indicates that 
inhibiting sesquarterpene biosynthesis accumulates a UPP mimic that increases 
bacitracin sensitivity while overproducing this C35 terpene destabilizes membranes. 
Both Appendix B and Appendix C represent the beginnings of a promising future 
project that could uncover multiple novel resistance mechanisms.  In particular, the 
hypothesis that ytpB deletion causes the buildup of an undecaprenyl pyrophosphate 
mimic that interferes with bacitracin resistance mechanisms is quite intriguing and 
should be investigated in more detail. 
Chapter 2, Chapter 3, and the appendices comprise the bulk of my work at 
Cornell University. They have shown that specific genes in the ECF  factor regulons 
confer resistance to membrane stresses through novel resistance mechanisms that 
modify the cell envelope. Overall, these findings have contributed to our knowledge of 
CESR in B. subtilis and may help in the development of membrane targeting 
antibiotics. 
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APPENDIX A 
THE yuaFGI OPERON REDUCES MEMBRANE FLUIDITY WHEN ACTIVATED 
BY W 1 
 
A.1 Summary 
In Bacillus subtilis, a survey of σW-controlled genes for effects on CEF resistance 
identified both the NfeD protein YuaF and the flotillin homologue YuaG (FloT). The 
flotillin has been previously shown to localize to defined lipid microdomains, and we 
show here that the yuaFGI operon contributes to a σW-dependent decrease in 
membrane fluidity. 
1
The results of this experiment were published in Lee YH, Kingston AW, and 
Helmann JD. Molecular Microbiology. 2011 Jul;81(1):69-79. The experiment 
described here was performed by A.W.K. Y.H.L, A.W.K, and J.D.H wrote the 
original manuscript. 
 
A.2 Introduction 
Cefuroxime (CEF) belongs to the group of broad-spectrum β-lactam cephalosporin 
antibiotics which are reviewed in section 1.2.1. The extracytoplasmic function (ECF) 
sigma (σ) factor σW of B. subtilis has been shown to confer resistance against CEF 
(14). Of the ∼60 genes in the σW regulon, we identified the yuaFGI operon as playing 
a pivotal role in CEF resistance (14). This operon encodes both the NfeD protein YuaF 
and the flotillin YuaG (FloT) which are reviewed in section 1.1.1. Here, we show that 
W dependent activation of the yuaFGI operon reduces membrane fluidity in tandem 
with the P5 promoter (Chapter 2). This reduction in membrane fluidity may directly or 
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indirectly increase CEF resistance. 
 
A.3 Materials and methods 
Bacterial strains and growth conditions. The bacterial strains used in this study are 
listed in Table A.1. Cells were routinely cultured in Luria-Bertani (LB) broth at 37°C 
with vigorous shaking or on solid LB medium containing 1.5% Bacto agar (Difco). 
Difco sporulation medium (DSM) agar was used for spore formation and maintenance 
of B. subtilis strains. The following antibiotics were used when appropriate: 
Kanamycin (Kan) (15 μg/ml), chloramphenicol (Cat) (10 μg/ml), or macrolide-
lincosamide-streptogramin B (MLS) (contains 1 μg/ml erythromycin and 25 μg/ml 
lincomycin). 
Fluorescence anisotropy. Fluorescence anisotropy analysis of B. subtilis strains 
treated with 1,6-diphenyl-1,3,5-hexatriene (DPH) was performed as described 
previously (26) with slight modifications. Strains were grown to mid-log phase (OD600 
of 0.4 ± 0.01) in LB supplemented with 2% xylose. A 0.5-mL sample of each culture 
was then washed once and suspended in 2 mL of phosphate buffer (100 mM, pH 7.0) 
containing 5 μM DPH. After a 30-min incubation at room temperature, fluorescence 
anisotropy measurements (λex = 358 nm, slit width = 10 nm; λem = 428 nm, slit width 
= 15 nm) were taken with a Perkin-Elmer LS55 luminescence spectrometer. The 
correction for the fluorescence intensity of nonlabeled cells was calculated as 
described by Kuhry et al. (13). 
 161 
 
Table A.1: Bacterial strains used in Appendix A.
a 
Strain Genotype or description Source or reference
a
 
W168 trpC2  BGSC 1A1 
HB6156 CU1065 yuaFGI::kan  (4) 
HB13159 W168 yuaFGI::kan  HB6156 chr DNA  W168 
HB5331 CU1065 yqeZ-yqfAB::kan  (4) 
HB13566 W168 yqeZ-yqfAB::kan  HB5331 chr DNA  W168 
HB13042 W168 amyE::Pxyl-sigW (cat) (11) 
HB13122 
W168 PfabHAF fabHA(P5*)-fabF 
amyE::Pxyl-sigW (cat) 
(11) 
HB13160 
W168 yuaFGI::kan amyE::Pxyl-
sigW (cat) 
HB6156 chr DNA  HB13042 
HB13226 
W168 PfabHAF fabHA(P5*) fabF 
yuaFGI::kan amyE::Pxyl-
sigW (cat) 
HB6156 chr DNA  HB13122 
HB13236 
W168 yqeZ-yqfAB::kan 
amyE::Pxyl-sigW(cat) 
HB13566 chr DNA  HB13042 
 
a 
Abbreviations used:  indicates transformation; chrDNA indicates chromosomal DNA. 
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Statistical analysis. All experiments were performed with a minimum of three 
biological replicates. Unless otherwise noted, data is presented as mean ± standard 
error. Statistical evaluation of the data was performed
 
by the use of unpaired 
Student's t tests. A value of P < 0.05 was considered statistically significant. 
 
A.3 Results and discussion 
The yuaFGI operon reduces membrane fluidity under σW-inducing conditions. To 
better understand how yuaFGI and yqeZ-yqfAB contribute to intrinsic CEF resistance, 
we investigated the influence of these genes on membrane fluidity. Both of these 
operons encode a NfeD protein (YuaF and YqeZ) and a putative flotillin-like protein, 
(YuaG and YqfA) that are believed to organize the cell membrane into functional 
microdomains (2, 15). In addition, σW overexpression has previously been shown to 
reduce membrane fluidity by altering expression of fatty acid biosynthesis genes (11). 
The σW-dependent activation of a promoter (P5) within the fabHAF operon leads to an 
increase in the proportion of straight-chain fatty acids and an increase in overall chain 
length. Since activation of P5 accounts for some, but not all, of the σ
W
-dependent 
decrease in membrane fluidity (11), we reasoned that upregulation of yuaFGI and/or 
yqeZ-yqfAB might alter membrane fluidity. 
Membrane fluidity was assessed by measuring the fluorescence anisotropy of 
B. subtilis cells labeled with DPH (Figure A.1). Under normal growth conditions, both 
wild-type and yuaFGI knockout cells exhibited similar anisotropy levels. However, 
when sigW was overexpressed with a xylose-inducible promoter (Pxyl-sigW), the  
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Figure 1.A: Inactivation of yuaFGI prevents the decrease in membrane fluidity 
induced by overexpression of σW. Cells were grown in LB medium with xylose (2%) 
to an OD600 of 0.4 and then incubated in phosphate buffer (100 mM, pH 7.0) with 
DPH (5 μM) at 25°C for 30 min. In strains containing the Pxyl-sigW construct, σ
W
 was 
expressed under the control of a xylose-inducible promoter. The membrane fluidity of 
each strain was determined via fluorescence anisotropy measurements. Data are 
presented as the average of at least three trials, and the standard error is indicated by 
error bars. 
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resulting increase in anisotropy was significantly lower in the yuaFGI knockout strain 
than in control cells. Since a higher anisotropy is indicative of a less-fluid membrane, 
these results indicate that expression of the yuaFGI operon reduces membrane fluidity 
when activated by σW. In contrast, deleting yqeZ-yqfAB had no effect on anisotropy 
levels, even under sigW overexpression conditions. The effect of yuaFGI on 
membrane fluidity is comparable to that of the σW-dependent promoter (P5) within the 
fabHAF operon (11). In a σW overexpression strain both lacking yuaFGI and 
containing a mutation (P5*) that abolishes P5 activity (Pxyl-sigW yuaFGI P5*), 
anisotropy levels were the same as in wild-type cells. This demonstrates that both P5 
and yuaFGI function to reduce membrane fluidity and that they are the primary 
components of the σW regulon to do so. 
The effect of yuaFGI on membrane fluidity might explain how this operon 
contributes to CEF resistance. Adjustments in membrane fluidity can influence 
numerous properties of the lipid bilayer, such as permeability, protein mobility, and 
protein-protein interactions (16). However, not all changes in membrane fluidity result 
in CEF resistance, since the P5-inactive strain was not any more susceptible to CEF 
than the wild-type strain (data not shown). YuaG (FloT) has also been linked to the 
formation of lipid domains, which have been shown to regulate sporulation, biofilm 
formation, and other signal transduction pathways (6, 15). 
 
A.4 Conclusion 
 We show that expression of the yuaFGI operon reduces membrane fluidity 
under σW-inducing conditions and that this protein-based mechanism is additive with a 
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previously described lipid-based pathway (11). These findings suggest that YuaFG 
influences CEF resistance by altering the physical properties of the membrane, but the 
origins of this effect are presently unclear. YuaFG are thought to help organize 
membrane microdomains (6, 15), and this could affect the assembly or activity of cell 
wall biosynthetic complexes known to be targeted by CEF. 
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APPENDIX B 
THE M-INDUCED PHOSPHOLIPASE YtpA MAY RESIST DAPTOMYCIN BY 
REDUCING MEMBRANE PHOSPHATIDYLGLYCEROL LEVELS  
 
B.1 Summary 
Preliminary evidence indicates that the phospholipase YtpA resists daptomycin by 
reducing phosphatidylglycerol levels in the cell membrane. 
 
B.2 Introduction 
In B. subtilis, the M-dependent gene ytpA encodes a phospholipase that 
hydrolyzes fatty acids from the two position of phosphatidylglycerol (PG) (27). This 
function suggests that YtpA may play a role in phospholipid turnover and could 
specifically be activated to reduce the PG content of the plasma membrane. 
Daptomycin is a lipopeptide antibiotic (section 1.2.2) that interacts with PG, and 
previous studies have shown that a reduction in PG levels could lead to increased 
daptomycin resistance (8). Here, we show that ytpA makes a minor contribution to 
daptomycin resistance and may be able to reduce PG levels. 
 
B.3 Materials and methods 
Strains, plasmids, and growth conditions. All B. subtilis strains used in this study 
are listed Table B.1. Bacteria were grown in liquid Luria-Bertani (LB) medium at 
37°C with vigorous shaking or on solid LB medium containing 1.5% Bacto agar 
(Difco) with appropriate selection. Plasmids were amplified in Escherichia coli DH5 
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Table B.1: Bacterial strains used in Appendix B.
a
 
Strains Genotype or description Source or reference 
168  trpC2  Lab stock  
CU1065  trpC2 attspβ  Lab Stock  
HB0031  CU1065 sigM::kan  (5) 
HB13129  168 ytpA::MLS  LFH PCR  168  
HB13130  168 amyE::Pxyl-ytpA (cat)  pTK048  168  
HB13185  168 sigM::kan  HB0031 chrDNA  168  
HB13188  168 amyE::ytpA (cat)  pTK074  168  
HB13189  
168 ytpA::MLS 
 amyE::ytpA (cat)  
HB13188 chrDNA  HB13129  
HB13209  168 ytpa::MLS sigM::kan  HB 0031 chrDNA  HB13129  
 
a 
Abbreviations used:  indicates transformation; chrDNA indicates chromosomal 
DNA. 
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before transformation of B. subtilis strains. Ampicillin (amp; 100 g ml-1) was used to 
select E. coli transformants. For B. subtilis, antibiotics used for selection were: 
Kanamycin (kan; 15 g ml-1), chloramphenicol (cat; 10 g ml-1), and macrolide-
lincosoamide-streptogramin B (MLS; contains 1 g ml-1 erythromycin and 25 g ml-1 
lincomycin).  
Genetic techniques. Chromosomal and plasmid DNA transformations were 
performed as described previously (9). Unless otherwise stated, all PCR products were 
generated using W168 chromosomal DNA as a template and all strains were verified 
by sequence analysis (Cornell University Life Sciences Core Laboratories Center).  
Disk diffusion assays. Disk diffusion assays were performed as described (18). 
Briefly, strains were grown to an OD600 of 0.4. A 100 μl aliquot of these cultures was 
mixed with 4 ml of 0.7% LB soft agar (kept at 50°C and supplemented with 50 g/L 
Ca
2+
) and directly poured onto LB plates (containing 15 ml of 1.5% LB agar and 
supplemented with 50 g/L Ca
2+
). The plates were dried for 20 min in a laminar airflow 
hood. Filter paper disks containing 100 μg, daptomycin were placed on the top of the 
agar and the plates were incubated at 37°C overnight. The distances between the edge 
of the inhibition zones and the edge of the filter paper disks were measured.  
Lipid extraction and thin-layer chromatography. Protocol adapted from (23). Ten-
mL aliquots cultures treated with 1 µg/mL daptomycin at OD600 ~0.1 for 1 hour were 
centrifuged for 10 min at 4,500 × g. The cell pellet was resuspended in 100 μL ddH2O 
with the addition of perchloric acid to a final concentration of 1 M. The cell 
suspension was then incubated at 0 °C for 30 min, after which lipids were extracted by 
the addition of 1 mL methanol-chloroform-water (12:6:2 [vol/vol]) followed by 
 169 
 
incubation for 50 min on ice. Phase separation was achieved by the sequential addition 
of 0.3 mL water and 0.3 mL chloroform, after which suspensions were incubated 
overnight at −20°C and then centrifuged for 5 min at 720 × g at 4 °C. The organic 
phase was then removed and dried under nitrogen. The lipids were resuspended in 20 
μL of chloroform-methanol (2:1 [vol/vol]), spotted to silica gel 60 plates (VWR), and 
separated using the solvent mixture chloroform-methanol-water (65:25:4 [vol/vol]). 
Phospholipids were detected using molybdenum blue spray reagent (Sigma-Aldrich). 
PG and PE standards were obtained from Sigma-Aldrich. Densitometry analysis with 
ImageJ was used to compare the relative levels of PE and PG in a cell culture. This 
assay was performed 3 separate times with biological replicates. 
Statistical analysis. All experiments were performed with a minimum of three 
biological replicates. Unless otherwise noted, data is presented as mean ± standard 
error. Statistical evaluation of the data was performed
 
by the use of unpaired 
Student's t tests.
 
A value of P < 0.05 was considered statistically significant. 
 
B.3 Results and discussion 
We became interested in ytpA because it is known to be activated by M (7), and its 
PG hydrolysis activity (27) had the potential to affect the cell membrane. Previous 
studies have shown a connection between decreasing PG levels and increased 
daptomycin resistance (8), so we tested the sensitivity of a ytpA knockout strain to 
daptomycin using a disk diffusion assay (Figure B.1). Deleting ytpA significantly 
increased daptomycin sensitivity, introducing an ectopic copy of this gene into the 
ytpA background restored daptomycin sensitivity to WT levels, and overexpressing 
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Figure B.1: ytpA contributes to daptomycin resistance. Daptomycin disk diffusion 
assays of the WT (168), ytpA::MLS (HBHB13129), ytpA::MLS amyE::ytpA 
(HB13189), Pxyl-ytpA (HB13130), sigM::kan (HB13185), and ytpA::MLS sigM::kan 
(HB13209) strains. When compared to WT, daptomycin sensitivity was significantly 
higher in the ytpA::MLS strain and significantly lower in the Pxyl-ytpA strain. There 
was no significant difference between the ytpA::MLS, sigM::kan, and ytpA::MLS 
sigM::kan strains.  
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ytpA with a xylose inducible promoter increased daptomycin resistance. These results, 
when taken together, confirm that ytpA contributes to daptomycin resistance. We also  
showed that a sigM strain exhibited daptomycin sensitivity comparable to that of the 
ytpA strain, but a double mutant lacking both sigM and ytpA was not more 
sensitive than either single gene deletion strain. Thus, M primarily resists daptomycin 
by activating ytpA expression. 
 To determine whether or not YtpA is capable of significantly altering PG 
levels in the cell membrane, we performed thin layer chromatography analysis on 
lipids extracted from daptomycin treated WT and ytpA cells (Figure B.2). TLC is not 
as quantitative as assays like ESI-MS, but this assay allows for the comparison of 
relative PE and PG levels in a group of cells. Through densitometry analysis, we 
determined that the PG/PE ratio was higher in the ytpA strain, but this difference 
only trended towards significance.  
 
B.4 Conclusion 
Taken together, the results from this study suggest that YtpA resists 
daptomycin by reducing PG content in the membrane under daptomycin stress 
conditions. However, additional assays are required definitively confirm this 
hypothesis.
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Figure B.2: TLC analysis of WT and ytpA membranes. Membrane lipids were 
extracted from exponential cultures of WT or the ytpA (HB13129) mutant grown in 
LB. Daptomycin (1 µg/mL) was added for one hour prior to extraction. Extracted 
lipids were spotted to silica TLC plates and detected with molybdenum blue (Sigma). 
Bands indicating PE and PG were identified by comparison with standards. A. 
Representative image of TLC plate. B. PG/PE ratio of the two strains as determined by 
comparing the relative densities of the two bands with ImageJ.  
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APPENDIX C 
BACITRACIN AND MEMBRANE STRESS RESISTANCE MECHANISMS 
ASSOCIATED WITH ytpB 
 
C.1 Summary 
The M regulated ytpB encodes a tetraprenyl-β-curcumene synthase involved 
in the production of sesquarterpene. Deleting this gene increases bacitracin resistance, 
possibly due to the buildup of an undecaprenyl pyrophosphate mimic. Overexpressing 
ytpB increases detergent sensitivity which could be caused by the over-production of 
an unconventional membrane lipid. 
 
C.2 Introduction 
B. subtilis is known to make long polycyclic carbons that are derived from 
squalene (12). These squalene derivatives have been implicated in sporulation and 
oxidative stress resistance. The compounds (which are also known as sporulenes, 
terpenes, and isoprenoids, among other names) are believed to integrate into the cell 
membrane and affect its organization/fluidity (10). Sesquarterpene is one such C35 
terpene produced by B. subtilis (Figure C.1) (24). We were particularly interested in 
this compound because the tetraprenyl-β-curcumene synthase YtpB required for its 
synthesis is regulated by M (7). Here, I show that deleting the gene encoding this 
enzyme increases bacitracin sensitivity while overexpressing it increases detergent 
sensitivity and propose hypotheses to explain these phenotypes. 
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Figure C.1: Proposed pathway for the biosynthesis of sesquarterpenes in B. subtilis. 
Adapted from (24). 
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C.3 Materials and methods 
Strains, plasmids, and growth conditions. All B. subtilis strains used in this study 
are listed Table C.1. Bacteria were grown in liquid Luria-Bertani (LB) medium at 
37°C with vigorous shaking or on solid LB medium containing 1.5% Bacto agar 
(Difco) with appropriate selection. Plasmids were amplified in Escherichia coli DH5 
before transformation of B. subtilis strains. Ampicillin (amp; 100 g ml-1) was used to 
select E. coli transformants. For B. subtilis, antibiotics used for selection were: 
Chloramphenicol (cat; 10 g ml-1) and macrolide-lincosoamide-streptogramin B 
(MLS; contains 1 g ml-1 erythromycin and 25 g ml-1 lincomycin). 
Genetic techniques. Chromosomal and plasmid DNA transformations were 
performed as described previously (9). Unless otherwise stated, all PCR products were 
generated using W168 chromosomal DNA as a template and all strains were verified 
by sequence analysis (Cornell University Life Sciences Core Laboratories Center). 
Disk diffusion assays. Disk diffusion assays were performed as described (18). 
Briefly, strains were grown to an OD600 of 0.4. A 100 μl aliquot of these cultures was 
mixed with 4 ml of 0.7% LB soft agar (kept at 50°C) and directly poured onto LB 
plates (containing 15 ml of 1.5% LB agar). The plates were dried for 20 min in a 
laminar airflow hood. Filter paper disks containing the chemicals to be tested were 
placed on the top of the agar and the plates were incubated at 37°C overnight. The 
distances between the edge of the inhibition zones and the edge of the filter paper 
disks were measured. The following chemicals and quantities were used in the disk 
diffusion assays: Triton X-100 10 μl of a 25% solution, N-lauryl-sarcosine 10 uL of a  
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Table C.1: Bacterial strains used in Appendix C.
a
 
Strains Genotype or description Source or reference 
168  trpC2  Lab stock  
HB13320 168 amyE::Pspac(hy)-ytpB (cat)  pTK083  168  
HB13321 168 ytpB::MLS  LFH PCR  168  
HB13346 
168 ytpB::MLS amyE::Pspac(hy)-
ytpB (cat) 
HB13321 chrDNA  
HB13320 
 
a 
Abbreviations used:  indicates transformation; chrDNA indicates chromosomal 
DNA. 
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10% solution, sodium dodecyl sulfate 500 μg, colistin 100 μg, clofazimine 1 mg, bile 
salts 1 mg, poly-L-lysine 5 μg, ethylenediaminetetraacetic acid (EDTA) 365 μg, 
polymyxin B 50 μg, vancomycin 50 μg, daptomycin 100 μg, D-cycloserine 500 μg, 
cefuroxime 5 μg, novobiocin 50 μg, nisin 20 μg, bacitracin 200 μg, cerulenin 5 μg, 
moenomycin 5 μg, amitriptyline 200 μg, and dodecyltrimethylammonium bromide 
(DTAB) 100 μg. For Nisin assays, a 2.5 mg ml-1 nisin stock solution was prepared by 
dissolving a 2.5% nisin mixture balanced with sodium chloride and denatured milk 
solids (Sigma-Aldrich Co. St. Louis, MO USA) in 0.02 M HCl. For daptomycin 
assays, the media was supplemented with 1.25 mM CaCl2. 
MIC determination. We analyzed the growth of B. subtilis strains in bacitracin media 
using a variation of the broth dilution assay described previously (17). Briefly, strains 
were grown to an OD600 of 0.4, then diluted 1:200 in MH broth. 200 µl of the diluted 
culture was dispensed in a Bioscreen 100-well microtitre plate. Each strain was grown 
in Bacitrain concentrations ranging from 0 to 300 µg/mL. Growth was measured 
spectrophotometrically (OD600) every 15 min for 48 h using a Bioscreen C incubator 
(Growth Curves USA, Piscataway, NJ) at 37°C with continuous shaking. 
Statistical analysis. All experiments were performed with a minimum of three 
biological replicates. Unless otherwise noted, data is presented as mean ± standard 
error. Statistical evaluation of the data was performed
 
by the use of unpaired 
Student's t tests.
 
A value of P < 0.05 was considered statistically significant. 
 
C.4 Results and discussion 
Sensitivity phenotypes arising from ytpB overexpresion or deletion. ytpB initially 
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attracted our interest as a potential CESR contributor because it is both activated by an 
ECF  factor (7), and it encodes a protein that can influence the composition of the 
cell membrane (24). To determine if ytpB plays a role in the CESR of B. subtilis, we 
analyzed the effect of deleting or overexpressing ytpB on sensitivity to cell envelope 
stresses with disk diffusion assays (Figure C.2). We used a variety of stresses, 
including detergents (triton X-100, bile salts, SDS, amitriptyline, DTAB, N-lauryl-
sarcosine, EDTA, and poly-L-lysine) cell wall synthesis inhibitors (moenomycin, 
vancomycin, D-cycloserine, cefuroxime, and bacitracin), membrane active agents 
(daptomycin, polymyxin B, colistin, and clofazimine), a fatty acid synthesis inhibitor 
(cerulenin), and a DNA gyrase inhibitor (novobiocin). The most notable phenotype 
from this assay was that deleting ytpB resulted in a substantial increase in bacitracin 
zone of inhibition, but had little effect on sensitivity to other stresses. We also found 
that overexpressing ytpB with an IPTG induicible promoter slightly increased 
sensitivity to triton X-100, cefuroxime, cerulenin, poly-L-lysine, DTAB, EDTA, and 
clofazamine. 
Bacitracin induced early-onset cell cell death in ytpB cells may be caused by the 
accumulation of a UPP mimic. The bacitracin sensitivity phenotype of the ytpB 
strain is unusual and needed to be analyzed in more detail. WT cells treated with a 
bacitracin disk exhibit a clear albeit small zone of inhibition surrounding the disk 
representing complete inhibition of growth or cell death (Figure C.3A). In the ytpB 
strain, the zone of death is only slightly bigger than that of WT cells, but a large halo 
of diminished cell density can be observed around the disk as well. The edge of this  
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Figure C.2: Disk diffusion assays displaying the sensitivities of WT (168), ytpB 
(HB13321), and Pspac(hy)-ytpB (HB13320) strains to various stresses. WT was tested 
in media with and without 1 mM IPTG, ytpB was tested in media without IPTG, and 
Pspac(hy)-ytpB was tested in media with 1 mM IPTG. The ytpB strain exhibited a 
large sensitivity phenotype to bacitracin, but was not significantly more sensitive to 
the other stresses tested. Small but significant sensitivity phenotypes were observed 
for the Pspac(hy)-ytpB strain to triton X-100, cefuroxime, cerulenin, poly-L-lysine, 
DTAB, EDTA, and clofazamine. 
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Figure C.3: Analyzing the bacitracin sensitivity phenotype exhibited by the ytpB 
strain. A. Representative image of a bacitracin disk diffusion assay with WT and 
ytpB (HB13321) cells. B. Representative growth curve assay of WT and ytpB 
(HB13321) cells in various concentrations of bacitracin. C. Bacitracin sensitivity of 
the WT, ytpB (HB13321), Pspac(hy)-ytpB (HB13320), and Pspac(hy)-ytpB ytpB 
(HB13346) strains as measured with a disk diffusion assay. Bacitracin sensitivity in 
the ytpB background reverts to wild type upon the introduction of the Pspac(hy)-ytpB 
fusion even in the absence of IPTG induction. 
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halo was recorded as the zone of inhibition, but we were not certain as to what the 
halo represented. We further investigated this phenotype by comparing the growth of 
WT and ytpB cells in bacitracin media over the course of 48 hours (Figure C.3B). 
We used bacitracin concentrations ranging from 50 µg/mL, which had little effect on 
WT cells, to 300 µg/mL, which was able to increase the lag phase of WT cells for over 
20 hours. Bacitracin had only a minor effect on the lag phase of ytpB cells compared 
to WT cells. The major difference in growth between these two strains occurred 
shortly after they entered the stationary phase. Under bacitracin stress the WT strain 
would maintain a fairly constant stationary phase for at least 48 hours, but the ytpB 
strain would exhibit only a brief stationary phase followed by cell death. For all 
bacitracin concentrations tested, the ytpB cell death phase would reduce the OD600 of 
cells by ~50% over the course of ~10 hours. We reasoned that this early-onset death 
phase was responsible for the halo of reduced cell density observed in our disk 
diffusion assays. 
We also wanted to make sure that the bacitracin sensitivity phenotype of the 
ytpB strain was exclusively caused by the lack of YtpB. We introduced an IPTG-
induicible copy of ytpB (Pspac(hy)-ytpB) into a ytpB background and tested the 
sensitivity of this strain to bacitracin (Figure C.3C). The sensitivity of the ytpB 
Pspac(hy)-ytpB double mutant was equivalent to that of the WT strain confirming that 
ytpB is involved in this resistance mechanism. Furthermore, this strain maintained WT 
levels of bacitracin resistance in the absence of IPTG indicating that even the low 
levels of YtpB produced by the uninduced Pspac(hy) promoter are sufficient to resist 
bacitracin. 
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A careful analysis of the literature has revealed several clues that may explain 
why the ytpB strain is bacitracin sensitive. Bacitracin inhibits cell wall synthesis by 
binding to undecaprenyl pyrophosphate (UPP) (25). As explained in section 1.1.2, 
UPP is recycled to undecaprenyl phosphate (UP) which translocates peptidoglycan 
subunits across cytoplasmic membrane and is converted back to UPP (19). Two major 
bacitracin resistance mechanisms have already been discovered in B. subtilis. The 
bacitracin-induced BceRS TCS activates the expression of the ABC transporter 
BceAB which confers substantial bacitracin resistance, potentially by transporting 
UPP to the cytoplasm (20). In addition, the M dependent gene bcrC encodes an 
alternative UPP phosphatase that can compete with bacitracin for UPP (3). The major 
connection that links bacitracin resistance and these two resistance mechanisms to 
YtpB is that the substrate for YtpB, C35-PP, is a UPP mimic (24). We hypothesized 
that the C35-PP accumulates in the absence of YtpB. Such accumulation may inhibit 
the flipping of UPP across the membrane by BceAB or the ability of BcrC to 
dephosphorylate UPP.  
ytpB overexpression may negatively affect the cell membrane via sesquarterpene 
overproduction. Compared to the ytpB strain’s bacitracin sensitivity phenotype, our 
explanation for why ytpB overexpression slightly increased sensitivity to triton X-100, 
cefuroxime, cerulenin, poly-L-lysine, DTAB, EDTA, and clofazamine is relatively 
straightforward. The key connection between these stresses is that they all target the 
membrane in one way or another. Triton X-100, poly-L-lysine, and DTAB are 
detergents (1.2.2), cerulenin inhibits FA synthesis enzymes (22), clofazamine 
increases phospholipase A2 activity (1), and EDTA destabilizes membranes (21). 
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Since YtpB contributes to the synthesis of sesquarterpenes that integrate into the 
membrane, it is possible that the overproduction of this unusual membrane lipid 
reduces overall membrane integrity rendering the cell more susceptible to these 
membrane stresses. 
 
C.5 Conclusion 
The data from this study have led to the formation of two hypotheses that explain the 
sensitivity phenotypes observed in the ytpB deletion and overexpression strains.  We 
believe that a strain lacking ytpB exhibits early-onset cell death in the presence of 
bacitracin because of the accumulation of a UPP mimic that interferes with known 
bacitracin resistance mechanisms.  Future studies could begin to confirm this 
mechanism by showing that the ytpB strain exhibits altered expression levels of the 
known bacitracin resistance genes.   The membrane stress sensitivity of the ytpB-
overexpression strain could be attributed to excessive sesquarterpene levels interfering 
with membrane stability. 
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